mhtx_10k.htm

0001477932-22-002079.txt : 20220406 0001477932-22-002079.hdr.sgml : 20220406 20220405180216 ACCESSION NUMBER: 0001477932-22-002079 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 55 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220406 DATE AS OF CHANGE: 20220405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MANHATTAN SCIENTIFICS INC CENTRAL INDEX KEY: 0001099132 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] IRS NUMBER: 850460639 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-28411 FILM NUMBER: 22808557 BUSINESS ADDRESS: STREET 1: 244 FIFTH AVENUE STREET 2: SUITE 2341 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-726-2107 MAIL ADDRESS: STREET 1: 244 FIFTH AVENUE STREET 2: SUITE 2341 CITY: NEW YORK STATE: NY ZIP: 10001 10-K 1 mhtx_10k.htm FORM 10-K mhtx_10k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

☒	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2021

☐	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _______.

MANHATTAN SCIENTIFICS, INC.

(Name of small business issuer in its charter)

Delaware		000-28411		85-0460639
(State of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

244 Fifth Avenue, Suite 2341, New York, New York 10001

(Address of principal executive offices) (Zip code)

Issuer’s telephone number: (212) 541-2405

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, $0.001 par value

(Title of Class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the issuer as of June 30, 2021 was $13,139,946 based upon a closing price of $0.0.03 on June 30, 2021. For purposes of this computation, all executive officers, directors and 10% shareholders were deemed affiliates. Such a determination should not be construed as an admission that such 10% shareholders are affiliates.

As of April 4, 2022 there were 559,281,064 shares of common stock issued and outstanding.

TABLE OF CONTENTS

		PAGE
PART I

ITEM 1.	DESCRIPTION OF BUSINESS		3
ITEM 1A.	RISK FACTORS		6
ITEM 2.	DESCRIPTION OF PROPERTIES		6
ITEM 3.	LEGAL PROCEEDINGS		6
ITEM 4.	MINE SAFETY DISCLOSURES		6

PART II

ITEM 5.	MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES		7
ITEM 6.	SELECTED FINANCIAL DATA		9
ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS		9
ITEM7A.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK		13
ITEM 8.	FINANCIAL STATEMENTS		F-1
ITEM 9.	CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE		30
ITEM 9A	CONTROLS AND PROCEDURES		30
ITEM 9B.	OTHER INFORMATION		31

PART III

ITEM 10.	DIRECTORS, EXECUTIVE OFFICERS, PROMOTORS AND CONTROL PERSONS; COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT		32
ITEM 11.	EXECUTIVE COMPENSATION		33
ITEM 12.	SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.		35
ITEM 13.	CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE		36
ITEM 14.	PRINCIPAL ACCOUNTANT FEES AND SERVICES		36
ITEM 15.	EXHIBITS, FINANCIAL STATEMENT SCHEDULES		37
	SIGNATURES		39

Table of Contents

PART I

Forward Looking Statements

This Form 10-K contains “forward-looking” statements including statements regarding our expectations of our future operations. For this purpose, any statements contained in this Form 10-K that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, words such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” or “continue” or comparable terminology are intended to identify forward-looking statements. These statements by their nature involve substantial risks and uncertainties, and actual results may differ materially depending on a variety of factors, many of which are not within our control. These factors include, but are not limited to, economic conditions generally and in the industries in which we may participate, competition within our chosen industry, including competition from much larger competitors, technological advances, our ability to obtain approval from the FDA or other governmental agencies and the failure by us to successfully develop business relationships. In addition, these forward-looking statements are subject, among other things, to our successful completion of the research and development of our technologies; successful commercialization and mass production of, among other things, the advanced materials, the nanomedicine, successful protection of our licensed patents; and effective significant industry competition from various entities whose research and development, financial, sales and marketing and other capabilities far exceeds ours. In light of these risks and uncertainties, you are cautioned not to place undue reliance on these forward-looking statements. Except as required by law, we undertake no obligation to announce publicly revisions to these forward-looking statements to reflect the effect of events or circumstances that may arise after the date of this report. All written and oral forward-looking statements made subsequent to the date of this report and attributable to us or persons acting on our behalf are expressly qualified in their entirety by this section.

ITEM 1. DESCRIPTION OF BUSINESS

OVERVIEW

COMPANY HISTORY AND OVERVIEW

Manhattan Scientifics, Inc. (the “Company” or “Manhattan Scientifics”), a Delaware corporation, was established on July 31, 1992 and has one operating wholly-owned subsidiary: Metallicum, Inc., (“Metallicum”). The Company also holds a 5%, noncontrolling interest in Imagion Biosystems, Inc. (f/k/a Senior Scientific LLC) (“Imagion”).

Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in various fields To achieve this goal, the Company continues to identify emerging technologies through strategic alliances with scientific laboratories, educational institutions, scientists and leaders in industry and government. The Company and its executives have a long-standing relationship with Los Alamos Laboratories in New Mexico.

In June 2008, we acquired Metallicum and its licensed patented technology. In January 2009, Metallicum was granted an exclusive license by The Los Alamos National Laboratory on patents related to nanostructured metals.

On May 31, 2011, we entered into an Agreement and Plan of Reorganization to acquire Senior Scientific. The total purchase price was 21,668,000 restricted shares of our common stock (less 7,667,000 shares previously issued pursuant to an option agreement). As a result of this acquisition, Senior Scientific owned patented technologies that can use biosafe nanoparticles and sensitive magnetic sensors to detect and measure cancer cells in biopsies or in the human body with the potential to transform how cancer is detected and treated. On November 17, 2016, Senior Scientific merged with and into Imagion, a Nevada company. Following the merger, Imagion held all of the liabilities, obligations and assets of Senior Scientific and the Company continued as the sole equity holder of Imagion. On June 30, 2017, Imagion completed its initial public offering and listing on the Australian Stock Exchange (ASX). As of December 31, 2020, the Company owns 53,516,508 shares of Imagion (1,000,000 restricted shares), now resulting in a noncontrolling interest of approximately 5% of Imagion’s issued and outstanding common stock decreased primarily as a result of dilutive issuances by Imagion. Based upon Imagion’s latest trading price of approximately $0.11 per share, the fair value of the Imagion shares is approximately $5,875,000.

OUR DEVELOPMENT MODEL

Our goal has been to influence the future through the development of potentially life changing technologies. Our business model is to: (i) identify significant technologies, (ii) acquire them or the rights to them, (iii) secure the services of inventors, engineers or other staff who were instrumental in their creation, (iv) provide or contract for suitable work facilities, laboratories, and other aids where appropriate, (v) prototype the technologies to demonstrate “proof of principle” feasibility, (vi) secure patent and or other intellectual property protection, (vii) secure early customers for product trials where feasible and appropriate, and (viii) commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms.

Since our technologies are still in their development phase, the need for operating and acquisition capital is a continuous concern requiring the ongoing efforts of our management. The Company’s success will depend in part on its ability to obtain patents and license rights, maintain trade secrets, and operate without infringing on the proprietary rights of others, both in the United States and other countries. There can be no assurance that patents issued to or licensed by the Company will not be challenged, invalidated, or circumvented, or that the rights granted thereunder will provide proprietary protection or competitive advantages to the Company.

We utilize the intellectual property sale/licensing model, and not a production model, though management is opportunistic and is open to explore all methods leading to commercializing our technologies. We intend to consider all appropriate avenues for the commercialization of our technologies.

The Company is not engaged in the business of investing, reinvesting, or trading in securities. The Company has not sold some of its investments on the open market.

Table of Contents

DESCRIPTION OF TECHNOLOGIES

ADVANCED METALS

Our business model is based on licensing metals technology to metals manufacturers. Although competing commercial products are provided by existing specialty metals companies, the only competing processes for creating nanostructured metals are either limited or cannot be economically scaled. Metallicum does not yet face direct competition, but expects competition will emerge as the metal is commercialized.

In January 2009, we entered into a patent license agreement with Los Alamos National Security, LLC for the exclusive licensing use of certain technology relating to the manufacture and application of nanostructuring metals and alloys. Pursuant to such agreement we provided a non-refundable fee and 2,000,000 shares of our common stock with a fair market value of $33,000. Additionally, we are required to pay an annual license fee of $10,000 starting in February 2010 and royalties on future net sales.

The nanostructured metals technology may have wide implications for use in the medical device and prosthetics industries including dental implants, replacements for hips, shoulders, knees and cardio vascular stents. In December 2008, a manufacturing joint venture partner in Albuquerque, NM received U.S. Food and Drug Administration 510(k) clearance to market nanostructured titanium metal dental implants using our technology. This clearance positions us closer to our goal of commercializing our technology for nanostructured metals. We are in talks with many of the key manufacturers of dental implants and have signed material testing agreements with several manufacturers.

In September 2009, the Company entered into a contract with Carpenter to sell certain nanostructured metal technologies acquired from Metallicum, its wholly owned subsidiary, to Carpenter and to provide sub-license rights to Carpenter covering license agreements that the Company has from Los Alamos Laboratories. In January 2013, the Company entered into a licensing agreement with a party granting certain licensing rights to the Company’s nanostructured metal technology. On February 11, 2015, the Company and Carpenter entered into a Settlement Agreement and Mutual Release pursuant to which the parties provided a full release of one another, Carpenter paid the Company $8,000,000, Carpenter transferred to the Company all intellectual and physical property that was part of the original agreement, Carpenter agreed to provide follow-up technical assistance and Carpenter provided a list of all customers and contacts. Following the return of the Company’s nanostructured metal technology, the Company has commenced exploring strategic alternatives for its Metallicum division. At this time we are exploring and working with partner companies in the fields of titanium dental implants, titanium and magnesium medical devices, high voltage aluminum conductors as well as oil and gas field applications.

INTELLECTUAL PROPERTY / RESEARCH AND DEVELOPMENT

In June 2008, we acquired Metallicum and its licensed rights to patented technology. The technology is comprised of three US Patents (US Patent numbers 7152448, 6197129 and 6399215) for which Metallicum (subsequently, Manhattan) had been assigned an exclusive license rights by Los Alamos National Security LLC (LANL). Under the license rights, Metallicum had all rights, title and interest throughout the world in and to any and all inventions, original works of authorship, developments, concepts, know-how, and improvements on the patents or trade secrets whether or not patentable or registerable under copyright or similar laws. The purchase price paid for these licenses was $305,000, which represents its fair value. The Company obtained an exclusive license on two patents and a non-exclusive license on the third patent. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years.

Our ability to compete depends in part on the protection of and our ability to defend our proprietary technology and on the goodwill associated with our trade names, service marks and other proprietary rights. However, we do not know if current laws will provide us with sufficient enough protection that others will not develop technologies similar or superior to ours, or that third parties will not copy or otherwise obtain or use our technologies without our authorization.

The success of our business will depend, in part, to identify technology, obtain patents, protect and enforce patents once issued and operate without infringing on the proprietary rights of others. Our success will also depend on our ability to maintain exclusive rights to trade secrets and proprietary technology we own are currently developing and will develop. We can give no assurance that any issued patents will provide us with competitive advantages or will not be challenged by others, or that the patents of others will not restrict our ability to conduct business.

In addition, we rely on certain technology licensed with a perpetual term from the Los Alamos National Laboratory and may be required to license additional technologies in the future. We do not know if these third-party licenses will be available or will continue to be available to us on acceptable commercial terms or at all. The inability to enter into and maintain any of these licenses could have a material adverse effect on our business, financial condition or results of our operations.

Policing unauthorized use of our proprietary technology and other intellectual property rights could entail significant expense. In addition, we do not know if third parties will bring claims of copyright or trademark infringement against us or claim that our use of certain technologies violates a patent or other intellectual property. Any claims of infringement, with or without merit, could be time consuming and expensive to defend, result in costly litigation, divert management attention, require us to enter into costly royalty or licensing arrangements or prevent us from using important technologies or methods, any of which could have a material adverse effect on our business, financial condition or results of our operations.

Table of Contents

SALES AND MARKETING

Although our technologies presently are in the development stage, we are engaged in an early commercialization program intended to facilitate the transition from development to licensing, manufacturing and/or sale. This program consists of preliminary dialogues with potential strategic partners, investors, manufacturers, potential licensees and/or purchasers.

COMPETITION

As a result of our licensed technology, we do not have any direct competitors in our advanced materials operations. We may, however, face competition from leading researchers and manufacturers worldwide that develop competing technology.

With respect to our nanomedicine technology, our cancer detection technology will face competition primarily from companies such as Abbott Laboratories Inc., Cepheid Inc., Philips, GE Healthcare, Siemens, Gen-Probe Incorporated, MDxHealth SA, EpiGenomics AG, Roche Diagnostics and Sequenom, Inc.

Competitors may successfully challenge our licensed technology, produce similar products that do not infringe our licensed technology or produce products in countries where we have not applied for intellectual property protection. Many of these competitors may have longer operating histories and significantly greater financial, marketing and other resources than we have. Furthermore, competitors may introduce new products that address our potential markets. Competition could have a material adverse effect on our business, financial condition and results of our operations.

The markets in which we compete are highly competitive and constantly evolving. We believe that the principal competitive factors in our technology markets include without limitation:

·	capitalization;
·	cost of product;
·	first to market with product in market segment;
·	strong intellectual portfolio;
·	product reliability;
·	strong customer base; and
·	strong manufacturing and supplier relationships.

CUSTOMERS AND SUPPLIERS

For the years ended December 31, 2021 and 2020, one customer generated all of our revenue. We did not have any significant suppliers.

EMPLOYEES

As of December 31, 2021, we had no full-time employees. We do not expect any significant change in the total number of employees in the near future. Most of our research and development work has been performed by employees of our various research and development independent contractors (see below). We have historically indirectly funded the salaries of these individuals through our contract research and development payments to their employers. Although not technically our employees, we have considered these individuals to be an integral part of our research and development team. None of our employees or contractors are members of any union or collective bargaining organization. We consider our relationships with independent contractor employees to be good.

As noted above, a significant portion of our research and development has been performed by independent contractors from whom we acquired or licensed certain technologies, and their various employees. Our independent contractors utilize a number of their own various employees to satisfy their research and development obligations to us, and their employees are considered to be part of our research and development team.

The Company’s officer and its directors spend substantially all of their time managing the Company’s business of developing and licensing its intellectual property in the metals industry.

ITEM 1A. RISK FACTORS

Item 1A Risk Factors

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

Table of Contents

ITEM 2. DESCRIPTION OF PROPERTIES

Our principal executive office is at 244 Fifth Avenue, Suite 2341, New York, New York, 10001. We lease approximately 300 square feet of office space on a month-to-month basis. The aggregate annual rent for this office space was $719 in 2021.

Since October 2016, we lease an approximately 3,000 square foot office at 331 Corporate Circle, Golden, CO 80401. In June 2019, we entered into an assignment and assumption of lease with the landlord and another entity for two years and is set to expire in April 2021. The average aggregate annual rent for this space is $30,360.

We believe our facilities are adequate for our current and planned business operations.

ITEM 3. LEGAL PROCEEDINGS

We are subject from time to time to litigation, claims and suits arising in the ordinary course of business. As of December 31, 2021, we were not a party to any material litigation, claim or suit whose outcome could have a material effect on our financial statements other than the litigation described above which was subsequently settled.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

Table of Contents

PART II

ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

We are currently trading on the OTCQB operated by www.otcmarkets.com. The following sets forth for the periods indicated, the high and low per share bid information for our common stock for the fiscal years ended December 31, 2021 and 2020, as reported by www.otcmarkets.com. Such high and low bid information reflects inter-dealer quotes, without retail mark-ups, mark-downs or commissions and may not represent actual transactions.

As of April 4, 2022, there were 559,281,064 shares of common stock of the issuer issued and outstanding and approximately 635 record shareholders.

DIVIDENDS

We have never paid any cash dividends. We presently intend to reinvest earnings, if any, to fund the development and expansion of our business and, therefore, do not anticipate paying cash dividends on our common stock in the foreseeable future. The declaration of cash dividends will be at the discretion of our board of directors and will depend upon our earnings, capital requirements, financial position, general economic conditions and other pertinent factors.

RECENT SALES OF UNREGISTERED SECURITIES

During the past two years, we have issued unregistered shares of common stock and options and warrants for the purchase of common stock in the following transactions in reliance on an exemption from registration pursuant to Section 4(2) of the Securities Act:

2021 and 2020

During the year ended December 31, 2020, the Company issued 1,500,000 shares of common stock for services valued at $24,000. The shares were valued based on the market price of the Company’s common shares of $0.016 on the grant date.

Securities Authorized for Issuance under Equity Incentive Plans

The 2000 Plan is administered by a committee of two or more members of the Board of Directors or, if no committee is appointed, then by the Board of Directors. The 2000 Plan allows for the issuance of incentive stock options (which, pursuant to Section 422 of the Internal Revenue Code, can only be granted to employees), non-qualified stock options, stock appreciation rights, stock awards, or stock bonuses. The committee, or the Board of Directors if there is no committee, determines the type of option granted, the exercise price, the option term, which may be no more than ten years, terms and conditions of exercisability and methods of exercise. Options must vest within ten-years. Under the 2000 Plan, the exercise price may not be less than fair market value on the date of grant for the incentive stock options. The 2000 Plan also allows for the granting of Stock Appreciation Rights. No Stock Appreciation Rights have been granted. The number of shares under the 2000 Plan available for grant at December 31, 2021 was 18,869,763.

In November 2004, our Board of Directors adopted the 2004 Consultant Stock Plan (the “2004 Plan”). The purpose of this 2004 Consultant Stock Plan is to advance our interests by helping us obtain and retain the services of persons providing consulting services upon whose judgment, initiative, efforts and/or services we are substantially dependent, by offering to or providing those persons with incentives or inducements affording such persons an opportunity to become owners of our capital stock. We reserved 2,000,000 shares of our Common Stock for awards to be made under the 2004 Plan. We filed a registration statement on Form S-8 with the SEC on November 26, 2004 to register the shares underlying the 2004 plan. The 2004 Plan is administered by a committee of two or more members of the Board of Directors or, if no committee is appointed, then by the Board of Directors. The committee or the Board of Directors if there is no committee, determines who is eligible to receive awards under the plan, grant awards and interpret the 2004 Plan. The number of shares under the 2004 Plan available for grant at December 31, 2021 was 500,000.

Table of Contents

On May 9, 2005, our Board of Directors adopted the 2005 Equity Compensation Plan (the “2005 Plan”). The purpose of this Plan is to provide incentives to attract, retain and motivate eligible persons whose present and potential contributions are important to our success, by offering them an opportunity to participate in the our future performance through awards of Options, the right to purchase Common Stock and Stock Bonuses. We reserved 10,000,000 shares of our Common Stock for awards to be made under the 2005 Plan. The 2005 Plan is administered by a committee of two or more members of the Board of Directors or, if no committee is appointed, then by the Board of Directors. The committee, or the Board of Directors if there is no committee, determines who is eligible to receive awards under the plan, grant awards and interpret the 2005 Plan. We filed a registration statement on Form S-8 with the SEC on June 8, 2005 to register the shares underlying the 2005 plan. The number of shares under the 2006 Plan available for grant at December 31, 2021 was -0-.

In January 2015, our Board of Directors adopted the 2015 Incentive Stock Plan (the “2015 Plan”). The purpose of this Plan is to provide incentive stock options (which, pursuant to Section 422 of the Internal Revenue Code, can only be granted to employees), non-qualified stock options, stock appreciation rights, stock awards, or stock bonuses. The committee, or the Board of Directors if there is no committee, determines the type of option granted, the exercise price, the option term, which may be no more than ten years, terms and conditions of exercisability and methods of exercise. Options must vest within ten-years. Under the 2015 Plan, the exercise price may not be less than fair market value on the date of grant for the incentive stock options. The 2015 Plan also allows for the granting of Stock Appreciation Rights. No Stock Appreciation Rights have been granted. The number of shares under the 2015 Plan available for grant at December 31, 2021 was 4,000,000.

Set forth in the table below is information regarding awards made through compensation plans or arrangements through December 31, 2021.

Equity Compensation Plan Information

Plan category	Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)		Weighted-average exercise price of outstanding options, warrants and rights		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
Equity compensation plans approved by security holders		—		—		—
Equity compensation plans not approved by security holders		—		—		23,369,763
Total		—		—		23,369,763

A summary of the Company’s stock option activity and related information is as follows:

	Number of Options			Exercise Price Per Share		Weighted Average Exercise Price		Number of Options Exercisable
Outstanding as of December 31, 2019		22,075,000							22,075,000
Granted		-			-		-		500,000
Exercised		-			-		-		-
Expired		(3,575,000	)		0.07		0.07		(3,575,000	)
Outstanding as of December 31, 2020		18,500,000							18,500,000
Granted		15,000,000			0.02		0.02		15,000,000
Exercised		-			-		-		-
Expired		(7,000,000	)		-		-		(7,000,000	)
Outstanding as of December 31, 2021		26,500,000							26,500,000

Table of Contents

Exercise prices and weighted-average contractual lives of 26,500,000 stock options outstanding as of December 31, 2021 are as follows:

				Options Outstanding				Options Exercisable
Exercise Price		Number Outstanding		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$	0.02		15,500,000		8.80	$	0.02		15,500,000	$	0.02
$	0.05		3,000,000		3.50	$	0.05		3,000,000	$	0.05
$	0.06		5,000,000		4.35	$	0.06		5,000,000	$	0.06
$	0.14		3,000,000		2.75	$	0.14		3,000,000	$	0.14

The fair value for options granted were determined using the Black-Scholes option-pricing model. At December 31, 2021, the 26,500,000 outstanding options had an aggregate intrinsic value of $1,340,000.

Warrants:

The Company issued the following warrants at the corresponding weighted average exercise price as of December 31, 2020.

	Warrants			Weighted average Exercise Price
Outstanding as of December 31, 2019		9,700,000		$	0.07
Issued/Vested		-			-
Cancelled/Expired		(9,700,000	)		(0.07	)
Outstanding as of December 31, 2020		-		$	-
Issued/Vested		-			-
Exercised		-			-
Cancelled/Expired		-			-
Outstanding as of December 31, 2021		-		$	-

ITEM 6. SELECTED FINANCIAL DATA

N/A

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The following discussion and analysis should be read in conjunction with our financial statements and accompanying notes appearing elsewhere in this Form 10-K.

OVERVIEW

Manhattan Scientifics, Inc. (the “Company” or “Manhattan Scientifics”), a Delaware corporation, was established on July 31, 1992 and has one operating wholly-owned subsidiary: Metallicum, Inc., (“Metallicum”). Manhattan Scientifics is focused on technology transfer and commercialization of these transformative technologies.

The Company operates as a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in various fields, with emphasis in the areas of nanotechnology. Nanotechnology is the use and manipulation of matter on an atomic and molecular scale. To achieve this goal, the Company is actively seeking to identify emerging technologies through strategic alliances with scientific laboratories, educational institutions, scientists and leaders in industry and government. The Company and its executives have a long-standing relationship with Los Alamos Laboratories in New Mexico.

Metallicum

In June 2008, we acquired Metallicum and its licensed patented technology. We entered into a stock purchase agreement with Metallicum to acquire all of the outstanding capital in exchange for 15,000,000 restricted shares of our common stock. An additional 15,000,000 shares of our common stock will be payable to Metallicum in the event of meeting certain milestones. On December 31, 2011, one milestone was met. Metallicum was granted an exclusive license by The Los Alamos National Laboratory on patents related to nanostructured metals. In September 2009, we entered into a technology transfer agreement and sale with Carpenter Technology Corporation, (“Carpenter”) wherein Carpenter was to fully develop, manufacture and market a new class of high strength metals. On February 11, 2015, the Company and Carpenter entered into a Settlement Agreement and Mutual Release pursuant to which the parties provided a full release of one another, Carpenter paid the Company $8,000,000, Carpenter transferred to the Company all intellectual and physical property that was part of the original agreement, Carpenter agreed to provide follow-on technical assistance and Carpenter provided a list of all customers and contacts.

Table of Contents

On May 1, 2019, Manhattan Scientifics, Inc., a Delaware corporation (the “Company”), and Metallicum, Inc., a wholly-owned subsidiary of the Company, entered into an Overarching Agreement with a non-affiliated third party (“Third Party”), providing for an exclusive license by the Company of its ECAP technology to the Third Party for a term of 17 years unless terminated sooner, a sublicense by the Company to the Third Party of its rights under that certain Exclusive Field-of-Use Patent License Agreement dated January 5, 2009 entered with The Los Alamos National Laboratory for a term until the expiration of the last valid claim to expire of the patents pursuant to such agreement and the sale by the Company of ECAP-C machines to the Third party. As part of the above license agreements, the Company will receive royalty payments, including minimum payments, based on a percentage of the Third Party’s sales. The Company anticipates royalty income as the nanotitanium is commercialized for use in medial prosthetics. Royalties will be 10% on sales of licensed dental products and an average of 5% in all other sales of licensed products. We expect to start earning royalties in 2023.

Imagion

As of December 31, 2021, Manhattan Scientifics presently owns 52,516,508 shares of Imagion, with a fair market value of approximately $2,901,000, based upon the closing price per share of Imagion common stock on the Australian Stock Exchange. The Company accounts for its investment in Imagion in accordance with ASC 825-10 and elected fair value option. We initially held 31% of the total issued and outstanding shares of Imagion and had one seat on the Board of Directors of Imagion. The guidance allows entities to elect to measure certain financial assets and financial liabilities (as well as certain nonfinancial instruments that are similar to financial instruments) at fair value. Investments over which an investor has the ability to exercise significant influence are eligible for the fair value option as they represent recognized financial assets. When the fair value option is elected for an instrument, all subsequent changes in fair value for that instrument are reported in earnings. As of December 31, 2021, we hold approximately 5% of the total issued and outstanding shares of Imagion and no longer have a seat on the Board of Directors of Imagion.

Novint

We made an investment in Novint Technologies Inc. (“Novint”) in 2001. Novint is currently engaged in the development and sale of 3D haptics products and equipment. Haptics refers to one’s sense of touch and Novint’s focus is in the consumer interactive computer gaming market. The Company owns 1,028,425 shares of Novint’s common stock. The fair value of the Novint shares are not recorded on the balance sheet as of December 31, 2021.

RESULTS OF OPERATIONS

YEAR ENDED DECEMBER 31, 2021 COMPARED TO YEAR ENDED DECEMBER 31, 2020

REVENUES. In the year ended December 31, 2021, we recognized $50,000 in revenue compared to $50,000 of revenue recognized for the year ended December 31, 2020.

GENERAL AND ADMINISTRATIVE. General and administrative expenses consist of consultants, contractors, accounting, legal, travel, rent, telephone and other day-to-day operating expenses. General and administrative expenses were $727,000 for the year ended December 31, 2021 compared with $714,000 for the year ended December 31, 2020. The primary increase in general and administrative expense was the result of the increase in computer expenses and filing expenses. During the year ended, the officers and directors total compensation was $531,000 of which a total of $255,000 was paid to two individuals that are an officer and directors of the Company and the unpaid balance is recorded in accrued expenses – related party.

RESEARCH AND DEVELOPMENT. Research and development expenses consist of consultants and contractors. Research and development expenses were $10,000 for the year ended December 31, 2021 compared with $11,000 for the year ended December 31, 2020.

OTHER INCOME AND (EXPENSES). Total other income (expense) for the year ended December 31, 2021 totaled ($2,952,000), compared to the other income of $4,989,000 for the year ended December 31, 2020. This is primarily attributable to the loss on fair value adjustments of its investment in Imagion partially offset in part by gain on settlement of legal fees.

INCOME (LOSS). As of the year ended December 31, 2021, the Company has net loss of $3,639,000, compared to the net income of $4,314,000 for the year ended December 31, 2020. This is primarily attributable to the loss on fair value adjustment of investment in Imagion, offset in part by gain on forgiveness of debt.

Table of Contents

LIQUIDITY AND PLAN OF OPERATIONS

Stockholders’ equity totaled $1,035,000 on December 31, 2021 and the working capital deficit was $(684,000) on such date. We had a decrease of $121,000 in cash and cash equivalents for the year ended December 31, 2021.

Based upon current projections, our principal cash requirements for the next 12 months consists of (1) fixed expenses, including payroll, and professional services and (2) variable expenses, including technology research and development, milestone payments and intellectual property protection, and additional scientific consultants. As of December 31, 2021, we had $232,000 in cash. We believe our current cash position may not be sufficient to maintain our operations for the next twelve months. Accordingly, we may need to engage in equity or debt financings to secure additional funds. If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of holders of our common stock. Any debt financing that we secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. We may not be able to obtain additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth and to respond to business challenges could be impaired, and our business may be harmed.

On October 17, 2019, we executed a secured note with our only independent director for $100,000 and a secured note with an unrelated party for $50,000. The secured notes are due on October 17, 2022. The Company agreed that the notes bear interest at 10% per annum, to be paid in advance with shares of Imagion Biosystems Limited common stock (“IBX”), calculated at $0.015 per share or 3,000,000 shares of IBX. We currently do not plan any further sale of transfer of IBX common stock to raise funds for operations. To fund operations, we plan on relying on payments of $300,000, to be collected during the next two years in equal increments from the sale of assets in 2019 and future royalties from the Metallicum license.

CASH FLOW INFORMATION

The Company had cash and cash equivalents of approximately $232,000 and $353,000 at December 31, 2021 and 2020, respectively. This represents an decrease in cash of $121,000.

OPERATING ACTIVITIES

The Company used approximately $421,000 of cash for operating activities in the year ended December 31, 2021 as compared to using $388,000 of cash for operating activities in the year ended December 31, 2020. The reason for the increase in cash used for operating activities is a lower increase in current liabilities partially offset by a lower net loss after adjustment for non-cash items.

INVESTING ACTIVITIES

The Company received approximately $300,000 of cash for investing activities in the year ended December 31, 2021 as compared to receiving $480,000 of cash for investing activities in the year ended December 31, 2020. This decrease in cash received in investing activities, is primarily attributed to proceeds from sale of investment of Imagion Biosystems shares in the prior year, but not in the current year and sale of assets.

FINANCING ACTIVITIES

The Company received $0 of cash for financing activities in the year ended December 31, 2021 and 2020.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. A significant estimate includes the carrying value of our patents, fair value of our common stock, assumptions used in calculating the value of stock options, depreciation and amortization.

License Agreements

In 2008, the Company obtained licenses to the rights of certain patents regarding nano-structured materials developed by another company as a result of the acquisition of Metallicum. The purchase price paid for these licenses was $305,000, which represents its fair value. The Company obtained an exclusive license on two patents and a non-exclusive license on the third patent. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years. Under the terms of the agreement, the Company may be required to pay royalties, as defined, to the licensors.

Table of Contents

In 2009, the Company entered into a patent license agreement with Los Alamos National Security LLC for the exclusive use of certain technology relating to the manufacture and application of nanostructuring metals and alloys. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years. Under the terms of the agreement the Company is required to pay an annual license fee of $10,000 and, may be required to pay royalties, as defined, to the licensors.

Revenue Recognition

The Company recognizes revenue in accordance with generally accepted accounting principles as outlined in the Financial Accounting Standard Board’s (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue From Contracts with Customers, which consists of five steps to evaluating contracts with customers for revenue recognition: (i) identify the contract with the customer; (ii) identity the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price; and (v) recognize revenue when or as the entity satisfied a performance obligation.

Revenue recognition occurs at the time we satisfy a performance obligation to our customers, when control transfers to customers, provided there are no material remaining performance obligations required of the Company or any matters of customer acceptance. We only record revenue when collectability is probable.

Marketable Securities:

The Company considers securities with original maturities of greater than 90 days to be available for sale securities. Securities under this classification are recorded at fair value and unrealized gains and losses within other income (loss). The estimated fair value of the available for sale securities is determined based on quoted market prices or rates for similar instruments. In addition, the cost of debt securities in this category is adjusted for amortization of premium and accretion of discount to maturity. For available for sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other income (loss). For the year ended December 31, 2021, no allowance was recorded for credit losses.

Stock-Based Compensation:

In June 2018, FASB issued ASU No. 2018-07, Compensation – Stock Compensation (Topic 718),Improvements to Nonemployee Share Based Payment Accounting. The amendments in this Update expand the scope of stock compensation to include share-based payment transactions for acquiring goods and services from nonemployees. The guidance in this Update does not apply to transactions involving equity instruments granted to a lender or investor that provides financing to the issuer. The guidance is effective for fiscal years beginning after December 31, 2018 including interim periods within the fiscal year. The Company adopted with an effective date of January 1, 2019. Upon adoption, there was no material impact to the financial statements.

Due from the Sale of Assets:

Non-current assets are classified as held for sale if it is highly probably that they will be recovered primarily through sale rather than through continuing use.

Immediately before classification as held for sale, the assets are remeasured at the lower of their carrying amount and fair value less costs to sell. Any impairment loss on initial classification as held for sale and subsequent gains and losses on remeasurement are recognized in profit or loss. Gains are not recognized in excess of any cumulative impairment loss.

During the year ended December 31, 2019, the Company sold the assets held for sale that were presented on the balance sheet as of December 31, 2018. During the year ended December 31, 2018, the Company recorded impairment and adjusted the asset valuation to $1.2 million. On May 1, 2021 and 2020, the Company received $300,000 for sale of assets for a total of $1.2 million during the year ended December 31, 2019. The remaining $300,000 will be collected during the next two years in equal increments on the anniversary date of the agreement, May 1. As of December 31, 2021, the Company evaluated the collectability and determined that no allowance is needed at this time due to the payment history with this third party and the subsequent receipt of funds.

Table of Contents

Fair Value Measurements:

The Company recognized the fair value of financial instruments in accordance with FASB ASC 820, Fair Value Measurements and Disclosures, “Fair Value Measurements”, which provides a framework for measuring fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The standard also expands disclosures about instruments measured at fair value and establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1 — Quoted prices for identical assets and liabilities in active markets;

Level 2 — Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and

Level 3 — Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

GOING CONCERN

As of December 31, 2021, the Company has an accumulated deficit of 68,520,000 and negative working capital of $684,000. Because of these conditions, the Company will require additional working capital to develop business operations. The Company intends to raise additional working capital through the continued licensing of its technology as well as to generate revenues for other services. There are no assurances that the Company will be able to achieve the level of revenues adequate to generate sufficient cash flow from operations to support the Company’s working capital requirements. To the extent that funds generated are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available, the Company may not continue its operations.

As of the filing date, the Coronavirus (“COVID-19”) has caused significant volatility in global markets, including the market price of our securities. The demand for our products and services has decreased and the ability of our customers to make payments for the products and services they purchased has been negatively impacted.

These factors raise substantial doubt about the Company’s ability to continue within one year from the date of filing. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

The ability to continue as a going concern is dependent on out generating cash from the sale of our common stock and/or obtaining debt financing and attaining future profitable operations. Management’s plan includes selling our equity securities and/or obtaining debt financing to fund our capital requirement and ongoing operations; however, there can be no assurance the Company will be successful in these efforts.

OFF BALANCE SHEET ARRANGEMENTS

We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations liquidity, capital expenditures or capital resources and would be considered material to investors.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a Small Reporting Company, we are not required to provide the information under Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

Table of Contents

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

REPORTS OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID: 3627)			F-2
CONSOLIDATED BALANCE SHEETS AS OF DECEMBER 31, 2021 AND 2020			F-3
CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020			F-4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020			F-5
CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020			F-6
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS			F-7

F-1

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Shareholders of Manhattan Scientifics, Inc.:

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Manhattan Scientifics, Inc. ("the Company") as of December 31, 2021 and 2020, the related consolidated statements of operations, stockholders' equity (deficit), and cash flows for each of the the years in the two-year period ended December 31, 2021 and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows each of the the years in the two-year period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.

Explanatory Paragraph Regarding Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has an accumulated deficit, negative cash flows from operations, and negative working capital, which raises substantial doubt about its ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there were no critical audit matters.

/s/ Sadler, Gibb & Associates, LLC

We have served as the Company's auditor since 2020.

Draper, UT

April 5, 2022

F-2

Table of Contents

MANHATTAN SCIENTIFICS, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

	December 31,			December 31,
	2021			2020

ASSETS
Current assets:
Cash and cash equivalents	$	232,000		$	353,000
Prepaid expenses		15,000			12,000
Due from the sale of assets - current portion		300,000			300,000
Total current assets		547,000			665,000

Investment in equity securities		2,901,000			5,875,000
Property and equipment, net		4,000			6,000
Due from the sale of assets		-			300,000
Other assets		2,000			2,000
Total assets	$	3,454,000		$	6,848,000

LIABILITIES
Current liabilities:
Accounts payable and accrued expenses	$	102,000		$	159,000
Accrued expenses - related parties		1,129,000			853,000
Notes payable - related parties, net of discounts		130,000			-
Total current liabilities		1,361,000			1,012,000

Long-term liabilities:
Notes payable - related parties, net of discounts		-			104,000
Total long-term liabilities		-			104,000
Total liabilities		1,361,000			1,116,000

Commitments and Contingencies - Note 8

Series D convertible preferred mandatory redeemable, authorized 105,761 shares, 105,761 and 105,761 shares issued and outstanding, respectively		1,058,000			1,058,000

STOCKHOLDERS’ EQUITY
Capital stock $0.001 par value
Preferred, authorized 1,000,000 and 447,804 shares undesignated, 0 and 0 shares issued, and outstanding, respectively		-			-
Class A Convertible Preferred, authorized 182,525, 0 and 0 shares issued and outstanding, respectively		-			-
Class B Convertible Preferred, authorized 250,000, 49,999 and 49,999 shares issued and outstanding, respectively		-			-
Class C Redeemable Convertible Preferred, authorized 14,000, 0 and 0 shares issued and outstanding, respectively		-			-
Common, authorized 950,000,000 shares, 559,281,064 and 559,281,064 shares issued, and outstanding, respectively		559,000			559,000
Additional paid-in-capital		68,996,000			68,996,000
Accumulated deficit		(68,520,000	)		(64,881,000	)
Total stockholders' equity		1,035,000			4,674,000
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY	$	3,454,000		$	6,848,000

The accompanying notes are an integral part of these audited consolidated financial statements.

F-3

Table of Contents

MANHATTAN SCIENTIFICS, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

	FOR THE YEARS ENDED
	DECEMBER 31,
	2021			2020

Revenue	$	50,000		$	50,000

Operating costs:
General and administrative expenses		727,000			714,000
Research and development		10,000			11,000

Total operating costs and expenses		737,000			725,000

Loss from operations before other income and expenses		(687,000	)		(675,000	)

Other income and (expenses):
Gain (Loss) on fair value adjustment of investments		(2,974,000	)		5,014,000
Gain on settlement of legal fees		48,000			-
Interest expense		(26,000	)		(25,000	)
Total other income (expense)		(2,952,000	)		4,989,000

NET INCOME (LOSS)	$	(3,639,000	)	$	4,314,000

INCOME (LOSS) PER COMMON SHARE:

Weighted average number of common shares outstanding (Basic)		559,281,064			558,322,048

Basic income (loss) per common share	$	(0.01	)	$	0.01

Weighted average number of common shares outstanding (Diluted)		559,281,064			593,051,310

Diluted income (loss) per common share	$	(0.01	)	$	0.01

The accompanying notes are an integral part of these audited consolidated financial statements.

F-4

Table of Contents

MANHATTAN SCIENTIFICS, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

FOR THE YEARS ENDED DECEMBER 31, 2021 and 2020

	Preferred Stock - Series B				Preferred Stock - Series C				Common Stock				Additional					Total
	$0.001 Par Value				$0.001 Par Value				$0.001 Par Value				Paid-In		Accumulated			Shareholders' Equity
	Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			(Deficit)

Balance
December 31, 2019		49,999	$	-		14,000	$	-		557,781,064	$	558,000	$	67,632,000	$	(69,195,000	)	$	(1,005,000	)

Reclassification of liability to equity		-		-		-		-		-		-		1,341,000		-			1,341,000

Comman stock payable for services		-		-		-		-		1,500,000		1,000		23,000		-			24,000

Net income		-		-		-		-		-		-		-		4,314,000			4,314,000

Balance
December 31, 2020		49,999	$	-		14,000	$	-		559,281,064	$	559,000	$	68,996,000	$	(64,881,000	)	$	4,674,000

Net loss		-		-		-		-		-		-		-		(3,639,000	)		(3,639,000	)

Balance
December 31, 2021		49,999	$	-		14,000	$	-		559,281,064	$	559,000	$	68,996,000	$	(68,520,000	)	$	1,035,000

The accompanying notes are an integral part of these audited consolidated financial statements.

F-5

Table of Contents

MANHATTAN SCIENTIFICS, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

	FOR THE YEARS ENDED
	DECEMBER 31,
	2021			2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$	(3,639,000	)	$	4,314,000
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Common stock issued for services		-			24,000
Depreciation and amortization		2,000			2,000
Loss (Gain) on fair value adjustment of investments		2,974,000			(5,014,000	)
Gain on settlement of legal fees		48,000			-
Amortization of debt discount		26,000			26,000
Changes in:
Prepaid expenses		(3,000	)		1,000
Accounts payable and accrued expenses		(105,000	)		(10,250	)
Accounts payable and accrued expenses - related party		276,000			269,250

Net cash used in operating activities		(421,000	)		(388,000	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of fixed assets		-			(4,000	)
Proceeds from sale of assets held for sale		300,000			300,000
Proceeds from sale of investments		-			184,000

Net cash provided by (used in) investing activities		300,000			480,000

CASH FLOWS FROM FINANCING ACTIVITIES:
Net cash provided by financing activities		-			-

NET DECREASE IN CASH		(121,000	)		92,000
CASH, BEGINNING OF PERIOD		353,000			261,000

CASH, END OF PERIOD	$	232,000		$	353,000

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid	$	-		$	-
Income taxes paid	$	-		$	-

SUPPLEMENTAL DISCLOSURES OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Reclassification of liabilities to equity	$	-		$	1,341,000

The accompanying notes are an integral part of these audited consolidated financial statements.

F-6

Table of Contents

MANHATTAN SCIENTIFICS, INC. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2021

NOTE 1 – BASIS OF PRESENTATION

Manhattan Scientifics, Inc., a Delaware corporation (formerly Grand Enterprises, Inc) (“Grand”) was established on July 31, 1992 and has a wholly-owned subsidiary: Metallicum, Inc. (“Metallicum”). On June 12, 2008, the Company acquired Metallicum, Inc, for 15,000,000 shares of Company’s common stock, Manhattan Scientifics, Inc., operates as a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in various fields, with emphasis in the areas of nano-technologies and nano-medicine. In this capacity, the Company continues to identify emerging technologies through strategic alliances with scientific laboratories, educational institutions, and scientists and leaders in industry and government. The Company has a long standing relationship with Los Alamos Laboratories in New Mexico. During 2008, the Company refocused its efforts from the development of its fuel cell technologies to its current focus on the development of nanomaterials through the acquisition of Metallicum.

Metallicum is a nanotechnology start-up company located in Colorado. Metallicum Inc. has focused on the development and manufacture of nanostructured metals for medical implants and other applications. Metallicum intends to establish manufacturing partner relationships with major Fortune 500 metals companies and strategic partnering with significant customers in the medical device & prosthetics industries as well as in auto, truck, & aircraft manufacturing industries. Metallicum’s initial products include nanostructured bulk metals and alloys in the form of rod, bar, wire and foil. The Company conducts its operations primarily in the United States.

Manhattan Scientifics purchased Metallicum to acquire its licensed rights to patented technology. The technology is comprised of three US Patents (US Patent numbers 7152448, 6197129 and 6399215) for which Metallicum (subsequently, Manhattan) had been assigned an exclusive license rights by Los Alamos National Security LLC (LANL). Under the license rights, Metallicum had all rights, title and interest throughout the world in and to any and all inventions, original works of authorship, developments, concepts, know-how, and improvements on the patents or trade secrets whether or not patentable or registrable under copyright or similar laws.

In January 2009, the Company entered into a patent license agreement with Los Alamos National Security, LLC for the exclusive licensing use of certain technology relating to the manufacture and application of nanostructuring metals and alloys. Pursuant to such agreement the Company provided a non-refundable fee and 2,000,000 shares of common stock. Additionally, the Company is required to pay an annual license fee which started in February 2010 and royalties on future net sales.

In September 2009, the Company entered into a technology transfer agreement with Carpenter Technologies Corporation (“Carpenter”). Wherein Carpenter will fully develop, manufacture and market a new class of high strength metals under an exclusive technology transfer agreement from Manhattan Scientifics and the Los Alamos National Laboratory. The proprietary process will enable super-strength metals and alloys to make products that weigh far less than in the past and without significant cost premiums. On February 11, 2015, the Company entered into a Settlement Agreement and Mutual General Releases (the “Settlement Agreement”) with Carpenter Technology Corporation related to the agreement discussed in Note 7, pursuant to which the parties settled and released each other from any and all liabilities and claims related to the Carpenter Agreements.

On November 17, 2016, Senior Scientific merged with and into Imagion Biosystems, Inc., a Nevada corporation (“Imagion”). Following the merger, Imagion held all of the liabilities, obligations and assets of Senior Scientific and the Company continued as the sole equity holder of Imagion. On June 30, 2017, Imagion completed an IPO and listing on the Australian Stock Exchange (ASX). As of December 31, 2021 , the Company owns 52,516,508 shares (1,000,000 restricted shares related to issued promissory notes interest) of Imagion, resulting in a noncontrolling interest of approximately 5% of Imagion’s issued and outstanding common stock. The Company elected to record the investment at fair value.

Manhattan Scientifics success will depend in part on its ability to obtain patents and product license rights, maintain trade secrets, and operate without infringing on the proprietary rights of others, both in the United States and other countries. There can be no assurance that patents issued to or licensed by the Company will not be challenged, invalidated, or circumvented, or that the rights granted thereunder will provide proprietary protection or competitive advantages to the Company.

F-7

Table of Contents

MANHATTAN SCIENTIFICS, INC. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2021

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS

BASIS OF CONSOLIDATION:

The condensed consolidated financial statements include the accounts of Manhattan Scientific, Inc., and its wholly owned subsidiary Metallicum. All significant intercompany balances and transactions have been eliminated.

GOING CONCERN:

USE OF ESTIMATES:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. A significant estimate includes the carrying value of the Company’s patents, fair value of the Company’s common stock, assumptions used in calculating the value of stock options, depreciation and amortization.

CASH AND CASH EQUIVALENTS:

The Company considers all highly liquid investments purchased with an original maturity of year or less at the time of purchase to be cash equivalents for the purposes of the statement of cash flows.

CASH CONCENTRATION:

The Company’s cash accounts are federally insured up to $250,000 for each financial institution we hold our accounts in. As of December 31, 2021 and December 31, 2020, we had cash balances of $-0- and $103,000 exceeding the federally insured limits.

PROPERTY AND EQUIPMENT:

Property and equipment are recorded at cost. Expenditures for major additions and improvements are capitalized, and minor replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets, the useful lives range between 3-10 years, using the straight-line method for financial statement purposes.

F-8

Table of Contents

MANHATTAN SCIENTIFICS, INC. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2021

INTANGIBLE ASSETS:

License Agreements

In 2008, the Company obtained licenses to the rights of certain patents regarding nanostructured materials developed by another company as a result of the acquisition of Metallicum. The purchase price paid for these licenses was $305,000, which represented its fair value. The Company obtained an exclusive license on two patents and a non-exclusive license on the third patent. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years. At December 31, 2021 and December 31, 2020, the license agreements were fully amortized. Under the terms of the agreement, the Company may be required to pay royalties, as defined, to the licensors.

In 2009, the Company entered into a patent license agreement with Los Alamos National Security LLC for the exclusive use of certain technology relating to the manufacture and application of nanostructuring metals and alloys. The purchase price paid for this license agreement was $33,000 based on the fair market value of 2,000,000 shares of common stock issued. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years. At December 31, 2021 and December 31, 2020, the license agreements were fully amortized. Beginning in 2010, the Company was required to pay an annual license fee of $10,000 and may be required to pay royalties, as defined, to the licensors.

DUE FROM THE SALE OF ASSETS:

Non-current assets are classified as held for sale if it is highly probably that they will be recovered primarily through sale rather than through continuing use.

Immediately before classification as held for sale, the assets are remeasured at the lower of their carrying amount and fair value less costs to sell. Any impairment loss on initial classification as held for sale and subsequent gains and losses on re-measurement are recognized in profit or loss. Gains are not recognized in excess of any cumulative impairment loss.

During the year ended December 31, 2019, the Company sold the assets held for sale that were presented on the balance sheet as of December 31, 2018. During the year ended December 31, 2018, the Company recorded impairment and adjusted the asset valuation to $1.2 million. The Company sold the assets for a total of $1.2 million of which $300,000 was received during the year ended December 31, 2019. The remaining $900,000 will be collected during the next three years in equal increments on the anniversary date of the agreement, May 1. During May 2020 and 2021, the Company received $300,000 and $300,000 respectively and reduced the due from the sale of assets. As of December 31, 2021, the Company evaluated the collectability and determined that no allowance is needed at this time due to the payment history with this third party and the subsequent receipt of funds.

MARKETABLE SECURITIES:

F-9

Table of Contents

MANHATTAN SCIENTIFICS, INC. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2021

REVENUE RECOGNITION:

FAIR VALUE OF FINANCIAL INSTRUMENTS:

Level 1 — Quoted prices for identical assets and liabilities in active markets;

Level 3 — Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The Company designates cash equivalents (consisting of money market funds) and investments in securities of publicly traded companies as Level 1. The total amount of the Company’s investment classified as Level 3 is de minimis. Fair value of financial instruments: The carrying amounts of financial instruments, including cash and cash equivalents, short-term investments, accounts payable, accrued expenses and notes payables approximated fair value as of December 31, 2021 and December 31, 2020 because of the relative short term nature of these instruments.

During the year ended December 31, 2017, the Company elected fair value option for its investment in Imagion Biosystems, Inc. a Nevada company (“Imagion”) based on triggering event of dilution of ownership, which lead to the deconsolidation of Imagion. Investments in Imagion are measured at fair value as opposed to equity method based on ASC 825-10. The guidance allows entities to elect to measure certain financial assets and financial liabilities (as well as certain nonfinancial instruments that are similar to financial instruments) at fair value. Investments over which an investor has the ability to exercise significant influence are eligible for the fair value option as they represent recognized financial assets. When the fair value option is elected for an instrument, all subsequent changes in fair value for that instrument are reported in earnings.

As of December 31, 2021, the Company holds 52,516,508 shares of Imagion and is reported under fair value method under ASC 320. Any change in the value is reported on the income statement as an unrealized gain or loss on fair value adjustment of investments.

Our financial assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2021 and 2020, consisted of the following:

	Total fair value at December 31, 2021		Quoted prices in active markets for identical assets (Level1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Investment in equity securities	$	2,901,000	$	2,901,000	$	-	$	-

	Total fair value at December 31, 2020		Quoted prices in active markets for identical assets (Level1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Investment in equity securities	$	5,875,000	$	5,875,000	$	-	$	-

F-10

Table of Contents

MANHATTAN SCIENTIFICS, INC. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2021

INTELLECTUAL PROPERTY / RESEARCH AND DEVELOPMENT

LEASES

The Company leases a facility with terms of month to month for its headquarters. The Company adopted ASC 842 on January 1, 2019 and has evaluated that has no impact on the financial statements as under the practical expedient the leases consist of terms less than one year, and therefore is not required to capitalize the lease.

During June 2019, the Company entered into an assignment and assumption of lease with the landlord and another entity for the lease term through April 2021. The average aggregate annual rent for this space is $30,360.

F-11

Table of Contents

MANHATTAN SCIENTIFICS, INC. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2021

INCOME TAXES

The Company accounts for income taxes under an asset and liability approach. This process involves calculating the temporary and permanent differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The temporary differences result in deferred tax assets and liabilities, which would be recorded on the Company’s consolidated balance sheets in accordance with ASC 740, which established financial accounting and reporting standards for the effect of income taxes. The Company must assess the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes that recovery is not likely, the Company must establish a valuation allowance. Changes in the Company’s valuation allowance in a period are recorded through the income tax provision on the consolidated statements of operations.

ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in an entity’s financial statements and prescribes a recognition threshold and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on a tax return.

Under ASC 740-10, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, ASC 740-10 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As a result of the implementation of ASC 740-10, the Company recognized no material adjustment in the liability for unrecognized income tax benefits.

BASIC AND DILUTED EARNINGS (LOSS) PER SHARE

In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net income (loss) per share excludes the dilutive effect of stock options or warrants and convertible notes Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2021 and 2020, 26,655,760 and 33,655,760, respectively, dilutive shares were excluded from the calculation of diluted earnings (loss) per common share, as the effect of these shares on earnings per share would have been anti-dilutive; however, dilutive shares were included from the calculation of diluted income common shares for the year ended December 31, 2021.

The following table shows the computation of basic and diluted earnings (loss) per share for the year ended December 31, 2021 and 2020:

	The Years Ended
	December 31, 2021			December 31, 2020
Numerator:
Net income (loss)	$	(3,639,000	)	$	4,314,000

Denominator:
Weighted-average basic shares outstanding		559,281,064			558,322,048
Effect of dilutive securities		-			34,729,262
Weighted-average diluted shares		559,281,064			593,051,310

Basic earnings (loss) per share	$	(0.01	)	$	0.01
Diluted earnings (loss) per share	$	(0.01	)	$	0.01

F-12

Table of Contents

STOCK BASED COMPENSATION

In June 2018, FASB issued ASU No. 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Nonemployee Share Based Payment Accounting. The amendments in this Update expand the scope of stock compensation to include share-based payment transactions for acquiring goods and services from nonemployees. The guidance in this Update does not apply to transactions involving equity instruments granted to a lender or investor that provides financing to the issuer. The guidance is effective for fiscal years beginning after December 31, 2018 including interim periods within the fiscal year. The Company adopted with an effective date of January 1, 2019. Upon adoption, there was no material impact to the financial statements.

RECENT ACCOUNTING PRONOUNCEMENTS

In August 2018, the FASB issued ASU 2018-13, Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement, which removes, modifies, and adds certain disclosure requirements related to fair value measurements in ASC Topic 820. This guidance is effective for public companies in fiscal years beginning after December 15, 2019, with early adoption permitted. Effective January 1, 2020, we adopted ASU 2018-13. The implementation of this standard did not have any material impact on our consolidated financial statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. This amendment is effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company implemented on January 1, 2022 and the implementation of this standard did not have any material impact on our consolidated financial statements.

The Company has evaluated all recent accounting pronouncements and none are expected to have a material impact on the condensed consolidated financial statements.

NOTE 3 – INVESTMENT IN IMAGION BIOSYSTEMS

As of December 31, 2021, the Company owns 52,516,508 shares of Imagion, resulting in a noncontrolling interest of Imagion’s issued and outstanding common stock. Based upon Imagion’s trading price on December 31, 2021, approximately $0.05 per share, the fair value of the Imagion shares was approximately $2,901,000. During the year ended December 31, 2021, the Company recorded an unrealized loss in its investment of $2,974,000.

Below is reconciliation for the changes to the investment in Imagion for the year ended December 31, 2021:

Balance as of December 31, 2020	$	5,875,000
Change in the unrealized fair value of securities		(2,974,000	)
Balance as of December 31, 2021	$	2,901,000

NOTE 4 – NOTES PAYABLE

On October 17, 2019, The Company executed a secured note with a related party for $100,000. The secured note is due on October 17, 2022. The Company agreed that the note bears interest at 10% per annum, to be paid in advance in shares of Imagion Biosystems Limited common stock (IBX), calculated at $0.015 per share with 2 million shares of IBX common stock. The amortization of debt discount for the year ended December 31, 2021 was $17,000.

On October 17, 2019, The Company executed a secured note with an individual for $50,000. The secured note is due on October 17, 2022. The Company agreed that the note bears interest at 10% per annum, to be paid in advance in shares of Imagion Biosystems Limited common stock (IBX), calculated at $0.015 per share with 1 million shares of IBX common stock. The amortization of debt discount for the year ended December 31, 2021 was $9,000.

Notes payable	$	150,000
Less: Discounts on notes payable		(20,000	)
Notes payable, net of discounts	$	130,000

F-13

Table of Contents

MANHATTAN SCIENTIFICS, INC. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2021

NOTE 5 – CAPTIAL TRANSACTIONS

Preferred Stock

The Company has a total of 1,000,000 shares of authorized preferred shares which are segregated into four classes of preferred stock.

The Company has 182,525 authorized shares of convertible, redeemable, 10 percent cumulative, Class A, Preferred Stock with $0.001 par value. One Class A, Preferred share is convertible into 50 restricted common shares and will be entitled to the number of votes equal to the number of shares of common stock into which such holder’s shares of Series A Preferred stock could be converted at the time of the vote. Class A, Preferred Stock is redeemable by the Company at $15 per share. Upon liquidation the holders of Series A Preferred stock will be entitled to be paid out of the assets available for distribution of the corporation an amount equal to $10 per share, before any payment will be made to the common shareholders. As of December 31, 2021 and 2020, no shares of Preferred Stock were issued and outstanding.

The Company has 250,000 authorized shares of Class B, Preferred Stock with $0.001 par value. As of December 31, 2021 and 2020, 49,999 and 49,999 shares of Preferred Stock were issued and outstanding, respectively. Class B preferred shares are convertible at a rate of 1 Series B preferred share to 10 common shares.

The Company has 14,000 authorized shares of redeemable, convertible, Class C, Preferred Stock with $100 stated value. Class C, Preferred Stock is not entitled to receive dividends unless dividends are paid on common stock. Upon liquidation Class C, Preferred Stock shall be treated as if it were converted to common stock prior to liquidation. Class C, Preferred Stock is convertible at $100 divided by the 10 day average closing price of common stock. The Class C, Preferred Stock is redeemable by the Company at the stated value. As of December 31, 2021 and 2020, no shares of Preferred Stock were issued and outstanding.

On November 5, 2013, the Company entered into a Conversion Agreement with Marvin Maslow (the “Holder”) pursuant to which the Company agreed to convert $1,057,608 of debt (the “Debt”), including principal and interest, currently owed to Holder into 105,761 shares of Series D Preferred Shares of the Company. The Debt had been outstanding since 2007.

The above transactions were approved by the Board of Directors of the Company. The Series D Preferred Stock does not pay dividends and does not have a liquidation preference. The Holder of the Series D Preferred Stock will be entitled to 20 votes for each share of common stock that the Series D Preferred Stock are convertible into. The Series D Preferred Stock has a conversion price of $0.055 (the “Conversion Price”) and a stated value of $10.00 (the “Stated Value”) per share. Each share of Series D Preferred Stock is convertible, at the option of the Holder, into such number of shares of common stock of the Company as determined by dividing Stated Value by the Conversion Price.

Holder may only convert the Series D Preferred Stock upon certain Convertible Promissory Notes, whether presently outstanding or to be issued, issued to three accredited investors (the “Note Investors”) in accordance with those certain Convertible Note Purchase Agreements between the Company and the Note Investors dated April 3, 2013, have either (i) been converted in full or in part by the Note Investors into shares of common stock of the Company, (ii) the Note Investors have sold or assigned all or a part of their Convertible Promissory Notes to third parties, or (iii) the Note Investors have been paid in full or in part. The Holder will only be permitted to convert such number of Series D Preferred Stock equal to the pro rata amount of the Convertible Promissory Notes converted, assigned or paid. In the event the Note Investors agree in writing that these restrictions may be terminated, then the Holder will be entitled to convert the Series D Preferred Stock at the Holder’s election and the above restrictions will be null and void. Additionally, Holder may not convert the Series D Preferred Stock until the ten day average daily trading volume is greater than $20,000. As of the date of this filing, this has not occurred yet.

F-14

Table of Contents

MANHATTAN SCIENTIFICS, INC. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2021

In the event the Holder terminates its consulting agreement or violates a non-compete covenant, then the Series D Preferred Shares shall be returned to the Company for cancellation and the Company shall be obligated on the Debt. As the Series D Preferred Stock is conditionally redeemable, the Company has recorded the Series D Preferred Stock as mezzanine equity in the accompanying consolidated balance sheet.

The Company has 447,804 and 447,804 undesignated blank check preferred stock, $0.001 par value, authorized as of December 31, 2021 and 2020. The preferred shares are to be issued in such series and to have such rights, preferences, and designation as determine by the Board of Directors of the Company.

Common Stock

The Company has a total of 950,000,000 shares of authorized common shares. As of December 31, 2021 and 2020, 559,281,064 and 559,281,064 shares of common stock were issued and outstanding, respectively.

During the year ended December 31, 2020, the Company reclassified $1,341,000 liabilities to equity as it became certain cash would not be paid to settle and equity would be issued.

Stock Activity during 2021 and 2020

During the year ended December 31, 2021, the Company had not issued common stock.

Options

On March 22, 2021, the Company entered into a settlement with a third party, which the Company granted 15,000,000 shares of common stock options to purchase 15,000,000 shares of common stock at an exercise price of $0.0154. The options price was based on the closing market price of common stock on October 1, 2020. The Settlement is for the Employment Agreement with a third party, dated January 12, 2015 to which the Company agreed to issued common shares.

At December 31, 2021, the 26,500,000 outstanding options had an aggregate intrinsic value of $1,595,000. A summary of the Company’s stock option activity and related information is as follows:

	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Life		Number of Options Exercisable			Aggregate Intrinsic Value
Outstanding as of December 31, 2019		22,075,000			0.07		3.2		22,075,000		$	-
Granted		-			-		-		500,000
Exercised		-			-		-		-
Expired		(3,575,000	)	$	0.07		-		(3,575,000	)		-
Outstanding as of December 31, 2020		18,500,000			0.07		2.84		18,500,000			-
Granted		15,000,000			0.02		9.68		15,000,000			15,500
Exercised		-			-		-		-
Expired		(7,000,000	)		0.07		-		(7,000,000	)		-
Outstanding as of December 31, 2021		26,500,000		$	0.04		6.06		26,500,000		$	15,000

F-15

Table of Contents

MANHATTAN SCIENTIFICS, INC. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2021

Exercise prices and weighted-average contractual lives of 26,500,000 stock options outstanding as of December 31, 2021 are as follows:

				Options Outstanding				Options Exercisable
Exercise Price		Number Outstanding		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$	0.02		15,500,000		8.80	$	0.02		15,500,000	$	0.02
$	0.05		3,000,000		3.50	$	0.05		3,000,000	$	0.05
$	0.06		5,000,000		4.35	$	0.06		5,000,000	$	0.06
$	0.14		3,000,000		2.75	$	0.14		3,000,000	$	0.14

The fair value for options granted were determined using the Black-Scholes option-pricing model.

The Company did not recognize compensation expense during the year ended December 31, 2021.

NOTE 6 – INCOME TAXES

The provision for income taxes on the statements of operations consists of $-0- and $-0- for the years ended December 31, 2021 and 2020, respectively. Deferred tax assets are comprised of the following at December 31:

	2021			2020
Net operating loss carryforward	$	12,704,000		$	12,630,000
Temporary differences		6,988,000			6,988,000
Less valuation allowance		(19,692,000	)		(19,618,000	)
Deferred tax asset, net		-			-

Deferred taxes arise from temporary differences in the recognition of certain expenses for tax and financial reporting purposes. At December 31, 2021 and 2020, management determined that realization of these benefits is not assured and has provided a valuation allowance for the entire amount of such benefits. At December 31, 2021 and 2020, net operating loss carryforwards were approximately $47,275,000 and $47,043,000, respectively, for federal tax purposes that expire at various dates through 2031 and for state tax purposes expire through 2025.

Utilization of net operating loss carryforwards may be subject to substantial annual limitations due to the “change in ownership” provisions of the Internal Revenue Code of 1986, as amended, and similar state regulations. The annual limitation may result in the expiration of substantial net operating loss carryforwards before utilization.

For December 31, 2021 and 2020, the provision for income taxes differs from the amount computed by applying the U.S. federal statutory tax rate (21% in 2021 and 2020) to income taxes as follows:

	2021		2020
Tax benefit computed at 21%	$	-	$	-
Change in valuation allowance		-		-
Change in carryovers and tax attributes		-
Income tax provision	$	-	$	-

NOTE 7 – LICENSE AGREEMENT

On May 1, 2019, the Company, entered into an agreement with a non-affiliated third party (“Third Party”), providing for an exclusive license by the Company of its ECAP technology to the Third Party for a term of 17 years unless terminated sooner, a sublicense by the Company to the Third Party of its rights under that certain Exclusive Field-of-Use Patent License Agreement dated January 5, 2009 entered with The Los Alamos National Laboratory for a term until the expiration of the last valid claim to expire of the patents pursuant to such agreement and the sale by the Company of ECAP-C machines to the Third party. As part of the above license agreements, the Company will receive royalty payments, including minimum payments, based on a percentage of the Third Party’s sales. Royalties will be 10% on gross sales of licensed dental products and average of 5% on all other sales of licensed products.

During the years ended December 31, 2021 and 2020, the Company received $50,000 and $50,000, respectively, as a minimum royalty payment.

F-16

Table of Contents

MANHATTAN SCIENTIFICS, INC. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2021

NOTE 8 – COMMITMENTS AND CONTINGENCIES

Legal matter contingencies

The Company believes, based on current knowledge and after consultation with counsel, that it is not currently party to any material pending proceedings, individually or in the aggregate, the resolution of which would have a material effect on the Company. Provisions for losses are established in accordance with ASC 450, “Contingencies” when warranted. Once established, such provisions are adjusted when there is more information available of when an event occurs requiring a change.

NOTE 9 – RELATED PARTY TRANSACTIONS

As of December 31, 2021 and December 31, 2020, the Company had accrued expenses to related parties of approximately $1,129,000 and $853,000.

As of December 31, 2021, the amounts are due to the Company’s sole officer for compensation $276,000 and the chairman of the board for compensation of $786,000 and the members of the board of directors of $66,250.

NOTE 10 – SUBSEQUENT EVENTS

In accordance with ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2021 to the date these financial statements were issued, and there were no other material subsequent events to disclose in these financial statements, except as noted.

F-17

Table of Contents

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS

None

ITEM 9T. CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

Our principal executive and principal financial officers have evaluated the effectiveness of our disclosure controls and procedures, as defined in Rules 13a – 15(e) and 15d – 15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that arc designed to ensure that information required to be disclosed in our reports under the Exchange Act, is recorded, processed, summarized and reported within the time periods required under the SEC’s rules and forms and that the information is gathered and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure.

Our principal executive officer and principal financial officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(c) as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this report due to the reasons described below.

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission.

Management’s Annual Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(t) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that:

1. Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;

2. Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that our receipts and expenditures are being made only in accordance with the authorization of our management and directors; and

3. Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management assessed the effectiveness of our internal control over financial reporting as of December 31, 2021. Based on this assessment, management concluded that the Company did not maintain effective internal controls over financial reporting as a result of the identified material weakness in our internal control over financial reporting described below. In making this assessment, management used the framework set forth in the report entitled Internal Control--Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO (2013). The COSO framework summarizes each of the components of a company’s internal control system, including (i) the control environment, (ii) risk assessment, (iii) control activities, (iv) information and communication. and (v) monitoring.

Identified Material Weakness

A material weakness in our internal control over financial reporting is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement or the financial statements will not be prevented or detected.

Management identified the following material weakness during its assessment of internal controls over financial reporting as or December 31, 2021:

Resources: As of December 31, 2021, we had no full-time employees in general management and no full-time employees with the requisite expertise in the key functional areas of finance and accounting. As a result, there is a lack of proper segregation of duties necessary to insure that all transactions are accounted for accurately and in a timely manner.

Table of Contents

Written Policies & Procedures: We need to prepare written policies and procedures for accounting and financial reporting to establish a formal process to close our books monthly on an accrual basis and account for all transactions, including equity transactions, and prepare, review and submit SEC filings in a timely manner.

Audit Committee: We do not have, and are not required, to have an audit committee. An audit committee would improve oversight in the establishment and monitoring of required internal controls and procedures. The Company lacks sufficient monitoring and review controls with respect to accounting for complex transactions.

Management’s Remediation Initiatives

We plan to prepare written policies and procedures for accounting and financial reporting to establish a formal process to close our books monthly on an accrual basis and account for all transactions, including equity transactions. We also plan to add an audit committee financial expert to our board and create an audit committee made up of our independent directors.

(b) Changes in Internal Control Over Financial Reporting

There were no changes in our internal controls over financial reporting during this fiscal quarter that materially affected, or is reasonably likely to have a materially affect, on our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

Table of Contents

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS; COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT

The names, ages and biographical information of each of our directors and executive officers as of April 4, 2022 are set forth below. There are no existing family relationships between or among any of our executive officers or directors.

NAME	AGE	POSITION

Emmanuel Tsoupanarias	69	President and Chief Executive Officer, Director
Frank Georgiou	71	Director
Marvin Maslow	84	Chairman of the Board

Members of the Board serve until the next annual meeting of stockholders and until their successors are elected and qualified. Officers are appointed by and serve at the discretion of the Board. There are no family relationships among any of our directors or officers.

None of our directors or executive officers has, during the past ten years:

·	been convicted in a criminal proceeding and none of our directors or executive officers is subject to a pending criminal proceeding,
·	been subject to any order, judgment, or decree not subsequently reversed, suspended or vacated of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities, futures, commodities or banking activities, or
·	been found by a court of competent jurisdiction (in a civil action), the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.

EMMANUEL TSOUPANARIAS has served as our chief executive officer and director since November 1, 2007. Mr. Tsoupanarias is the president, founder and editor of FuelCellsWorks.com, a weekly trade publication that has become the voice of the fuel cell industry. He is internationally recognized as an expert in fuel cell development. Prior to his tenure at FuelCellsWorks.com, Mr. Tsoupanarias was an executive in the power generation manufacturing sector. From 1992 to 2007 Mr. Tsoupanarias has served as a Project Manager in the power generation sector and from 2000 has served as a consultant in the fuel cell industry. His technical and engineering background and his 11-year tenure as the Company’s CEO qualify him for the Company’s Board.

FRANK GEORGIOU has served as a director since October 2007. Since 1993, Mr. Georgiou has been the President of Three Diamond Diner Corp., a private company that owns and operates the Mount Kisco Coach Diner. He is the former President of the Upper New York Pangregorian, a consortium of restaurant owners. Mr. Georgiou’s business experience as president of a private company is valuable to the Company’s Board.

MARVIN MASLOW served as the CEO of Manhattan Scientifics from January 1998 until November 2007. On March 13, 2015, Mr. Maslow was appointed as a director of the Company. From June 1990 through September 1996, Mr. Maslow served as chief executive officer of Projectavision, Inc., a company he co-founded to develop and market video projection technology. For more than 20 years, Mr. Maslow has been President of Normandie Capital Corp., a private investment and consulting company. Mr. Maslow is credited with the starting up and financing of more than 20 enterprises during his career. Mr. Maslow received an A.A.S. degree from the Rochester Institute of Technology in 1957 and an honorable discharge from the U.S. Army Signal Corps in 1963. Mr. Maslow serves as a paid consultant to the Company, attends board meetings and serves as a special advisor to the Board of Directors. He also serves as a Manager of the Company’s Senior Scientifics LLC subsidiary.

Table of Contents

SECCTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities Exchange Act of 1934 requires our executive officers and directors, and persons who own more than ten percent of our common stock to file reports of ownership and change in ownership with the Securities and Exchange Commission and the exchange on which the common stock is listed for trading. Executive officers, directors and more than ten percent stockholders are required by regulations promulgated under the Exchange Act to furnish us with copies of all Section 16(a) reports filed. Based solely on our review of copies of the Section 16(a) reports filed for the fiscal year ended December 31, 2021, we believe that our executive officers, directors and ten percent stockholders complied with all reporting requirements applicable to them.

CODE OF ETHICS

On March 31, 2005, we adopted a code of ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of the Company’s Code of Ethics can be viewed obtained free of charge by sending a written request to the attention of the Company’s Chief Executive Officer, Emmanuel Tsoupanarias at 244 Fifth Avenue, Suite 2341, New York, New York, 10001.

CORPORATE GOVERNANCE

We do not have a separately-designated standing audit committee. The entire Board of Directors of the Company acts as the audit committee. The Board of Directors of the Company has determined that it does not have an “audit committee financial expert” as such term is defined in the rules adopted by the SEC requiring companies to disclose whether or not at least one member of the audit committee is an “audit committee financial expert.” The Board of Directors believes that the aggregate technical, commercial and financial experience of its members, together with their knowledge of the Company, provides the Board with the ability to monitor and direct the goals of the Company and to protect the best interests of its shareholders. Four of the five members of the Board of Directors are “independent,” as that term is defined in Section 10A(m) of the Securities Exchange Act of 1934, and that the members’ independence qualifies it to monitor the performance of management, the public disclosures by the Company of its financial condition and performance, the Company’s internal accounting operations and its independent auditors. In addition, the Board of Directors is authorized to engage independent financial consultants, auditors and counsel whenever it believes it is necessary and appropriate.

ITEM 11. EXECUTIVE COMPENSATION

The following tables set forth all compensation awarded by us to our executive officers for the fiscal years ended December 31, 2021 and 2020. Other than the Employment Agreement entered into between the Company and Emmanuel Tsoupanarias, our CEO, we do not have employment agreements with any of our other officers.

Name	Year	Salary ($)		Bonus ($)		Stock Awards ($)		Option Awards ($)		Non-Equity Incentive Plan Compensation ($)		Changes in Pension Value and Nonqualified Deferred Compensation Earnings ($)		All Other Compensation ($)		Total ($)

Emmanuel Tsoupanarias	2021		186,000		--		--		--		--		--		--		186,000
CEO and Director	2020		186,000		--		--		--		--		--		--		186,000

Prior to entering an Employment Agreement with the Company on March 28, 2013, Mr. Emmanuel Tsoupanarias, our Chief Executive Officer, did not have an employment agreement. His salary, was originally set at $100,000, was set by the Board of Directors in 2007. On March 28, 2013, the Company entered into an Employment Agreement with Emmanuel Tsoupanarias, our CEO. The agreement is for a term of five years and Mr. Tsoupanarias shall receive an annual salary of $150,000 per year and additional cash incentive consideration as determined by the Board. Effective January 1, 2015, the Company renewed the agreement for a period of ten years with automatic extensions for one-year periods thereafter. His salary remains at $150,000 per year and cash incentive of $3,000 per month . In the event the employment agreement is terminated by the Company without cause, then the Mr. Tsoupanarias shall receive 50% of the base salary remaining on the term and all options and other securities he would have been entitled to for an additional three months shall vest.

The independent members of the Company’s board of directors, acting as a compensation committee, reviewed the compensation policies and practices relating to the compensation provided to the Company’s employees to determine whether such policies and practices are reasonably likely to have a material adverse effect on the Company. Based on the review and the compensation paid by the Company to its only employee, the Company determined that any risks associated with the Company’s compensation practices were not reasonably likely to have a material adverse effect on the Company.

Table of Contents

Director Compensation

For the year ended December 31, 2021, for their service as directors, each of the directors received $1,250 per quarter.

Compensation Committee Interlocks and Insider Participation

Our entire board currently acts as our compensation committee. Emmanuel Tsoupanarias is the sole executive officer of our company. No member of the compensation committee is employed by or serving as a member of the board of directors or compensation committee of any entity that has one or more of its executive officers serving as a member of our board.

OUTSTANDING EQUITY AWARDS

Name	Grant Date	Number of Securities Underlying Unexercised Warrants (#) Exercisable		Number of Securities Underlying Unexercised Warrants (#) Unexercisable (1)		Warrant Exercise Price ($)		Warrant Expiration Date

Emmanuel Tsoupanarias, Director and CEO	08/05/2011		6,000,000		-	$	0.070	08/05/2021

Emmanuel Tsoupanarias, Director and CEO	06/30/2014		500,000		-	$	0.140	06/30/2024

Frank Georgiou, Director	06/30/2014		500,000		-	$	0.140	06/30/2024

Chris Theoharis, Former Director (2)	06/30/2014		500,000		-	$	0.140	06/30/2024

Leonard Friedman, Former Director (1)	06/30/2014		500,000		-	$	0.140	06/30/2024

Marvin Maslow, Chairman of the Board	06/30/2014		500,000		-	$	0.140	06/30/2024

Leonard Friedman, Former Director (1)	06/30/2015		500,000		-	$	0.05	06/30/2025

Marvin Maslow, Chairman of the Board	06/30/2015		500,000		-	$	0.05	06/30/2025

Saraklis, Inc. (Emmanuel Tsoupanarias)	06/30/2015		500,000		-	$	0.05	06/30/2025

Frank Georgiou, Director	06/30/2015		500,000		-	$	0.05	06/30/2025

Chris Theoharis, Former Director (2)	06/30/2015		500,000		-	$	0.05	06/30/2025

Leonard Friedman, Former Director (1)	06/30/2016		500,000		-	$	0.06	06/30/2026

Marvin Maslow, Chairman of the Board	06/30/2016		500,000		-	$	0.06	06/30/2026

Saraklis, Inc. (Emmanuel Tsoupanarias)	06/30/2016		500,000		-	$	0.06	06/30/2026

Frank Georgiou, Director	06/30/2016		500,000		-	$	0.06	06/30/2026

Chris Theoharis, Former Director (2)	06/30/2016		500,000		-	$	0.06	06/30/2026

___________

(1) Mr. Friedman resigned as a director on January 3, 2018.

(2) Mr. Theoharis resigned as a director on July 10, 2017.

Table of Contents

Grant of Plan Based Awards

No plan-based awards were made during the fiscal year ended December 31, 2021.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth, as of April 14, 2021, the names, addresses and number of shares of common stock beneficially owned by (i) all persons known to us to be the beneficial owners of more than 5% of the outstanding shares of common stock, (ii) each of our directors, (iii) each of our executive officers, and (iv) all of our directors and executive officers as a group. Except as indicated, each beneficial owner listed exercises sole voting power and sole dispositive power over the shares beneficially owned. Share ownership in each case includes shares issuable upon exercise of options exercisable within 60 days of the date of this Annual Report that would be required to be reported pursuant to Rule 13d-3 of the Securities Exchange Act of 1934 for purposes of computing the percentage of common stock owned by such person but not for purposes of computing the percentage owned by any other person. Unless otherwise indicated, the address of the below-listed persons is our address, 244 Avenue, Suite 2341, New York, New York 10001.

Name and Address of Beneficial Owner	Number of Shares Beneficially Owned		Percent of Class (1)

Emmanuel Tsoupanarias (2)		30,430,773		5.4	%
Frank Georgiou (3)		30,937,075		5.5	%

Marvin Maslow (4)(5)		54,982,546		9.8	%
Directors and Executive Officers as a group (3 persons)		116,350,394		20.8	%

Total		116,350,394		20.8	%

______________

(1) This tabular information is intended to conform to Rule 13d-3 promulgated under the Securities Exchange Act of 1934 relating to the determination of beneficial ownership of securities. The percent of class is based on 559,281,064 shares and, for each beneficial owner, gives effect to the exercise of warrants or options exercisable within 60 days of the date of this table owned, in each case, by the person or group whose percentage ownership is set forth herein.

(2) Includes 10,930,773 shares owned by Saraklis Inc. (“Saraklis”), a corporation controlled by Mr. Tsoupanarias, 12,000,000 shares owned by Saraklis Consultant Inc., a corporation controlled by Mr. Tsoupanarias, options for Saraklis to purchase 7,500,000 shares.

(3) Includes 28,437,075 shares of Common Stock owned by Mr. Georgiou, 1,000,000 shares of Common Stock owned by relatives of Mr. Georgiou, options to purchase 1,500,000 shares.

(4) Includes 28,028,273 shares of Common Stock, options to purchase 1,500,000 shares, 6,000,000 shares owned by Normandie New Mexico Corp., a corporation controlled 100% by Mr. Maslow, 225,000 shares owned in joint tenancy by Mr. Maslow’s wife and son, and options for Mr. Maslow to purchase 1,500,000 shares.

(5) Includes 105,761 shares of Series D Preferred Stock on an as converted basis. The Series D Preferred Stock has a conversion price of $0.055 and a stated value of $10.00 per share. Such Series D Preferred Stock is convertible into 19,229,273 shares of common stock of the Company calculated by dividing the stated value by the conversion price.

Table of Contents

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

None.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

INDEPENDENT AUDITOR FEES

The following is a summary of the fees billed to us by our independent auditors for the fiscal years ended December 31, 2021 and December 31, 2020:

Fee Category	2021		2020

Audit and audit related fees	$	29,000	$	29,000
Tax fees		-		-
Other fees		-		-
Total fees	$	29,000	$	29,000

Audit Fees. Consists of aggregate fees billed for professional services rendered for the audit of our consolidated financial statements and review of the interim consolidated financial statements included in quarterly reports and services that are normally provided by our auditors in connection with statutory and regulatory filings or engagements.

Tax Fees. Consists of aggregate fees billed for professional services for tax compliance, tax advice and tax planning. These services include assistance regarding federal and state tax compliance. There were no tax services provided in fiscal years ended December 31, 2021 and 2020.

Other Fees. Consists of fees for products and services other than the services reported above. There were no management consulting services provided in fiscal years ended December 31, 2021 and 2020.

We do not currently have an Audit Committee. Our full Board of Directors considers whether the provision of these services is compatible with maintaining the auditor’s independence, and has determined such services

BOARD OF DIRECTORS POLICY ON PRE-APPROVAL OF SERVICES OF INDEPENDENT AUDITORS

The Board of Directors’ policy is to pre-approve all audit and permissible non-audit services provided by the independent auditors on a case-by-case basis. These services may include audit services, audit-related services, tax services and other services.

Table of Contents

ITEM 15. EXHIBITS

(a) EXHIBITS

Exhibit Number			Description of Exhibit

2.1			Agreement and Plan of Reorganization (1)
2.2			Agreement and Plan of Merger (1)
3.1			Certificate of Incorporation dated August 1, 1995 (12)
3.2			Certificate of Amendment to Certificate of Incorporation dated January 8, 1998 (12)
3.3			Bylaws (1)
3.4			Certificate of Amendment of Certificate of Incorporation dated January 16, 2001 (12)
3.5			Certificate of Amendment of Certificate of Incorporation dated August 8, 2007 (12)
3.6			Certificate of Amendment of Certificate of Incorporation dated March 24, 2014
4.1			Certificate of Designation, Preferences and Rights of Series B Preferred Stock (12)
4.2			Amended Certificate of Designation, Preferences and Rights of Series B Preferred Stock (12)
4.3			Certificate of Designation, Preferences and Rights of Series C Preferred Stock (12)
4.4			Amended Certificate of Designation, Preferences and Rights of Series C Preferred Stock (2)
4.5			Certificate of Designation for the Series D Preferred Stock (14)
10.1			Manhattan Scientifics, Inc. 1998 Stock Option Plan (1)
10.2			Manhattan Scientifics, Inc. 2000 Equity Incentive Plan (5)
10.3			2004 Consultant Stock Plan (6)
10.4			Manhattan Scientifics 2005 Equity Incentive Plan (8)
10.5			Technology Transfer Agreement by and between Carpenter Technology Corporation and Manhattan Scientifics, Inc, effective as of the 12th day of September 2009 (7)
10.6			Acquisition Option Agreement by and among Senior Scientific LLC, Edward R. Flynn, Ph.D., Scientific Nanomedicine, Inc. and Manhattan Scientifics, Inc. (10)
10.7			Stock Purchase Agreement, dated as of June 12, 2008, among Manhattan Scientifics, Inc., Metallicum, Inc., and the shareholders of Metallicum (9)
10.8			Settlement and Memorandum of Agreement among Marvin Maslow, Jack B. Harrod and Manhattan Scientifics, Inc. (9)
10.9			Patent License Agreement Between Los Alamos National Security, LLC and Manhattan Scientifics, Inc. (10)
10.10			Agreement and Plan of Reorganization by and among the Company, Scientific Nanomedicine, Inc., Edward, R. Flynn and Edward R. Flynn and Maureen A. Flynn, as Co-Trustees of the Edward R. Flynn and Maureen A. Flynn Revocable Trust u/t/a dated 10/25/2006. (11)
10.11			Purchase Agreement by and among the Company, Senior Scientific LLC and Edward R. Flynn. (11)
10.12			Consulting Agreement dated June 1, 2011 between Manhattan Scientifics Inc. and V. Gerald Grafe (12)
10.13			Employment Agreement dated March 28, 2013 between Manhattan Scientifics Inc. and Emmanuel Tsoupanarias (12)
10.14			Consulting Agreement between Normandie New Mexico Corp. and Manhattan Scientifics Inc. dated October 1, 2009 (12)
10.15			Amendment to the Consulting Agreement between Normandie New Mexico Corp. and Manhattan Scientifics Inc. dated October 1, 2009 (12)
10.16			Settlement Agreement and Mutual General Releases by and between Manhattan Scientifics, Inc. and Carpenter Technology Corporation dated February 11, 2015 (22)
14.1			Code of Ethics (9)
16.1			Letter from L.L. Bradford & Company, LLC (21)
21.1			List of Subsidiaries (12)

Table of Contents

31.1				Certification of Principal Executive Officer Pursuant to Rule 13a-14(a) and 15d- 14(a)
32.1				Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
EX-101.INS**				Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
EX-101.SCH**				Inline XBRL Taxonomy Extension Schema Document.
EX-101.CAL**				Inline XBRL Taxonomy Extension Calculation Linkbase Document.
EX-101.DEF**				Inline XBRL Taxonomy Extension Definition Linkbase Document.
EX-101.LAB**				Inline XBRL Taxonomy Extension Labels Linkbase Document.
EX-101.PRE**				Inline XBRL Taxonomy Extension Presentation Linkbase Document.
EX-104**				Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

____________________

(1) Incorporated by reference to the registrant’s Form 10-SB filed with the Commission on December 8, 1999.

(2) Incorporated by reference to the registrant’s Form 10-QSB filed with the Commission on August 14, 2000 for the period ended June 30, 2000.

(3) Incorporated by reference as Amendment No. 2 to the registrant’s Form 10-SB filed with Commission on February 9, 2000.

(4) Reserved.

(5) Incorporated by reference to the registrant’s proxy statement filed on Schedule 14C filed with the Commission on December 26, 2000.

(6) Incorporated by reference to the registrant’s registration statement filed on Form S-8 filed with the Commission on November 26, 2004.

(7) Incorporated by reference to Amendment No. 2 to the registrant’s Form 10-Q/A for the period ended September 30, 2009 filed with the Commission on October 4, 2010.

(8) Incorporated by reference to the registrant’s registration statement in Form S-8 filed with the Commission on June 8, 2005.

(9) Incorporated by reference to the registrant’s Form 10-K filed with the Commission on April 9, 2010.

(10) Incorporated by reference to the registrant’s Form 10-K/A filed with the Commission on March 25, 2011.

(11) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on June 6, 2011.

(12) Incorporated by reference to the registrant’s Form 10-K filed with the Commission on March 30, 2012.

(13) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on April 9, 2013

(14) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on November 8, 2013

(15) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on January 31, 2014

(16) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on February 12, 2014

(17) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on November 18, 2014

(18) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on December 11, 2014

(19) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on January 5, 2015

(20) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on January 20, 2015

(21) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on February 9, 2015

(22) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on February 19, 2015

(23) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on March 19, 2015

(24) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on April 20, 2015

(25) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on May 7, 2015

(26) Incorporated by reference to the registrant’s Form 8-K filed with the Commission on August 28, 2015

** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

Table of Contents

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this April 5, 2022.

	MANHATTAN SCIENTIFICS, INC.

	By:	/s/ Emmanuel Tsoupanarias
		Emmanuel Tsoupanarias
		Chief Executive Officer

In accordance with the Exchange Act, this report has been signed below by the following persons on April 5, 2022 on behalf of the registrant and in the capacities indicated.

Signature		Title

/s/ Emmanuel Tsoupanarias		Chief Executive Officer, President, Director
Emmanuel Tsoupanarias		(Principal Executive, Financial and Accounting Officer)

/s/ Frank Georgiou		Director
Frank Georgiou

/s/ Marvin Maslow		Chairman of the Board
Marvin Maslow

EX-3.6 2 mhtx_ex36.htm CERTIFICATE OF AMENDMENT mhtx_ex36.htm

EXHIBIT 3.6

EX-31.1 3 mhtx_ex311.htm CERTIFICATION mhtx_ex311.htm

EXHIBIT 31.1

Certifications

I, Emmanuel Tsoupanarias, certify that:

1.	I have reviewed this annual report on Form 10-K of Manhattan Scientifics, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 5, 2022	By:	/s/ Emmanuel Tsoupanarias
		Emmanuel Tsoupanarias
		Chief Executive Officer
		(Principal Executive, Financial and Accounting Officer)

EX-32.1 4 mhtx_ex321.htm CERTIFICATION mhtx_ex321.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Manhattan Scientifics, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Emmanuel Tsoupanarias, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 5, 2022

By:

/s/ Emmanuel Tsoupanarias

Emmanuel Tsoupanarias

Chief Executive Officer (Principal Executive and,

Financial Accounting and Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Manhattan Scientifics, Inc. and will be retained by Manhattan Scientifics, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.SCH 5 mhtx-20211231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - INVESTMENT IN IMAGION BIOSYSTEMS link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - CAPITAL TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - LICENSE AGREEMENT link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - COMMITMENTS AND CONTIGENCIES link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Policies) link:presentationLink link:calculationLink link:definitionLink 000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Tables) link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - INVESTMENT IN IMAGION BIOSYSTEMS (Tables) link:presentationLink link:calculationLink link:definitionLink 000020 - Disclosure - NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 000021 - Disclosure - CAPITAL TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 000022 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 000023 - Disclosure - BASIS OF PRESENTATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details) link:presentationLink link:calculationLink link:definitionLink 000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details 1) link:presentationLink link:calculationLink link:definitionLink 000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000027 - Disclosure - INVESTMENT IN EQUITY SECURITIES (IMAGION BIOSYSTEMS) (Details) link:presentationLink link:calculationLink link:definitionLink 000028 - Disclosure - INVESTMENT IN IMAGION BIOSYSTEMS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000029 - Disclosure - NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 000030 - Disclosure - NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000031 - Disclosure - CAPITAL TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 000032 - Disclosure - CAPITAL TRANSACTIONS (Details 1) link:presentationLink link:calculationLink link:definitionLink 000033 - Disclosure - CAPITAL TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000034 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 000035 - Disclosure - INCOME TAXES (Details 1) link:presentationLink link:calculationLink link:definitionLink 000036 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000037 - Disclosure - LICENSE AGREEMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000038 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 mhtx-20211231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Voluntary Filers Current Fiscal Year End Date Entity Well Known Seasoned Issuer Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Common Stock Shares Outstanding Entity Public Float Document Annual Report Document Transition Report Entity Incorporation State Country Code Entity Tax Identification Number Entity Interactive Data Current Entity File Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Security 12b Title Local Phone Number Auditor Name Auditor Location Auditor Firm Id CONSOLIDATED BALANCE SHEETS Statement [Table] Statement [Line Items] Class of Stock [Axis] Class A Convertible Preferred Stock [Member] Class B Convertible Preferred Stock [Member] Class C Redeemable Convertible Preferred Stock [Member] ASSETS Current assets: Cash and cash equivalents Prepaid expenses Due from the sale of assets - current portion Total current assets [Assets, Current] Investment in equity securities Property and equipment, net Due from the sale of assets Other assets Total assets [Assets] LIABILITIES Current liabilities: Accounts payable and accrued expenses Accrued expenses - related parties Notes payable - related parties, net of discounts Total current liabilities [Liabilities, Current] Long-term liabilities: Notes payable - related parties, net of discounts [Notes Payable, Related Parties, Noncurrent] Total long-term liabilities [Liabilities, Noncurrent] Total liabilities [Liabilities] Series D convertible preferred mandatory redeemable, authorized 105,761 shares, 105,761 and 105,761 shares issued and outstanding, respectively STOCKHOLDERS' EQUITY Preferred, authorized 1,000,000 and 447,804 shares undesignated, 0 and 0 shares issued, and outstanding, respectively Common, authorized 950,000,000 shares, 559,281,064 and 559,281,064 shares issued, and outstanding, respectively Additional paid-in-capital Accumulated deficit Total stockholders' equity [Stockholders' Equity Attributable to Parent] TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY [Liabilities and Equity] Series D convertible preferred Stock [Member] Capital stock, shares par value Preferred stock, shares authorized Preferred stock, undesignated shares Preferred stock, shares issued Preferred stock, shares outstanding Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding CONSOLIDATED STATEMENTS OF OPERATIONS Revenue Operating costs: General and administrative expenses Research and development Total operating costs and expenses [Operating Costs and Expenses] Loss from operations before other income and expenses [Operating Income (Loss)] Other income and (expenses): Gain (Loss) on fair value adjustment of investments Gain on settlement of legal fees Interest expense [Interest Expense] Total other income (expense) [Nonoperating Income (Expense)] NET INCOME (LOSS) [Net Income (Loss) Attributable to Parent] INCOME (LOSS) PER COMMON SHARE: Weighted average number of common shares outstanding (Basic) Basic income (loss) per common share Weighted average number of common shares outstanding (Diluted) Diluted income (loss) per common share CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) Statement Equity Components [Axis] Preferred Stock Series B Common Stock Preferred Stock Series C Class A Convertible Preferred Stock [Member] Additional Paid-In Capital Retained Earnings (Accumulated Deficit) Balance, shares [Shares, Issued] Balance, amount Reclassification of liability to equity Comman stock payable for services, shares Comman stock payable for services, amount Net income Balance, shares Balance, amount CONSOLIDATED STATEMENTS OF CASH FLOWS CASH FLOWS FROM OPERATING ACTIVITIES: Net income (loss) Adjustments to reconcile net income (loss) to net cash used in operating activities: Common stock issued for services Depreciation and amortization Loss (Gain) on fair value adjustment of investments [Loss (Gain) on fair value adjustment of investments] Gain on settlement of legal fees [Gain on settlement of legal fees] Amortization of debt discount Changes in: Prepaid expenses [Increase (Decrease) in Prepaid Expense] Accounts payable and accrued expenses [Increase (Decrease) in Accounts Payable and Accrued Liabilities] Accounts payable and accrued expenses - related party Net cash used in operating activities [Net Cash Provided by (Used in) Operating Activities] CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of fixed assets [Payments to Acquire Property, Plant, and Equipment] Proceeds from sale of assets held for sale Proceeds from sale of investments Net cash provided by (used in) investing activities [Net Cash Provided by (Used in) Investing Activities] CASH FLOWS FROM FINANCING ACTIVITIES: Net cash provided by financing activities NET DECREASE IN CASH [Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect] CASH, BEGINNING OF PERIOD CASH, END OF PERIOD SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Interest paid Income taxes paid SUPPLEMENTAL DISCLOSURES OF NONCASH INVESTING AND FINANCING ACTIVITIES: Reclassification of liabilities to equity BASIS OF PRESENTATION NOTE 1 - BASIS OF PRESENTATION SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS INVESTMENT IN IMAGION BIOSYSTEMS NOTE 3 - INVESTMENT IN IMAGION BIOSYSTEMS NOTES PAYABLE NOTE 4 - NOTES PAYABLE CAPITAL TRANSACTIONS NOTE 5 - CAPITAL TRANSACTIONS INCOME TAXES NOTE 6 - INCOME TAXES LICENSE AGREEMENT NOTE 7 - LICENSE AGREEMENT COMMITMENTS AND CONTIGENCIES NOTE 8 - COMMITMENTS AND CONTIGENCIES RELATED PARTY TRANSACTIONS NOTE 9 - RELATED PARTY TRANSACTIONS SUBSEQUENT EVENTS NOTE 10 - SUBSEQUENT EVENTS BASIS OF CONSOLIDATION GOING CONCERN USE OF ESTIMATES CASH AND CASH EQUIVALENTS CASH CONCENTRATION PROPERTY AND EQUIPMENT INTANGIBLE ASSETS DUE FROM THE SALE OF ASSETS MARKETABLE SECURITIES REVENUE RECOGNITION FAIR VALUE OF FINANCIAL INSTRUMENTS RESEARCH AND DEVELOPMENT LEASE INCOME TAXES Income Tax, Policy [Policy Text Block] BASIC AND DILUTED EARNINGS (LOSS) PER SHARE STOCK-BASED COMPENSATION RECENT ACCOUNTING PRONOUNCEMENTS Schedule of fair value measurement of assets and liabilities Schedule of basic and diluted earnings (loss) per share INVESTMENT IN IMAGION BIOSYSTEMS (Tables) EX-101.CAL 7 mhtx-20211231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 8 mhtx-20211231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 9 mhtx-20211231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE GRAPHIC 10 mhtx_ex36img1.jpg begin 644 mhtx_ex36img1.jpg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

XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1

CONSOLIDATED BALANCE SHEETS - USD ($)

Dec. 31, 2021

Dec. 31, 2020

Current assets:

Cash and cash equivalents $ 232,000 $ 353,000

Prepaid expenses 15,000 12,000

Due from the sale of assets - current portion 300,000 300,000

Total current assets 547,000 665,000

Investment in equity securities 2,901,000 5,875,000

Property and equipment, net 4,000 6,000

Due from the sale of assets 0 300,000

Other assets 2,000 2,000

Total assets 3,454,000 6,848,000

Current liabilities:

Accounts payable and accrued expenses 102,000 159,000

Accrued expenses - related parties 1,129,000 853,000

Notes payable - related parties, net of discounts 130,000 0

Total current liabilities 1,361,000 1,012,000

Long-term liabilities:

Notes payable - related parties, net of discounts 0 104,000

Total long-term liabilities 0 104,000

Total liabilities 1,361,000 1,116,000

Series D convertible preferred mandatory redeemable, authorized 105,761 shares, 105,761 and 105,761 shares issued and outstanding, respectively 1,058,000 1,058,000

STOCKHOLDERS' EQUITY

Preferred, authorized 1,000,000 and 447,804 shares undesignated, 0 and 0 shares issued, and outstanding, respectively 0 0

Common, authorized 950,000,000 shares, 559,281,064 and 559,281,064 shares issued, and outstanding, respectively 559,000 559,000

Additional paid-in-capital 68,996,000 68,996,000

Accumulated deficit (68,520,000) (64,881,000)

Total stockholders' equity 1,035,000 4,674,000

TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY 3,454,000 6,848,000

Class A Convertible Preferred Stock [Member]

STOCKHOLDERS' EQUITY

Preferred, authorized 1,000,000 and 447,804 shares undesignated, 0 and 0 shares issued, and outstanding, respectively 0 0

Class B Convertible Preferred Stock [Member]

STOCKHOLDERS' EQUITY

Preferred, authorized 1,000,000 and 447,804 shares undesignated, 0 and 0 shares issued, and outstanding, respectively 0 0

Class C Redeemable Convertible Preferred Stock [Member]

STOCKHOLDERS' EQUITY

Preferred, authorized 1,000,000 and 447,804 shares undesignated, 0 and 0 shares issued, and outstanding, respectively $ 0 $ 0

X

- Definition
Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.
+ References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (g)(2)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(C))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(11))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3)(a)(2))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
+ Details

Name: us-gaap_DueFromRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due after one year (or one business cycle).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(C))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.11)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756
+ Details

Name: us-gaap_DueFromRelatedPartiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all investments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.1(h))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910
+ Details

Name: us-gaap_Investments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of obligation due after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 201.5-02(25))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(23))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 201.5-02(26))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 201.5-02(24))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988
+ Details

Name: us-gaap_LiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878
+ Details

Name: us-gaap_NotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.23)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_NotesPayableRelatedPartiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(17))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(10))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910
+ Details

Name: us-gaap_OtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316
+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 360
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of preferred shares (regardless of class), preferred partnership units (regardless of class), preferential membership interests, or any other form of preferred equity regardless of investee entity legal form.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph 14
-URI http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph (12)(c)
-URI http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph 15
-URI http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph (16)(c)
-URI http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764
+ Details

Name: us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (g)(2)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-URI http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-URI http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=mhtx_ClassAConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=mhtx_ClassBConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=mhtx_ClassCRedeemableConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.1

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares

Dec. 31, 2021

Dec. 31, 2020

Capital stock, shares par value $ 0.001 $ 0.001

Preferred stock, shares authorized 1,000,000 1,000,000

Preferred stock, undesignated shares 447,804 447,804

Preferred stock, shares issued 0 0

Preferred stock, shares outstanding 0 0

Common stock, shares authorized 950,000,000 950,000,000

Common stock, shares issued 559,281,064 559,281,064

Common stock, shares outstanding 559,281,064 559,281,064

Class A Convertible Preferred Stock [Member]

Preferred stock, shares issued 0 0

Preferred stock, shares outstanding 0 0

Class B Convertible Preferred Stock [Member]

Preferred stock, shares authorized 250,000 250,000

Preferred stock, shares issued 49,999 49,999

Preferred stock, shares outstanding 49,999 49,999

Class C Redeemable Convertible Preferred Stock [Member]

Preferred stock, shares authorized 14,000 14,000

Preferred stock, shares issued 0 0

Preferred stock, shares outstanding 0 0

Series D convertible preferred Stock [Member]

Preferred stock, shares authorized 105,761 105,761

Preferred stock, shares issued 105,761 105,761

Preferred stock, shares outstanding 105,761 105,761

X

- References
No definition available.
+ Details

Name: mhtx_PreferredStockUndesignatedShares

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementClassOfStockAxis=mhtx_ClassAConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=mhtx_ClassBConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=mhtx_ClassCRedeemableConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=mhtx_SeriesDconvertiblepreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

CONSOLIDATED STATEMENTS OF OPERATIONS

Revenue $ 50,000 $ 50,000

Operating costs:

General and administrative expenses 727,000 714,000

Research and development 10,000 11,000

Total operating costs and expenses 737,000 725,000

Loss from operations before other income and expenses (687,000) (675,000)

Other income and (expenses):

Gain (Loss) on fair value adjustment of investments (2,974,000) 5,014,000

Gain on settlement of legal fees 48,000 0

Interest expense (26,000) (25,000)

Total other income (expense) (2,952,000) 4,989,000

NET INCOME (LOSS) $ (3,639,000) $ 4,314,000

INCOME (LOSS) PER COMMON SHARE:

Weighted average number of common shares outstanding (Basic) 559,281,064 558,322,048

Basic income (loss) per common share $ (0.01) $ 0.01

Weighted average number of common shares outstanding (Diluted) 559,281,064 593,051,310

Diluted income (loss) per common share $ (0.01) $ 0.01

X

- Definition
The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings an
+ References
No definition available.
+ Details

Name: mhtx_GainOnSaleOfInvestment

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349
+ Details

Name: us-gaap_GainLossRelatedToLitigationSettlement

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227
+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (210.5-03(11))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7)
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227
+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingCostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingCostsAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherNonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 912
-SubTopic 730
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373
+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)

Total

Preferred Stock Series B

Common Stock

Preferred Stock Series C

Additional Paid-In Capital

Retained Earnings (Accumulated Deficit)

Balance, shares at Dec. 31, 2019 49,999 557,781,064 14,000

Balance, amount at Dec. 31, 2019 $ (1,005,000) $ 0 $ 558,000 $ 0 $ 67,632,000 $ (69,195,000)

Reclassification of liability to equity 1,341,000 0 $ 0 0 1,341,000 0

Comman stock payable for services, shares 1,500,000

Comman stock payable for services, amount 24,000 0 $ 1,000 0 23,000 0

Net income 4,314,000 $ 0 $ 0 $ 0 0 4,314,000

Balance, shares at Dec. 31, 2020 49,999 559,281,064 14,000

Balance, amount at Dec. 31, 2020 4,674,000 $ 0 $ 559,000 $ 0 68,996,000 (64,881,000)

Net income (3,639,000) $ 0 0 (3,639,000)

Balance, shares at Dec. 31, 2021 49,999 559,281,064 14,000

Balance, amount at Dec. 31, 2021 $ 1,035,000 $ 0 $ 559,000 $ 0 $ 68,996,000 $ (68,520,000)

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph c
-URI http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17A
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644
+ Details

Name: us-gaap_SharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income (loss) $ (3,639,000) $ 4,314,000

Adjustments to reconcile net income (loss) to net cash used in operating activities:

Common stock issued for services 0 24,000

Depreciation and amortization 2,000 2,000

Loss (Gain) on fair value adjustment of investments 2,974,000 (5,014,000)

Gain on settlement of legal fees 48,000 0

Amortization of debt discount 26,000 26,000

Changes in:

Prepaid expenses (3,000) 1,000

Accounts payable and accrued expenses (105,000) (10,250)

Accounts payable and accrued expenses - related party 276,000 269,250

Net cash used in operating activities (421,000) (388,000)

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchase of fixed assets 0 (4,000)

Proceeds from sale of assets held for sale 300,000 300,000

Proceeds from sale of investments 0 184,000

Net cash provided by (used in) investing activities 300,000 480,000

CASH FLOWS FROM FINANCING ACTIVITIES:

Net cash provided by financing activities 0 0

NET DECREASE IN CASH (121,000) 92,000

CASH, BEGINNING OF PERIOD 353,000 261,000

CASH, END OF PERIOD 232,000 353,000

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

Interest paid 0 0

Income taxes paid 0 0

SUPPLEMENTAL DISCLOSURES OF NONCASH INVESTING AND FINANCING ACTIVITIES:

Reclassification of liabilities to equity $ 0 $ 1,341,000

X

- References
No definition available.
+ Details

Name: mhtx_CommonStockIssuedForServices

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_GainLossRelatedToLitigationSettlements

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_LossGainOnFairValueAdjustmentOfInvestments

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_ReclassificationOfLiabilitiesToEquity

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.8)
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227
+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585
+ Details

Name: us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585
+ Details

Name: us-gaap_IncomeTaxesPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586
+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the sale of investment projects held by an entity in hopes of getting a future return or interest from it.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromSaleOfInvestmentProjects

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromSaleOfPropertyHeldForSale

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1

BASIS OF PRESENTATION
12 Months Ended

Dec. 31, 2021

BASIS OF PRESENTATION

NOTE 1 - BASIS OF PRESENTATION
NOTE 1 – BASIS OF PRESENTATION

Manhattan Scientifics, Inc., a Delaware corporation (formerly Grand Enterprises, Inc) (“Grand”) was established on July 31, 1992 and has a wholly-owned subsidiary: Metallicum, Inc. (“Metallicum”). On June 12, 2008, the Company acquired Metallicum, Inc, for 15,000,000 shares of Company’s common stock, Manhattan Scientifics, Inc., operates as a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in various fields, with emphasis in the areas of nano-technologies and nano-medicine. In this capacity, the Company continues to identify emerging technologies through strategic alliances with scientific laboratories, educational institutions, and scientists and leaders in industry and government. The Company has a long standing relationship with Los Alamos Laboratories in New Mexico. During 2008, the Company refocused its efforts from the development of its fuel cell technologies to its current focus on the development of nanomaterials through the acquisition of Metallicum.

Metallicum is a nanotechnology start-up company located in Colorado. Metallicum Inc. has focused on the development and manufacture of nanostructured metals for medical implants and other applications. Metallicum intends to establish manufacturing partner relationships with major Fortune 500 metals companies and strategic partnering with significant customers in the medical device & prosthetics industries as well as in auto, truck, & aircraft manufacturing industries. Metallicum’s initial products include nanostructured bulk metals and alloys in the form of rod, bar, wire and foil. The Company conducts its operations primarily in the United States.

Manhattan Scientifics purchased Metallicum to acquire its licensed rights to patented technology. The technology is comprised of three US Patents (US Patent numbers 7152448, 6197129 and 6399215) for which Metallicum (subsequently, Manhattan) had been assigned an exclusive license rights by Los Alamos National Security LLC (LANL). Under the license rights, Metallicum had all rights, title and interest throughout the world in and to any and all inventions, original works of authorship, developments, concepts, know-how, and improvements on the patents or trade secrets whether or not patentable or registrable under copyright or similar laws.

In January 2009, the Company entered into a patent license agreement with Los Alamos National Security, LLC for the exclusive licensing use of certain technology relating to the manufacture and application of nanostructuring metals and alloys. Pursuant to such agreement the Company provided a non-refundable fee and 2,000,000 shares of common stock. Additionally, the Company is required to pay an annual license fee which started in February 2010 and royalties on future net sales.

In September 2009, the Company entered into a technology transfer agreement with Carpenter Technologies Corporation (“Carpenter”). Wherein Carpenter will fully develop, manufacture and market a new class of high strength metals under an exclusive technology transfer agreement from Manhattan Scientifics and the Los Alamos National Laboratory. The proprietary process will enable super-strength metals and alloys to make products that weigh far less than in the past and without significant cost premiums. On February 11, 2015, the Company entered into a Settlement Agreement and Mutual General Releases (the “Settlement Agreement”) with Carpenter Technology Corporation related to the agreement discussed in Note 7, pursuant to which the parties settled and released each other from any and all liabilities and claims related to the Carpenter Agreements.

On November 17, 2016, Senior Scientific merged with and into Imagion Biosystems, Inc., a Nevada corporation (“Imagion”). Following the merger, Imagion held all of the liabilities, obligations and assets of Senior Scientific and the Company continued as the sole equity holder of Imagion. On June 30, 2017, Imagion completed an IPO and listing on the Australian Stock Exchange (ASX). As of December 31, 2021 , the Company owns 52,516,508 shares (1,000,000 restricted shares related to issued promissory notes interest) of Imagion, resulting in a noncontrolling interest of approximately 5% of Imagion’s issued and outstanding common stock. The Company elected to record the investment at fair value.

Manhattan Scientifics success will depend in part on its ability to obtain patents and product license rights, maintain trade secrets, and operate without infringing on the proprietary rights of others, both in the United States and other countries. There can be no assurance that patents issued to or licensed by the Company will not be challenged, invalidated, or circumvented, or that the rights granted thereunder will provide proprietary protection or competitive advantages to the Company.

X

- Definition
The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-URI http://asc.fasb.org/topic&trid=2122149

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI http://asc.fasb.org/topic&trid=2134479
+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS
12 Months Ended

Dec. 31, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS

BASIS OF CONSOLIDATION:

The condensed consolidated financial statements include the accounts of Manhattan Scientific, Inc., and its wholly owned subsidiary Metallicum. All significant intercompany balances and transactions have been eliminated.

GOING CONCERN:

As of December 31, 2021, the Company has an accumulated deficit of 68,520,000 and negative working capital of $684,000. Because of these conditions, the Company will require additional working capital to develop business operations. The Company intends to raise additional working capital through the continued licensing of its technology as well as to generate revenues for other services. There are no assurances that the Company will be able to achieve the level of revenues adequate to generate sufficient cash flow from operations to support the Company’s working capital requirements. To the extent that funds generated are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available, the Company may not continue its operations.

As of the filing date, the Coronavirus (“COVID-19”) has caused significant volatility in global markets, including the market price of our securities. The demand for our products and services has decreased and the ability of our customers to make payments for the products and services they purchased has been negatively impacted.

These factors raise substantial doubt about the Company’s ability to continue within one year from the date of filing. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

The ability to continue as a going concern is dependent on out generating cash from the sale of our common stock and/or obtaining debt financing and attaining future profitable operations. Management’s plan includes selling our equity securities and/or obtaining debt financing to fund our capital requirement and ongoing operations; however, there can be no assurance the Company will be successful in these efforts.

USE OF ESTIMATES:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. A significant estimate includes the carrying value of the Company’s patents, fair value of the Company’s common stock, assumptions used in calculating the value of stock options, depreciation and amortization.

CASH AND CASH EQUIVALENTS:

The Company considers all highly liquid investments purchased with an original maturity of year or less at the time of purchase to be cash equivalents for the purposes of the statement of cash flows.

CASH CONCENTRATION:

The Company’s cash accounts are federally insured up to $250,000 for each financial institution we hold our accounts in. As of December 31, 2021 and December 31, 2020, we had cash balances of $-0- and $103,000 exceeding the federally insured limits.

PROPERTY AND EQUIPMENT:

Property and equipment are recorded at cost. Expenditures for major additions and improvements are capitalized, and minor replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets, the useful lives range between 3-10 years, using the straight-line method for financial statement purposes.
INTANGIBLE ASSETS:

License Agreements

In 2008, the Company obtained licenses to the rights of certain patents regarding nanostructured materials developed by another company as a result of the acquisition of Metallicum. The purchase price paid for these licenses was $305,000, which represented its fair value. The Company obtained an exclusive license on two patents and a non-exclusive license on the third patent. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years. At December 31, 2021 and December 31, 2020, the license agreements were fully amortized. Under the terms of the agreement, the Company may be required to pay royalties, as defined, to the licensors.

In 2009, the Company entered into a patent license agreement with Los Alamos National Security LLC for the exclusive use of certain technology relating to the manufacture and application of nanostructuring metals and alloys. The purchase price paid for this license agreement was $33,000 based on the fair market value of 2,000,000 shares of common stock issued. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years. At December 31, 2021 and December 31, 2020, the license agreements were fully amortized. Beginning in 2010, the Company was required to pay an annual license fee of $10,000 and may be required to pay royalties, as defined, to the licensors.

DUE FROM THE SALE OF ASSETS:

Non-current assets are classified as held for sale if it is highly probably that they will be recovered primarily through sale rather than through continuing use.

Immediately before classification as held for sale, the assets are remeasured at the lower of their carrying amount and fair value less costs to sell. Any impairment loss on initial classification as held for sale and subsequent gains and losses on re-measurement are recognized in profit or loss. Gains are not recognized in excess of any cumulative impairment loss.

During the year ended December 31, 2019, the Company sold the assets held for sale that were presented on the balance sheet as of December 31, 2018. During the year ended December 31, 2018, the Company recorded impairment and adjusted the asset valuation to $1.2 million. The Company sold the assets for a total of $1.2 million of which $300,000 was received during the year ended December 31, 2019. The remaining $900,000 will be collected during the next three years in equal increments on the anniversary date of the agreement, May 1. During May 2020 and 2021, the Company received $300,000 and $300,000 respectively and reduced the due from the sale of assets. As of December 31, 2021, the Company evaluated the collectability and determined that no allowance is needed at this time due to the payment history with this third party and the subsequent receipt of funds.

MARKETABLE SECURITIES:

The Company considers securities with original maturities of greater than 90 days to be available for sale securities. Securities under this classification are recorded at fair value and unrealized gains and losses within other income (loss). The estimated fair value of the available for sale securities is determined based on quoted market prices or rates for similar instruments. In addition, the cost of debt securities in this category is adjusted for amortization of premium and accretion of discount to maturity. For available for sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other income (loss). For the year ended December 31, 2021, no allowance was recorded for credit losses.
REVENUE RECOGNITION:

The Company recognizes revenue in accordance with generally accepted accounting principles as outlined in the Financial Accounting Standard Board’s (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue From Contracts with Customers, which consists of five steps to evaluating contracts with customers for revenue recognition: (i) identify the contract with the customer; (ii) identity the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price; and (v) recognize revenue when or as the entity satisfied a performance obligation.

Revenue recognition occurs at the time we satisfy a performance obligation to our customers, when control transfers to customers, provided there are no material remaining performance obligations required of the Company or any matters of customer acceptance. We only record revenue when collectability is probable.

FAIR VALUE OF FINANCIAL INSTRUMENTS:

The Company recognized the fair value of financial instruments in accordance with FASB ASC 820, Fair Value Measurements and Disclosures, “Fair Value Measurements”, which provides a framework for measuring fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The standard also expands disclosures about instruments measured at fair value and establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1 — Quoted prices for identical assets and liabilities in active markets;
Level 2 — Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and
Level 3 — Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The Company designates cash equivalents (consisting of money market funds) and investments in securities of publicly traded companies as Level 1. The total amount of the Company’s investment classified as Level 3 is de minimis. Fair value of financial instruments: The carrying amounts of financial instruments, including cash and cash equivalents, short-term investments, accounts payable, accrued expenses and notes payables approximated fair value as of December 31, 2021 and December 31, 2020 because of the relative short term nature of these instruments.

During the year ended December 31, 2017, the Company elected fair value option for its investment in Imagion Biosystems, Inc. a Nevada company (“Imagion”) based on triggering event of dilution of ownership, which lead to the deconsolidation of Imagion. Investments in Imagion are measured at fair value as opposed to equity method based on ASC 825-10. The guidance allows entities to elect to measure certain financial assets and financial liabilities (as well as certain nonfinancial instruments that are similar to financial instruments) at fair value. Investments over which an investor has the ability to exercise significant influence are eligible for the fair value option as they represent recognized financial assets. When the fair value option is elected for an instrument, all subsequent changes in fair value for that instrument are reported in earnings.

As of December 31, 2021, the Company holds 52,516,508 shares of Imagion and is reported under fair value method under ASC 320. Any change in the value is reported on the income statement as an unrealized gain or loss on fair value adjustment of investments.

Our financial assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2021 and 2020, consisted of the following:

Total fair
value at December 31, 2021

Quoted prices in active markets for identical assets (Level1)

Significant other observable inputs (Level 2)

Significant unobservable inputs (Level 3)

Investment in equity securities

$ 2,901,000

$ 2,901,000

$ -

$ -

Total fair value at December 31, 2020

Quoted prices in active markets for identical assets (Level1)

Significant other observable inputs (Level 2)

Significant unobservable inputs (Level 3)

Investment in equity securities

$ 5,875,000

$ 5,875,000

$ -

$ -

INTELLECTUAL PROPERTY / RESEARCH AND DEVELOPMENT

In June 2008, we acquired Metallicum and its licensed rights to patented technology. The technology is comprised of three US Patents (US Patent numbers 7152448, 6197129 and 6399215) for which Metallicum (subsequently, Manhattan) had been assigned an exclusive license rights by Los Alamos National Security LLC (LANL). Under the license rights, Metallicum had all rights, title and interest throughout the world in and to any and all inventions, original works of authorship, developments, concepts, know-how, and improvements on the patents or trade secrets whether or not patentable or registerable under copyright or similar laws. The purchase price paid for these licenses was $305,000, which represents its fair value. The Company obtained an exclusive license on two patents and a non-exclusive license on the third patent. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years.

Our ability to compete depends in part on the protection of and our ability to defend our proprietary technology and on the goodwill associated with our trade names, service marks and other proprietary rights. However, we do not know if current laws will provide us with sufficient enough protection that others will not develop technologies similar or superior to ours, or that third parties will not copy or otherwise obtain or use our technologies without our authorization.

The success of our business will depend, in part, to identify technology, obtain patents, protect and enforce patents once issued and operate without infringing on the proprietary rights of others. Our success will also depend on our ability to maintain exclusive rights to trade secrets and proprietary technology we own are currently developing and will develop. We can give no assurance that any issued patents will provide us with competitive advantages or will not be challenged by others, or that the patents of others will not restrict our ability to conduct business.

In addition, we rely on certain technology licensed with a perpetual term from the Los Alamos National Laboratory and may be required to license additional technologies in the future. We do not know if these third-party licenses will be available or will continue to be available to us on acceptable commercial terms or at all. The inability to enter into and maintain any of these licenses could have a material adverse effect on our business, financial condition or results of our operations.

Policing unauthorized use of our proprietary technology and other intellectual property rights could entail significant expense. In addition, we do not know if third parties will bring claims of copyright or trademark infringement against us or claim that our use of certain technologies violates a patent or other intellectual property. Any claims of infringement, with or without merit, could be time consuming and expensive to defend, result in costly litigation, divert management attention, require us to enter into costly royalty or licensing arrangements or prevent us from using important technologies or methods, any of which could have a material adverse effect on our business, financial condition or results of our operations.

LEASES

The Company leases a facility with terms of month to month for its headquarters. The Company adopted ASC 842 on January 1, 2019 and has evaluated that has no impact on the financial statements as under the practical expedient the leases consist of terms less than one year, and therefore is not required to capitalize the lease.

During June 2019, the Company entered into an assignment and assumption of lease with the landlord and another entity for the lease term through April 2021. The average aggregate annual rent for this space is $30,360.
INCOME TAXES

The Company accounts for income taxes under an asset and liability approach. This process involves calculating the temporary and permanent differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The temporary differences result in deferred tax assets and liabilities, which would be recorded on the Company’s consolidated balance sheets in accordance with ASC 740, which established financial accounting and reporting standards for the effect of income taxes. The Company must assess the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes that recovery is not likely, the Company must establish a valuation allowance. Changes in the Company’s valuation allowance in a period are recorded through the income tax provision on the consolidated statements of operations.

ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in an entity’s financial statements and prescribes a recognition threshold and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on a tax return.

Under ASC 740-10, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, ASC 740-10 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As a result of the implementation of ASC 740-10, the Company recognized no material adjustment in the liability for unrecognized income tax benefits.

BASIC AND DILUTED EARNINGS (LOSS) PER SHARE

In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net income (loss) per share excludes the dilutive effect of stock options or warrants and convertible notes Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2021 and 2020, 26,655,760 and 33,655,760, respectively, dilutive shares were excluded from the calculation of diluted earnings (loss) per common share, as the effect of these shares on earnings per share would have been anti-dilutive; however, dilutive shares were included from the calculation of diluted income common shares for the year ended December 31, 2021.

The following table shows the computation of basic and diluted earnings (loss) per share for the year ended December 31, 2021 and 2020:

The Years Ended

December 31,
2021

December 31,
2020

Numerator:

Net income (loss)

$ (3,639,000 )

$ 4,314,000

Denominator:

Weighted-average basic shares outstanding

559,281,064

558,322,048

Effect of dilutive securities

-

34,729,262

Weighted-average diluted shares

559,281,064

593,051,310

Basic earnings (loss) per share

$ (0.01 )

$ 0.01

Diluted earnings (loss) per share

$ (0.01 )

$ 0.01

STOCK BASED COMPENSATION

In June 2018, FASB issued ASU No. 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Nonemployee Share Based Payment Accounting. The amendments in this Update expand the scope of stock compensation to include share-based payment transactions for acquiring goods and services from nonemployees. The guidance in this Update does not apply to transactions involving equity instruments granted to a lender or investor that provides financing to the issuer. The guidance is effective for fiscal years beginning after December 31, 2018 including interim periods within the fiscal year. The Company adopted with an effective date of January 1, 2019. Upon adoption, there was no material impact to the financial statements.

RECENT ACCOUNTING PRONOUNCEMENTS

In August 2018, the FASB issued ASU 2018-13, Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement, which removes, modifies, and adds certain disclosure requirements related to fair value measurements in ASC Topic 820. This guidance is effective for public companies in fiscal years beginning after December 15, 2019, with early adoption permitted. Effective January 1, 2020, we adopted ASU 2018-13. The implementation of this standard did not have any material impact on our consolidated financial statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. This amendment is effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company implemented on January 1, 2022 and the implementation of this standard did not have any material impact on our consolidated financial statements.

The Company has evaluated all recent accounting pronouncements and none are expected to have a material impact on the condensed consolidated financial statements.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.1

INVESTMENT IN IMAGION BIOSYSTEMS
12 Months Ended

Dec. 31, 2021

INVESTMENT IN IMAGION BIOSYSTEMS

NOTE 3 - INVESTMENT IN IMAGION BIOSYSTEMS
NOTE 3 – INVESTMENT IN IMAGION BIOSYSTEMS

As of December 31, 2021, the Company owns 52,516,508 shares of Imagion, resulting in a noncontrolling interest of Imagion’s issued and outstanding common stock. Based upon Imagion’s trading price on December 31, 2021, approximately $0.05 per share, the fair value of the Imagion shares was approximately $2,901,000. During the year ended December 31, 2021, the Company recorded an unrealized loss in its investment of $2,974,000.

Below is reconciliation for the changes to the investment in Imagion for the year ended December 31, 2021:

Balance as of December 31, 2020

$ 5,875,000

Change in the unrealized fair value of securities

(2,974,000 )
Balance as of December 31, 2021

$ 2,901,000

X

- Definition
The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-URI http://asc.fasb.org/topic&trid=2196965
+ Details

Name: us-gaap_EquityMethodInvestmentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.1

NOTES PAYABLE
12 Months Ended

Dec. 31, 2021

NOTES PAYABLE

NOTE 4 - NOTES PAYABLE
NOTE 4 – NOTES PAYABLE

On October 17, 2019, The Company executed a secured note with a related party for $100,000. The secured note is due on October 17, 2022. The Company agreed that the note bears interest at 10% per annum, to be paid in advance in shares of Imagion Biosystems Limited common stock (IBX), calculated at $0.015 per share with 2 million shares of IBX common stock. The amortization of debt discount for the year ended December 31, 2021 was $17,000.

On October 17, 2019, The Company executed a secured note with an individual for $50,000. The secured note is due on October 17, 2022. The Company agreed that the note bears interest at 10% per annum, to be paid in advance in shares of Imagion Biosystems Limited common stock (IBX), calculated at $0.015 per share with 1 million shares of IBX common stock. The amortization of debt discount for the year ended December 31, 2021 was $9,000.

Notes payable

$ 150,000

Less: Discounts on notes payable

(20,000 )
Notes payable, net of discounts

$ 130,000

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611
+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NotesPayableAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.1

CAPITAL TRANSACTIONS
12 Months Ended

Dec. 31, 2021

CAPITAL TRANSACTIONS

NOTE 5 - CAPITAL TRANSACTIONS
NOTE 5 – CAPTIAL TRANSACTIONS

Preferred Stock

The Company has a total of 1,000,000 shares of authorized preferred shares which are segregated into four classes of preferred stock.

The Company has 182,525 authorized shares of convertible, redeemable, 10 percent cumulative, Class A, Preferred Stock with $0.001 par value. One Class A, Preferred share is convertible into 50 restricted common shares and will be entitled to the number of votes equal to the number of shares of common stock into which such holder’s shares of Series A Preferred stock could be converted at the time of the vote. Class A, Preferred Stock is redeemable by the Company at $15 per share. Upon liquidation the holders of Series A Preferred stock will be entitled to be paid out of the assets available for distribution of the corporation an amount equal to $10 per share, before any payment will be made to the common shareholders. As of December 31, 2021 and 2020, no shares of Preferred Stock were issued and outstanding.

The Company has 250,000 authorized shares of Class B, Preferred Stock with $0.001 par value. As of December 31, 2021 and 2020, 49,999 and 49,999 shares of Preferred Stock were issued and outstanding, respectively. Class B preferred shares are convertible at a rate of 1 Series B preferred share to 10 common shares.

The Company has 14,000 authorized shares of redeemable, convertible, Class C, Preferred Stock with $100 stated value. Class C, Preferred Stock is not entitled to receive dividends unless dividends are paid on common stock. Upon liquidation Class C, Preferred Stock shall be treated as if it were converted to common stock prior to liquidation. Class C, Preferred Stock is convertible at $100 divided by the 10 day average closing price of common stock. The Class C, Preferred Stock is redeemable by the Company at the stated value. As of December 31, 2021 and 2020, no shares of Preferred Stock were issued and outstanding.

On November 5, 2013, the Company entered into a Conversion Agreement with Marvin Maslow (the “Holder”) pursuant to which the Company agreed to convert $1,057,608 of debt (the “Debt”), including principal and interest, currently owed to Holder into 105,761 shares of Series D Preferred Shares of the Company. The Debt had been outstanding since 2007.

The above transactions were approved by the Board of Directors of the Company. The Series D Preferred Stock does not pay dividends and does not have a liquidation preference. The Holder of the Series D Preferred Stock will be entitled to 20 votes for each share of common stock that the Series D Preferred Stock are convertible into. The Series D Preferred Stock has a conversion price of $0.055 (the “Conversion Price”) and a stated value of $10.00 (the “Stated Value”) per share. Each share of Series D Preferred Stock is convertible, at the option of the Holder, into such number of shares of common stock of the Company as determined by dividing Stated Value by the Conversion Price.

Holder may only convert the Series D Preferred Stock upon certain Convertible Promissory Notes, whether presently outstanding or to be issued, issued to three accredited investors (the “Note Investors”) in accordance with those certain Convertible Note Purchase Agreements between the Company and the Note Investors dated April 3, 2013, have either (i) been converted in full or in part by the Note Investors into shares of common stock of the Company, (ii) the Note Investors have sold or assigned all or a part of their Convertible Promissory Notes to third parties, or (iii) the Note Investors have been paid in full or in part. The Holder will only be permitted to convert such number of Series D Preferred Stock equal to the pro rata amount of the Convertible Promissory Notes converted, assigned or paid. In the event the Note Investors agree in writing that these restrictions may be terminated, then the Holder will be entitled to convert the Series D Preferred Stock at the Holder’s election and the above restrictions will be null and void. Additionally, Holder may not convert the Series D Preferred Stock until the ten day average daily trading volume is greater than $20,000. As of the date of this filing, this has not occurred yet.
In the event the Holder terminates its consulting agreement or violates a non-compete covenant, then the Series D Preferred Shares shall be returned to the Company for cancellation and the Company shall be obligated on the Debt. As the Series D Preferred Stock is conditionally redeemable, the Company has recorded the Series D Preferred Stock as mezzanine equity in the accompanying consolidated balance sheet.

The Company has 447,804 and 447,804 undesignated blank check preferred stock, $0.001 par value, authorized as of December 31, 2021 and 2020. The preferred shares are to be issued in such series and to have such rights, preferences, and designation as determine by the Board of Directors of the Company.

Common Stock

The Company has a total of 950,000,000 shares of authorized common shares. As of December 31, 2021 and 2020, 559,281,064 and 559,281,064 shares of common stock were issued and outstanding, respectively.

During the year ended December 31, 2020, the Company reclassified $1,341,000 liabilities to equity as it became certain cash would not be paid to settle and equity would be issued.

Stock Activity during 2021 and 2020

During the year ended December 31, 2021, the Company had not issued common stock.

During the year ended December 31, 2020, the Company issued 1,500,000 shares of common stock for services valued at $24,000. The shares were valued based on the market price of the Company’s common shares of $0.016 on the grant date.

Options

On March 22, 2021, the Company entered into a settlement with a third party, which the Company granted 15,000,000 shares of common stock options to purchase 15,000,000 shares of common stock at an exercise price of $0.0154. The options price was based on the closing market price of common stock on October 1, 2020. The Settlement is for the Employment Agreement with a third party, dated January 12, 2015 to which the Company agreed to issued common shares.

At December 31, 2021, the 26,500,000 outstanding options had an aggregate intrinsic value of $1,595,000. A summary of the Company’s stock option activity and related information is as follows:

Number of Options

Weighted Average Exercise Price

Weighted Average Remaining Life

Number of Options Exercisable

Aggregate Intrinsic Value

Outstanding as of December 31, 2019

22,075,000

0.07

3.2

22,075,000

$ -

Granted

-

-

-

500,000

Exercised

-

-

-

-

Expired

(3,575,000 )

$ 0.07

-

(3,575,000 )

-

Outstanding as of December 31, 2020

18,500,000

0.07

2.84

18,500,000

-

Granted

15,000,000

0.02

9.68

15,000,000

15,500

Exercised

-

-

-

-

Expired

(7,000,000 )

0.07

-

(7,000,000 )

-

Outstanding as of December 31, 2021

26,500,000

$ 0.04

6.06

26,500,000

$ 15,000

Exercise prices and weighted-average contractual lives of 26,500,000 stock options outstanding as of December 31, 2021 are as follows:

Options Outstanding

Options Exercisable

Exercise Price

Number Outstanding

Weighted Average Remaining Contractual Life

Weighted Average Exercise Price

Number Exercisable

Weighted Average Exercise Price

$ 0.02

15,500,000

8.80

$ 0.02

15,500,000

$ 0.02

$ 0.05

3,000,000

3.50

$ 0.05

3,000,000

$ 0.05

$ 0.06

5,000,000

4.35

$ 0.06

5,000,000

$ 0.06

$ 0.14

3,000,000

2.75

$ 0.14

3,000,000

$ 0.14

The fair value for options granted were determined using the Black-Scholes option-pricing model.

The Company did not recognize compensation expense during the year ended December 31, 2021.

X

- References
No definition available.
+ Details

Name: us-gaap_BusinessCombinationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.1

INCOME TAXES
12 Months Ended

Dec. 31, 2021

INCOME TAXES

NOTE 6 - INCOME TAXES
NOTE 6 – INCOME TAXES

The provision for income taxes on the statements of operations consists of $-0- and $-0- for the years ended December 31, 2021 and 2020, respectively. Deferred tax assets are comprised of the following at December 31:

2021

2020

Net operating loss carryforward

$ 12,704,000

$ 12,630,000

Temporary differences

6,988,000

6,988,000

Less valuation allowance

(19,692,000 )

(19,618,000 )
Deferred tax asset, net

-

-

Deferred taxes arise from temporary differences in the recognition of certain expenses for tax and financial reporting purposes. At December 31, 2021 and 2020, management determined that realization of these benefits is not assured and has provided a valuation allowance for the entire amount of such benefits. At December 31, 2021 and 2020, net operating loss carryforwards were approximately $47,275,000 and $47,043,000, respectively, for federal tax purposes that expire at various dates through 2031 and for state tax purposes expire through 2025.

Utilization of net operating loss carryforwards may be subject to substantial annual limitations due to the “change in ownership” provisions of the Internal Revenue Code of 1986, as amended, and similar state regulations. The annual limitation may result in the expiration of substantial net operating loss carryforwards before utilization.

For December 31, 2021 and 2020, the provision for income taxes differs from the amount computed by applying the U.S. federal statutory tax rate (21% in 2021 and 2020) to income taxes as follows:

2021

2020

Tax benefit computed at 21%

$ -

$ -

Change in valuation allowance

-

-

Change in carryovers and tax attributes

-

Income tax provision

$ -

$ -

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.1

LICENSE AGREEMENT
12 Months Ended

Dec. 31, 2021

LICENSE AGREEMENT

NOTE 7 - LICENSE AGREEMENT
NOTE 7 – LICENSE AGREEMENT

On May 1, 2019, the Company, entered into an agreement with a non-affiliated third party (“Third Party”), providing for an exclusive license by the Company of its ECAP technology to the Third Party for a term of 17 years unless terminated sooner, a sublicense by the Company to the Third Party of its rights under that certain Exclusive Field-of-Use Patent License Agreement dated January 5, 2009 entered with The Los Alamos National Laboratory for a term until the expiration of the last valid claim to expire of the patents pursuant to such agreement and the sale by the Company of ECAP-C machines to the Third party. As part of the above license agreements, the Company will receive royalty payments, including minimum payments, based on a percentage of the Third Party’s sales. Royalties will be 10% on gross sales of licensed dental products and average of 5% on all other sales of licensed products.

During the years ended December 31, 2021 and 2020, the Company received $50,000 and $50,000, respectively, as a minimum royalty payment.

X

- References
No definition available.
+ Details

Name: mhtx_LicenseAgreementTextBlock

Namespace Prefix: mhtx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.1

COMMITMENTS AND CONTIGENCIES
12 Months Ended

Dec. 31, 2021

COMMITMENTS AND CONTIGENCIES

NOTE 8 - COMMITMENTS AND CONTIGENCIES
NOTE 8 – COMMITMENTS AND CONTINGENCIES

Legal matter contingencies

The Company believes, based on current knowledge and after consultation with counsel, that it is not currently party to any material pending proceedings, individually or in the aggregate, the resolution of which would have a material effect on the Company. Provisions for losses are established in accordance with ASC 450, “Contingencies” when warranted. Once established, such provisions are adjusted when there is more information available of when an event occurs requiring a change.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-URI http://asc.fasb.org/topic&trid=2127136

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-URI http://asc.fasb.org/topic&trid=2144648

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 440
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.1

RELATED PARTY TRANSACTIONS
12 Months Ended

Dec. 31, 2021

RELATED PARTY TRANSACTIONS

NOTE 9 - RELATED PARTY TRANSACTIONS
NOTE 9 – RELATED PARTY TRANSACTIONS

As of December 31, 2021 and December 31, 2020, the Company had accrued expenses to related parties of approximately $1,129,000 and $853,000.

As of December 31, 2021, the amounts are due to the Company’s sole officer for compensation $276,000 and the chairman of the board for compensation of $786,000 and the members of the board of directors of $66,250.

X

- References
No definition available.
+ Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-URI http://asc.fasb.org/topic&trid=2122745

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864
+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.1

SUBSEQUENT EVENTS
12 Months Ended

Dec. 31, 2021

SUBSEQUENT EVENTS

NOTE 10 - SUBSEQUENT EVENTS
NOTE 10 – SUBSEQUENT EVENTS

In accordance with ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2021 to the date these financial statements were issued, and there were no other material subsequent events to disclose in these financial statements, except as noted.

X

- Definition
Tabular disclosure of significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, losses resulting from fire or flood, losses on receivables, significant realized and unrealized gains and losses that result from changes in quoted market prices of securities, declines in market prices of inventory, changes in authorized or issued debt (SEC), significant foreign exchange rate changes, substantial loans to insiders or affiliates, significant long-term investments, and substantial dividends not in the ordinary course of business.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662
+ Details

Name: us-gaap_ScheduleOfSubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Policies)
12 Months Ended

Dec. 31, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS

BASIS OF CONSOLIDATION
BASIS OF CONSOLIDATION:

The condensed consolidated financial statements include the accounts of Manhattan Scientific, Inc., and its wholly owned subsidiary Metallicum. All significant intercompany balances and transactions have been eliminated.

GOING CONCERN
GOING CONCERN:

As of December 31, 2021, the Company has an accumulated deficit of 68,520,000 and negative working capital of $684,000. Because of these conditions, the Company will require additional working capital to develop business operations. The Company intends to raise additional working capital through the continued licensing of its technology as well as to generate revenues for other services. There are no assurances that the Company will be able to achieve the level of revenues adequate to generate sufficient cash flow from operations to support the Company’s working capital requirements. To the extent that funds generated are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available, the Company may not continue its operations.

As of the filing date, the Coronavirus (“COVID-19”) has caused significant volatility in global markets, including the market price of our securities. The demand for our products and services has decreased and the ability of our customers to make payments for the products and services they purchased has been negatively impacted.

These factors raise substantial doubt about the Company’s ability to continue within one year from the date of filing. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

The ability to continue as a going concern is dependent on out generating cash from the sale of our common stock and/or obtaining debt financing and attaining future profitable operations. Management’s plan includes selling our equity securities and/or obtaining debt financing to fund our capital requirement and ongoing operations; however, there can be no assurance the Company will be successful in these efforts.

USE OF ESTIMATES
USE OF ESTIMATES:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. A significant estimate includes the carrying value of the Company’s patents, fair value of the Company’s common stock, assumptions used in calculating the value of stock options, depreciation and amortization.

CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS:

The Company considers all highly liquid investments purchased with an original maturity of year or less at the time of purchase to be cash equivalents for the purposes of the statement of cash flows.

CASH CONCENTRATION
CASH CONCENTRATION:

The Company’s cash accounts are federally insured up to $250,000 for each financial institution we hold our accounts in. As of December 31, 2021 and December 31, 2020, we had cash balances of $-0- and $103,000 exceeding the federally insured limits.

PROPERTY AND EQUIPMENT
PROPERTY AND EQUIPMENT:

Property and equipment are recorded at cost. Expenditures for major additions and improvements are capitalized, and minor replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets, the useful lives range between 3-10 years, using the straight-line method for financial statement purposes.

INTANGIBLE ASSETS
INTANGIBLE ASSETS:

License Agreements

In 2008, the Company obtained licenses to the rights of certain patents regarding nanostructured materials developed by another company as a result of the acquisition of Metallicum. The purchase price paid for these licenses was $305,000, which represented its fair value. The Company obtained an exclusive license on two patents and a non-exclusive license on the third patent. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years. At December 31, 2021 and December 31, 2020, the license agreements were fully amortized. Under the terms of the agreement, the Company may be required to pay royalties, as defined, to the licensors.

In 2009, the Company entered into a patent license agreement with Los Alamos National Security LLC for the exclusive use of certain technology relating to the manufacture and application of nanostructuring metals and alloys. The purchase price paid for this license agreement was $33,000 based on the fair market value of 2,000,000 shares of common stock issued. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years. At December 31, 2021 and December 31, 2020, the license agreements were fully amortized. Beginning in 2010, the Company was required to pay an annual license fee of $10,000 and may be required to pay royalties, as defined, to the licensors.

DUE FROM THE SALE OF ASSETS
DUE FROM THE SALE OF ASSETS:

Non-current assets are classified as held for sale if it is highly probably that they will be recovered primarily through sale rather than through continuing use.

Immediately before classification as held for sale, the assets are remeasured at the lower of their carrying amount and fair value less costs to sell. Any impairment loss on initial classification as held for sale and subsequent gains and losses on re-measurement are recognized in profit or loss. Gains are not recognized in excess of any cumulative impairment loss.

During the year ended December 31, 2019, the Company sold the assets held for sale that were presented on the balance sheet as of December 31, 2018. During the year ended December 31, 2018, the Company recorded impairment and adjusted the asset valuation to $1.2 million. The Company sold the assets for a total of $1.2 million of which $300,000 was received during the year ended December 31, 2019. The remaining $900,000 will be collected during the next three years in equal increments on the anniversary date of the agreement, May 1. During May 2020 and 2021, the Company received $300,000 and $300,000 respectively and reduced the due from the sale of assets. As of December 31, 2021, the Company evaluated the collectability and determined that no allowance is needed at this time due to the payment history with this third party and the subsequent receipt of funds.

MARKETABLE SECURITIES
MARKETABLE SECURITIES:

The Company considers securities with original maturities of greater than 90 days to be available for sale securities. Securities under this classification are recorded at fair value and unrealized gains and losses within other income (loss). The estimated fair value of the available for sale securities is determined based on quoted market prices or rates for similar instruments. In addition, the cost of debt securities in this category is adjusted for amortization of premium and accretion of discount to maturity. For available for sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other income (loss). For the year ended December 31, 2021, no allowance was recorded for credit losses.

REVENUE RECOGNITION
REVENUE RECOGNITION:

The Company recognizes revenue in accordance with generally accepted accounting principles as outlined in the Financial Accounting Standard Board’s (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue From Contracts with Customers, which consists of five steps to evaluating contracts with customers for revenue recognition: (i) identify the contract with the customer; (ii) identity the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price; and (v) recognize revenue when or as the entity satisfied a performance obligation.

Revenue recognition occurs at the time we satisfy a performance obligation to our customers, when control transfers to customers, provided there are no material remaining performance obligations required of the Company or any matters of customer acceptance. We only record revenue when collectability is probable.

FAIR VALUE OF FINANCIAL INSTRUMENTS
FAIR VALUE OF FINANCIAL INSTRUMENTS:

The Company recognized the fair value of financial instruments in accordance with FASB ASC 820, Fair Value Measurements and Disclosures, “Fair Value Measurements”, which provides a framework for measuring fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The standard also expands disclosures about instruments measured at fair value and establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1 — Quoted prices for identical assets and liabilities in active markets;
Level 2 — Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and
Level 3 — Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The Company designates cash equivalents (consisting of money market funds) and investments in securities of publicly traded companies as Level 1. The total amount of the Company’s investment classified as Level 3 is de minimis. Fair value of financial instruments: The carrying amounts of financial instruments, including cash and cash equivalents, short-term investments, accounts payable, accrued expenses and notes payables approximated fair value as of December 31, 2021 and December 31, 2020 because of the relative short term nature of these instruments.

During the year ended December 31, 2017, the Company elected fair value option for its investment in Imagion Biosystems, Inc. a Nevada company (“Imagion”) based on triggering event of dilution of ownership, which lead to the deconsolidation of Imagion. Investments in Imagion are measured at fair value as opposed to equity method based on ASC 825-10. The guidance allows entities to elect to measure certain financial assets and financial liabilities (as well as certain nonfinancial instruments that are similar to financial instruments) at fair value. Investments over which an investor has the ability to exercise significant influence are eligible for the fair value option as they represent recognized financial assets. When the fair value option is elected for an instrument, all subsequent changes in fair value for that instrument are reported in earnings.

As of December 31, 2021, the Company holds 52,516,508 shares of Imagion and is reported under fair value method under ASC 320. Any change in the value is reported on the income statement as an unrealized gain or loss on fair value adjustment of investments.

Our financial assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2021 and 2020, consisted of the following:

Total fair
value at December 31, 2021

Quoted prices in active markets for identical assets (Level1)

Significant other observable inputs (Level 2)

Significant unobservable inputs (Level 3)

Investment in equity securities

$ 2,901,000

$ 2,901,000

$ -

$ -

Total fair value at December 31, 2020

Quoted prices in active markets for identical assets (Level1)

Significant other observable inputs (Level 2)

Significant unobservable inputs (Level 3)

Investment in equity securities

$ 5,875,000

$ 5,875,000

$ -

$ -

RESEARCH AND DEVELOPMENT
INTELLECTUAL PROPERTY / RESEARCH AND DEVELOPMENT

In June 2008, we acquired Metallicum and its licensed rights to patented technology. The technology is comprised of three US Patents (US Patent numbers 7152448, 6197129 and 6399215) for which Metallicum (subsequently, Manhattan) had been assigned an exclusive license rights by Los Alamos National Security LLC (LANL). Under the license rights, Metallicum had all rights, title and interest throughout the world in and to any and all inventions, original works of authorship, developments, concepts, know-how, and improvements on the patents or trade secrets whether or not patentable or registerable under copyright or similar laws. The purchase price paid for these licenses was $305,000, which represents its fair value. The Company obtained an exclusive license on two patents and a non-exclusive license on the third patent. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years.

Our ability to compete depends in part on the protection of and our ability to defend our proprietary technology and on the goodwill associated with our trade names, service marks and other proprietary rights. However, we do not know if current laws will provide us with sufficient enough protection that others will not develop technologies similar or superior to ours, or that third parties will not copy or otherwise obtain or use our technologies without our authorization.

The success of our business will depend, in part, to identify technology, obtain patents, protect and enforce patents once issued and operate without infringing on the proprietary rights of others. Our success will also depend on our ability to maintain exclusive rights to trade secrets and proprietary technology we own are currently developing and will develop. We can give no assurance that any issued patents will provide us with competitive advantages or will not be challenged by others, or that the patents of others will not restrict our ability to conduct business.

In addition, we rely on certain technology licensed with a perpetual term from the Los Alamos National Laboratory and may be required to license additional technologies in the future. We do not know if these third-party licenses will be available or will continue to be available to us on acceptable commercial terms or at all. The inability to enter into and maintain any of these licenses could have a material adverse effect on our business, financial condition or results of our operations.

Policing unauthorized use of our proprietary technology and other intellectual property rights could entail significant expense. In addition, we do not know if third parties will bring claims of copyright or trademark infringement against us or claim that our use of certain technologies violates a patent or other intellectual property. Any claims of infringement, with or without merit, could be time consuming and expensive to defend, result in costly litigation, divert management attention, require us to enter into costly royalty or licensing arrangements or prevent us from using important technologies or methods, any of which could have a material adverse effect on our business, financial condition or results of our operations.

LEASE
LEASES

The Company leases a facility with terms of month to month for its headquarters. The Company adopted ASC 842 on January 1, 2019 and has evaluated that has no impact on the financial statements as under the practical expedient the leases consist of terms less than one year, and therefore is not required to capitalize the lease.

During June 2019, the Company entered into an assignment and assumption of lease with the landlord and another entity for the lease term through April 2021. The average aggregate annual rent for this space is $30,360.

INCOME TAXES
INCOME TAXES

The Company accounts for income taxes under an asset and liability approach. This process involves calculating the temporary and permanent differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The temporary differences result in deferred tax assets and liabilities, which would be recorded on the Company’s consolidated balance sheets in accordance with ASC 740, which established financial accounting and reporting standards for the effect of income taxes. The Company must assess the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes that recovery is not likely, the Company must establish a valuation allowance. Changes in the Company’s valuation allowance in a period are recorded through the income tax provision on the consolidated statements of operations.

ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in an entity’s financial statements and prescribes a recognition threshold and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on a tax return.

Under ASC 740-10, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, ASC 740-10 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As a result of the implementation of ASC 740-10, the Company recognized no material adjustment in the liability for unrecognized income tax benefits.

BASIC AND DILUTED EARNINGS (LOSS) PER SHARE
BASIC AND DILUTED EARNINGS (LOSS) PER SHARE

In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net income (loss) per share excludes the dilutive effect of stock options or warrants and convertible notes Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2021 and 2020, 26,655,760 and 33,655,760, respectively, dilutive shares were excluded from the calculation of diluted earnings (loss) per common share, as the effect of these shares on earnings per share would have been anti-dilutive; however, dilutive shares were included from the calculation of diluted income common shares for the year ended December 31, 2021.

The following table shows the computation of basic and diluted earnings (loss) per share for the year ended December 31, 2021 and 2020:

The Years Ended

December 31,
2021

December 31,
2020

Numerator:

Net income (loss)

$ (3,639,000 )

$ 4,314,000

Denominator:

Weighted-average basic shares outstanding

559,281,064

558,322,048

Effect of dilutive securities

-

34,729,262

Weighted-average diluted shares

559,281,064

593,051,310

Basic earnings (loss) per share

$ (0.01 )

$ 0.01

Diluted earnings (loss) per share

$ (0.01 )

$ 0.01

STOCK-BASED COMPENSATION
STOCK BASED COMPENSATION

In June 2018, FASB issued ASU No. 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Nonemployee Share Based Payment Accounting. The amendments in this Update expand the scope of stock compensation to include share-based payment transactions for acquiring goods and services from nonemployees. The guidance in this Update does not apply to transactions involving equity instruments granted to a lender or investor that provides financing to the issuer. The guidance is effective for fiscal years beginning after December 31, 2018 including interim periods within the fiscal year. The Company adopted with an effective date of January 1, 2019. Upon adoption, there was no material impact to the financial statements.

RECENT ACCOUNTING PRONOUNCEMENTS
RECENT ACCOUNTING PRONOUNCEMENTS

In August 2018, the FASB issued ASU 2018-13, Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement, which removes, modifies, and adds certain disclosure requirements related to fair value measurements in ASC Topic 820. This guidance is effective for public companies in fiscal years beginning after December 15, 2019, with early adoption permitted. Effective January 1, 2020, we adopted ASU 2018-13. The implementation of this standard did not have any material impact on our consolidated financial statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. This amendment is effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company implemented on January 1, 2022 and the implementation of this standard did not have any material impact on our consolidated financial statements.

The Company has evaluated all recent accounting pronouncements and none are expected to have a material impact on the condensed consolidated financial statements.

X

- References
No definition available.
+ Details

Name: mhtx_CashConcentration

Namespace Prefix: mhtx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_DueFromTheSaleOfAssetsPolicyTextBlock

Namespace Prefix: mhtx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_MarketableSecuritiesPolicyTextBlock

Namespace Prefix: mhtx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(1))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684
+ Details

Name: us-gaap_ConsolidationPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257
+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueMeasurementPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319
+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 926
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 920
-SubTopic 350
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 920
-SubTopic 350
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 920
-SubTopic 350
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783
+ Details

Name: us-gaap_IntangibleAssetsFiniteLivedPolicy

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 958
-SubTopic 360
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13(a))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 958
-SubTopic 360
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373
+ Details

Name: us-gaap_ResearchAndDevelopmentExpensePolicy

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790
+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(f)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901
+ Details

Name: us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy election for short-term lease to recognize lease payments on straight-line basis over lease term and variable lease payments as incurred.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 25
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123399704&loc=SL77918418-209957
+ Details

Name: us-gaap_ShortTermLeasesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 40
-URI http://asc.fasb.org/subtopic&trid=51888271
+ Details

Name: us-gaap_SubstantialDoubtAboutGoingConcernTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592
+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Tables)
12 Months Ended

Dec. 31, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS

Schedule of fair value measurement of assets and liabilities

Total fair
value at December 31, 2021

Quoted prices in active markets for identical assets (Level1)

Significant other observable inputs (Level 2)

Significant unobservable inputs (Level 3)

Investment in equity securities

$ 2,901,000

$ 2,901,000

$ -

$ -

Total fair value at December 31, 2020

Quoted prices in active markets for identical assets (Level1)

Significant other observable inputs (Level 2)

Significant unobservable inputs (Level 3)

Investment in equity securities

$ 5,875,000

$ 5,875,000

$ -

$ -

Schedule of basic and diluted earnings (loss) per share

The Years Ended

December 31,
2021

December 31,
2020

Numerator:

Net income (loss)

$ (3,639,000 )

$ 4,314,000

Denominator:

Weighted-average basic shares outstanding

559,281,064

558,322,048

Effect of dilutive securities

-

34,729,262

Weighted-average diluted shares

559,281,064

593,051,310

Basic earnings (loss) per share

$ (0.01 )

$ 0.01

Diluted earnings (loss) per share

$ (0.01 )

$ 0.01

X

- References
No definition available.
+ Details

Name: mhtx_ScheduleOfFairValueMeasurementOfAssetsAndLiabilitiesTableTextBlock

Namespace Prefix: mhtx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257
+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.1

INVESTMENT IN IMAGION BIOSYSTEMS (Tables)
12 Months Ended

Dec. 31, 2021

INVESTMENT IN IMAGION BIOSYSTEMS (Tables)

Schedule of changes to the investment in Imagion
Balance as of December 31, 2020

$ 5,875,000

Change in the unrealized fair value of securities

(2,974,000 )
Balance as of December 31, 2021

$ 2,901,000

X

- Definition
For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563
+ Details

Name: us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.1

NOTES PAYABLE (Tables)
12 Months Ended

Dec. 31, 2021

NOTES PAYABLE

Schedule of debt discount
Notes payable

$ 150,000

Less: Discounts on notes payable

(20,000 )
Notes payable, net of discounts

$ 130,000

X

- References
No definition available.
+ Details

Name: mhtx_ScheduleOfDebtDiscount

Namespace Prefix: mhtx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NotesPayableAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.1

CAPITAL TRANSACTIONS (Tables)
12 Months Ended

Dec. 31, 2021

CAPITAL TRANSACTIONS

Summary of Company's stock option activity

Number of Options

Weighted Average Exercise Price

Weighted Average Remaining Life

Number of Options Exercisable

Aggregate Intrinsic Value

Outstanding as of December 31, 2019

22,075,000

0.07

3.2

22,075,000

$ -

Granted

-

-

-

500,000

Exercised

-

-

-

-

Expired

(3,575,000 )

$ 0.07

-

(3,575,000 )

-

Outstanding as of December 31, 2020

18,500,000

0.07

2.84

18,500,000

-

Granted

15,000,000

0.02

9.68

15,000,000

15,500

Exercised

-

-

-

-

Expired

(7,000,000 )

0.07

-

(7,000,000 )

-

Outstanding as of December 31, 2021

26,500,000

$ 0.04

6.06

26,500,000

$ 15,000

Exercise prices and weighted-average contractual lives of stock options outstanding

Options Outstanding

Options Exercisable

Exercise Price

Number Outstanding

Weighted Average Remaining Contractual Life

Weighted Average Exercise Price

Number Exercisable

Weighted Average Exercise Price

$ 0.02

15,500,000

8.80

$ 0.02

15,500,000

$ 0.02

$ 0.05

3,000,000

3.50

$ 0.05

3,000,000

$ 0.05

$ 0.06

5,000,000

4.35

$ 0.06

5,000,000

$ 0.06

$ 0.14

3,000,000

2.75

$ 0.14

3,000,000

$ 0.14

X

- References
No definition available.
+ Details

Name: mhtx_ExercisePricesAndWeightedaverageContractualLivesOfStockOptionsOutstandingTableTextBlock

Namespace Prefix: mhtx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_BusinessCombinationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.1

INCOME TAXES (Tables)
12 Months Ended

Dec. 31, 2021

INCOME TAXES (Tables)

Summary of deferred tax assets

2021

2020

Net operating loss carryforward

$ 12,704,000

$ 12,630,000

Temporary differences

6,988,000

6,988,000

Less valuation allowance

(19,692,000 )

(19,618,000 )
Deferred tax asset, net

-

-

Provision for income taxes differs from amount computed by applying U.S. federal statutory tax rate

2021

2020

Tax benefit computed at 21%

$ -

$ -

Change in valuation allowance

-

-

Change in carryovers and tax attributes

-

Income tax provision

$ -

$ -

X

- References
No definition available.
+ Details

Name: us-gaap_ReceivablesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319
+ Details

Name: us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319
+ Details

Name: us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.1

BASIS OF PRESENTATION (Details Narrative) - shares
1 Months Ended

Jun. 12, 2008

Jan. 31, 2009

Dec. 31, 2021

Metallicum, Inc [Member] | In 2008 [Member]

Common stock ,shares acquired 15,000,000

Los Alamos National Security LLC [Member] | Patent license agreement [Member]

Common stock shares issued 2,000,000

Imagion Biosystems, Inc. [Member]

Common stock owned shares 52,516,508

Issued and outstanding shares noncontrolling interest 5.00%

Restricted shares related to issued promissory notes interest 1,000,000

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to
+ References
No definition available.
+ Details

Name: mhtx_CommonStockOwnedShares

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: mhtx_IssuedAndOutstandingSharesNoncontrollingInterest

Namespace Prefix: mhtx_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: mhtx_RestrictedSharesRelatedToIssuedPromissoryNotesInterest

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of equity interests issued or issuable to acquire entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479
+ Details

Name: us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares of stock issued attributable to transactions classified as other.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesOther

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mhtx_MetallicumIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardDateAxis=mhtx_InTwoThousandEightMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mhtx_LosAlamosNationalSecurityLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=mhtx_PatentLicenseAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mhtx_ImagionBiosystemsIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details) - USD ($)

Dec. 31, 2021

Dec. 31, 2020

Investment in equity securities $ 2,901,000 $ 5,875,000

Quoted prices in active markets for identical assets [Member] | Level 1 [Member]

Investment in equity securities 2,901,000 5,875,000

Significant other observable inputs [Member] | Level 2 [Member]

Investment in equity securities 0 0

Significant unobservable inputs [Member] | Level 3 [Member]

Investment in equity securities $ 0 $ 0

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all investments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.1(h))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910
+ Details

Name: us-gaap_Investments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=mhtx_QuotedPricesInActiveMarketsForIdenticalAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=mhtx_SignificantOtherObservableInputsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=mhtx_SignificantUnobservableInputsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details 1) - USD ($)
12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

Numerator:

Net income (loss) $ (3,639,000) $ 4,314,000

Denominator:

Weighted-average basic shares outstanding 559,281,064 558,322,048

Effect of dilutive securities 0 34,729,262

Weighted-average diluted shares 559,281,064 593,051,310

Basic earnings (loss) per share $ (0.01) $ 0.01

Diluted earnings (loss) per share $ (0.01) $ 0.01

X

- References
No definition available.
+ Details

Name: mhtx_EffectOfDilutiveSecurities

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 23: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 31: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686

Reference 32: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended

May 31, 2020

Jun. 30, 2008

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Dec. 31, 2018

Dec. 31, 2009

Common stock owned shares 52,516,508

Proceeds from sale of assets held for sale $ 300,000 $ 300,000 $ 300,000 $ 300,000

Remaining amount of assets 900,000

Accumulated deficit (68,520,000) (64,881,000)

Working capital deficit 684,000

Cash FDIC insured amount 250,000

Cash exceeding insured amount $ 0 $ 103,000

Adjusted asset valuation $ 1,200,000

Sale of asset 1,200,000

Income Tax Examination, Likelihood of Unfavorable Settlement An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.

Weighted average number diluted shares 26,655,760 33,655,760

Minimum [Member]

Property and equipment useful lives 3 years

Maximum [Member]

Property and equipment useful lives 10 years

In 2008 [Member] | Metallicum, Inc [Member]

Licenses purchased price $ 305,000 $ 35,000

Amortization period 10 years 10 years

June 2019 [Member]

Aggregate annual rent $ 30,360

In 2009 [Member] | Los Alamos National Security LLC [Member] | Patent license agreement [Member]

Fair value of common stock issued $ 300,000

Annual license fee $ 10,000

X

- References
No definition available.
+ Details

Name: mhtx_AdjustedAssetValuation

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_AggregateAnnualRent

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_AnnualLicenseFee

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_CommonStockOwnedShare

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_RemainingAmountOfAssets

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: mhtx_SaleOfAsset

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_WorkingCapital

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.
+ References
No definition available.
+ Details

Name: us-gaap_CashFDICInsuredAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of expense for Federal Deposit Insurance Corporation (FDIC) insurance.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.14)
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260
+ Details

Name: us-gaap_FederalDepositInsuranceCorporationPremiumExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 15
-Paragraph 2
-Subparagraph (d)(1)
-URI http://asc.fasb.org/extlink&oid=121825205&loc=d3e27249-109313

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319
+ Details

Name: us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.
+ References
No definition available.
+ Details

Name: us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromSaleOfPropertyHeldForSale

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (g)(2)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-URI http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-URI http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586
+ Details

Name: us-gaap_SupplementalDeferredPurchasePrice

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardDateAxis=mhtx_InTwoThousandEightMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mhtx_MetallicumIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardDateAxis=mhtx_JuneTwoThousandNinteentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardDateAxis=mhtx_InTwoThousandNineMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mhtx_LosAlamosNationalSecurityLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=mhtx_PatentLicenseAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.1

INVESTMENT IN EQUITY SECURITIES (IMAGION BIOSYSTEMS) (Details)
12 Months Ended

Dec. 31, 2021

USD ($)

INVESTMENT IN IMAGION BIOSYSTEMS

Balance as of December 31, 2020 $ 5,875,000

Change in the unrealized fair value of securities (2,974,000)

Balance as of December 31, 2021 $ 2,901,000

X

- References
No definition available.
+ Details

Name: mhtx_BeginingBalance

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_ChangeInTheUnrealizedFairValueOfSecurities

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_EndingBalance

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.1

INVESTMENT IN IMAGION BIOSYSTEMS (Details Narrative) - Imagion Biosystems, Inc. [Member]

Dec. 31, 2021

USD ($)

$ / shares

shares

Common stock owned shares 52,516,508

Trading price per share | $ / shares $ 0.05

Fair value of investment | $ $ 2,901,000

Change in unrealized gain in investment 2,974,000

X

- References
No definition available.
+ Details

Name: mhtx_ChangeInUnrealizedGainInInvestment

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to
+ References
No definition available.
+ Details

Name: mhtx_CommonStockOwnedShares

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: mhtx_TradingPricePerShare

Namespace Prefix: mhtx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 5D
-Subparagraph (SX 210.12-13D(Column C))
-URI http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C))
-URI http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010
+ Details

Name: us-gaap_InvestmentOwnedAtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mhtx_ImagionBiosystemsIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.1

NOTES PAYABLE (Details) - USD ($)

Dec. 31, 2021

Dec. 31, 2020

NOTES PAYABLE

Notes payable $ 150,000

Less: Discounts on notes payable (20,000)

Notes payable, net of discounts $ 130,000 $ 0

X

- References
No definition available.
+ Details

Name: mhtx_LessDiscountsOnNotesPayable

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878
+ Details

Name: us-gaap_NotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_NotesPayableAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_NotesPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.1

NOTES PAYABLE (Details Narrative) - USD ($)
$ / shares in Units, shares in Millions
1 Months Ended 12 Months Ended

Oct. 17, 2019

Dec. 31, 2021

Dec. 31, 2020

Amortization of Debt Discount $ 26,000 $ 26,000

Individuals [Member]

Secured note $ 50,000

Price per share $ 0.015

Shares issued in advance for debt 1

Interest rate 10.00%

Amortization of Debt Discount $ 9,000

Debt due date Oct. 17, 2022

Related Party [Member]

Secured note $ 100,000

Price per share $ 0.015

Shares issued in advance for debt 2

Interest rate 10.00%

Amortization of Debt Discount $ 17,000

Debt due date Oct. 17, 2022

X

- References
No definition available.
+ Details

Name: mhtx_PricePerShare

Namespace Prefix: mhtx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_SharesIssuedInAdvanceForDebt

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.8)
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227
+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average effective interest rate during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1F
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateDuringPeriod

Namespace Prefix: us-gaap_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(2))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258
+ Details

Name: us-gaap_DebtInstrumentMaturityDate

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash inflow from borrowings supported by a written promise to pay an obligation that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromSecuredNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mhtx_IndividualsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mhtx_RelatedPartyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.1

CAPITAL TRANSACTIONS (Details) - USD ($)
12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

CAPITAL TRANSACTIONS

Number of Options, Outstanding Beginning Balance 18,500,000 22,075,000

Number of Options, Granted 15,000,000

Number of Options, Expired (7,000,000) (3,575,000)

Number of Options, Outstanding Ending Balance 26,500,000 18,500,000

Weighted Average Life

Weighted Average Life, Outstanding Beginning Balance 2 years 10 months 2 days 3 years 2 months 12 days

Weighted Average Life, Granted 9 years 8 months 4 days

Weighted Average Life, Outstanding Ending Balance 6 years 21 days 2 years 10 months 2 days

Weighted Average Exercise Price

Weighted Average Exercise Price, beginning $ 0.07 $ 0.07

Weighted Average Exercise Price, Granted 0.02

Weighted Average Exercise Price, Expired 0.07 0.07

Weighted Average Exercise Price, outstanding ending balance $ 0.04 $ 0.07

Number of Options Exercisable

Number of Options Exercisable,Outstanding Beginning Balance 18,500,000 22,075,000

Number of Options Exercisable, Granted 15,000,000 50,000

Number of Options Exercisable, Expired (7,000,000) (3,575,000)

Number of Options Exercisable,Outstanding Ending Balance 26,500,000 18,500,000

Aggregate intrinsic value

Aggregate intrinsic value, beginning $ 15,500 $ 0

Aggregate intrinsic value, granted 0

Aggregate intrinsic value, outstanding $ 15,000 $ 0

X

- References
No definition available.
+ Details

Name: mhtx_AggregateIntrinsicValueAbstract

Namespace Prefix: mhtx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_AggregateIntrinsicValueBeginning

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_AggregateIntrinsicValueGranted

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_AggregateIntrinsicValueOutstanding

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_NumberOfOptionsExercisableAbstract

Namespace Prefix: mhtx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_NumberOfOptionsExercisableOutstandingBeginningBalance

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_NumberOfOptionsExercisableOutstandingEndingBalance

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_NumberOfOptionsOutstandingBeginningBalance

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_NumberOfOptionsOutstandingEndingBalance

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.
+ References
No definition available.
+ Details

Name: mhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationInPeriod

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredExercisableNumber

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedExercisableNumber

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_WeightedAverageExercisePriceBeginning

Namespace Prefix: mhtx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_WeightedAverageExercisePriceExpired

Namespace Prefix: mhtx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_WeightedAverageExercisePriceOutstandingEndingBalance

Namespace Prefix: mhtx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_WeightedAverageLifeAbstract

Namespace Prefix: mhtx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_WeightedAverageLifeGranted

Namespace Prefix: mhtx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_WeightedAverageLifeOutstandingBeginningBalance

Namespace Prefix: mhtx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_WeightedAverageLifeOutstandingEndingBalance

Namespace Prefix: mhtx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_BusinessCombinationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.1

CAPITAL TRANSACTIONS (Details 1)
12 Months Ended

Dec. 31, 2021

$ / shares

shares

Number of Options, Outstanding Beginning Balance 26,500,000

Exercise Price 0.05 [Member]

Number of Options, Outstanding Beginning Balance 3,000,000

Weighted Average Remaining Contractual Life 3 years 6 months

Weighted Average Exercise Price | $ / shares $ 0.05

Number of Options Exercisable, Outstanding Beginning Balance 3,000,000

Weighted Average Exercise Price, exercisable | $ / shares $ 0.05

Exercise Price 0.06 [Member]

Number of Options, Outstanding Beginning Balance 5,000,000

Weighted Average Remaining Contractual Life 4 years 4 months 6 days

Weighted Average Exercise Price | $ / shares $ 0.06

Number of Options Exercisable, Outstanding Beginning Balance 5,000,000

Weighted Average Exercise Price, exercisable | $ / shares $ 0.06

Exercise Price 0.14 [Member]

Number of Options, Outstanding Beginning Balance 3,000,000

Weighted Average Remaining Contractual Life 2 years 9 months

Weighted Average Exercise Price | $ / shares $ 0.14

Number of Options Exercisable, Outstanding Beginning Balance 3,000,000

Weighted Average Exercise Price, exercisable | $ / shares $ 0.14

Exercise Price 0.02 [Member]

Number of Options, Outstanding Beginning Balance 15,500,000

Weighted Average Remaining Contractual Life 8 years 9 months 18 days

Weighted Average Exercise Price | $ / shares $ 0.02

Number of Options Exercisable, Outstanding Beginning Balance 15,500,000

Weighted Average Exercise Price, exercisable | $ / shares $ 0.02

X

- References
No definition available.
+ Details

Name: mhtx_WeightedAverageExercisePriceExercisable

Namespace Prefix: mhtx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mhtx_ExercisePriceRangeTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mhtx_ExercisePriceRangeThreeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mhtx_ExercisePriceRangeSixMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mhtx_ExercisePriceRangeSevenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.1

CAPITAL TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended

Nov. 05, 2013

Mar. 22, 2021

Dec. 31, 2021

Dec. 31, 2020

Reclassification of liability $ 1,341,000

Common Stock, shares authorized 950,000,000 950,000,000

Common Stock, shares issued 559,281,064 559,281,064

Common Stock, shares outstanding 559,281,064 559,281,064

Preferred stock shares outstanding 0 0

Preferred stock shares issued 0 0

Preferred stock, shares authorized 1,000,000 1,000,000

Number of Options, Outstanding Beginning Balance 26,500,000

Aggregate intrinsic value $ 1,595,000

Preferred stock, par value $ 0.001 $ 0.001

Common stock issued for service, value $ 24,000

Stock Option [Member]

Number of Options, Outstanding Beginning Balance 26,500,000

Exercisable price $ 0.0154

Option to purchase common stock 15,000,000

Stock options available for grant 15,000,000

Stock Activity [Member]

Common stock issued for services, shares 1,500,000

Common stock issued for service, value $ 24,000

Market price per share $ 0.016

Class A Preferred Stock [Member]

Preferred stock, shares authorized 182,525 182,525

Preferred stock, par value $ 0.001 $ 0.001

Cumulative preferred stock interest rate 10.00% 10.00%

Convertible preferred stock, terms of conversion feature One Class A, Preferred share is convertible into 50 restricted common shares and will be entitled to the number of votes equal to the number of shares of common stock into which such holder’s shares of Series A Preferred stock could be converted at the time of the vote

Conversion price $ 15

Preferred stock redemption terms Class A, Preferred Stock is redeemable by the Company at $15 per share

Preferred stock liquidation preference description Upon liquidation the holders of Series A Preferred stock will be entitled to be paid out of the assets available for distribution of the corporation an amount equal to $10 per share, before any payment will be made to the common shareholders

Class B Preferred Stock [Member]

Preferred stock shares outstanding 49,999 49,999

Preferred stock shares issued 49,999 49,999

Preferred stock, shares authorized 250,000 250,000

Preferred stock, par value $ 0.001 $ 0.001

Convertible preferred stock, terms of conversion feature Class B preferred shares are convertible at a rate of 1 Series B preferred share to 10 common shares

Class C Preferred Stock [Member]

Preferred stock shares outstanding 0 0

Preferred stock shares issued 0 0

Preferred stock, shares authorized 14,000 14,000

Preferred stock, par value $ 100 $ 100

Convertible preferred stock, terms of conversion feature Class C, Preferred Stock is convertible at $100 divided by the 10 day average closing price of common stock

Preferred stock liquidation preference description Upon liquidation Class C, Preferred Stock shall be treated as if it were converted to common stock prior to liquidation

Undesignated blank check [Member]

Preferred stock, shares authorized 447,804 447,804

Preferred stock, par value $ 0.001 $ 0.001

Coversion Agreement [Member] | Holder [Member] | Class D Preferred Stock [Member]

Preferred stock shares outstanding 105,761 105,761

Preferred stock shares issued 105,761 105,761

Preferred stock, par value $ 10.00 $ 10.00

Common stock converted amount $ 1,057,608

Conversion price $ 0.055 $ 0.055

Voting rights, description The Holder of the Series D Preferred Stock will be entitled to 20 votes for each share of common stock that the Series D Preferred Stock are convertible into

Convertible preferred stock terms of conversion Additionally, Holder may not convert the Series D Preferred Stock until the ten day average daily trading volume is greater than $20,000

X

- References
No definition available.
+ Details

Name: mhtx_CommonShareValuedAtMarketPrice

Namespace Prefix: mhtx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_CumulativePreferredStockInterestRate

Namespace Prefix: mhtx_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: mhtx_ExercisablePrice

Namespace Prefix: mhtx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_OptionToPurchaseCommonStock

Namespace Prefix: mhtx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_PreferredStockLiquidationPreferenceDescription

Namespace Prefix: mhtx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_ReclassificationOfLiability

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586
+ Details

Name: us-gaap_ConversionOfStockAmountConverted1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Description of conversion terms for preferred stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644
+ Details

Name: us-gaap_ConvertiblePreferredStockTermsOfConversion

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The price per share of the conversion feature embedded in the debt instrument.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 5
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611
+ Details

Name: us-gaap_DebtInstrumentConvertibleConversionPrice1

Namespace Prefix: us-gaap_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockConversionBasis

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21564-112644
+ Details

Name: us-gaap_PreferredStockRedemptionPricePerShare

Namespace Prefix: us-gaap_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The redemption terms of preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity. The redemption features of this capital stock are solely within the control of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21564-112644
+ Details

Name: us-gaap_PreferredStockRedemptionTerms

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644
+ Details

Name: us-gaap_PreferredStockVotingRights

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=mhtx_StockActivityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=mhtx_ClassAPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=mhtx_ClassBPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=mhtx_ClassCPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=mhtx_UndesignatedBlankCheckMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=mhtx_CoversionAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=mhtx_HolderMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=mhtx_ClassDPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.1

INCOME TAXES (Details) - USD ($)

Dec. 31, 2021

Dec. 31, 2020

INCOME TAXES

Net operating loss carryforward $ 12,704,000 $ 12,630,000

Temporary differences 6,988,000 6,988,000

Less valuation allowance (19,692,000) (19,618,000)

Deferred tax asset, net $ 0 $ 0

X

- References
No definition available.
+ Details

Name: mhtx_LessValuationAllowance

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards classified as current.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318

Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319

Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123427490&loc=d3e31928-109318

Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=123427490&loc=d3e31958-109318
+ Details

Name: us-gaap_DeferredTaxAssetsNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsOperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319
+ Details

Name: us-gaap_DeferredTaxAssetsOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.1

INCOME TAXES (Details 1) - USD ($)
12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

INCOME TAXES

Tax benefit computed at 21% $ 0 $ 0

Change in valuation allowance 0 0

Change in carryovers and tax attributes 0 0

Income tax provision $ 0 $ 0

X

- References
No definition available.
+ Details

Name: mhtx_ChangeInCarryoversAndTaxAttributes

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_TaxBenefitComputedAt21

Namespace Prefix: mhtx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(9))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319
+ Details

Name: us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.1

INCOME TAXES (Details Narrative) - USD ($)
12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

INCOME TAXES

Provision for income taxes $ 0 $ 0

Operating loss carryforwards net $ 47,275,000 $ 47,043,000

Provision for income taxes, rates 21.00% 21.00%

Federal net operating loss carryforwards expiration date through 2031

State net operating loss carryforwards expiration date through 2025

X

- References
No definition available.
+ Details

Name: mhtx_FederalTaxPurposesExpire

Namespace Prefix: mhtx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_StateTaxPurposesExpire

Namespace Prefix: mhtx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.Fact.4)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(9))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319
+ Details

Name: us-gaap_OperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.1

LICENSE AGREEMENT (Details Narrative) - USD ($)
12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

LICENSE AGREEMENT

Minimum Royalty Payment $ 50,000 $ 50,000

Royalty percentage on dental products 10.00%

Royalty percentage on other licensed products 5.00%

X

- References
No definition available.
+ Details

Name: mhtx_RoyaltyPercentageOnDentalProducts

Namespace Prefix: mhtx_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: mhtx_RoyaltyPercentageOnOtherLicensedProducts

Namespace Prefix: mhtx_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227
+ Details

Name: us-gaap_RoyaltyExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.1

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)

Dec. 31, 2021

Dec. 31, 2020

Accrued expenses - related parties $ 1,129,000 $ 853,000

Sole Officer [Member]

Accrued expenses - related parties 276,000

Chairman [Member]

Accrued expenses - related parties 786,000

Board of Director [Member]

Accrued expenses - related parties $ 66,250

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=mhtx_SoleOfficerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=mhtx_ChairmanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=mhtx_BoardOfDirectorMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 49 mhtx_10k_htm.xml IDEA: XBRL DOCUMENT 0001099132 2021-01-01 2021-12-31 0001099132 mhtx:BoardOfDirectorMember 2021-12-31 0001099132 mhtx:ChairmanMember 2021-12-31 0001099132 mhtx:SoleOfficerMember 2021-12-31 0001099132 us-gaap:StockOptionMember 2021-03-22 0001099132 us-gaap:StockOptionMember 2021-03-01 2021-03-22 0001099132 us-gaap:StockOptionMember 2021-12-31 0001099132 mhtx:StockActivityMember 2020-01-01 2020-12-31 0001099132 mhtx:ClassCPreferredStockMember 2021-01-01 2021-12-31 0001099132 mhtx:ClassBPreferredStockMember 2021-01-01 2021-12-31 0001099132 mhtx:ClassAPreferredStockMember 2021-01-01 2021-12-31 0001099132 mhtx:CoversionAgreementMember mhtx:HolderMember mhtx:ClassDPreferredStockMember 2021-01-01 2021-12-31 0001099132 mhtx:CoversionAgreementMember mhtx:HolderMember mhtx:ClassDPreferredStockMember 2013-11-01 2013-11-05 0001099132 mhtx:ClassCPreferredStockMember 2020-12-31 0001099132 mhtx:ClassCPreferredStockMember 2021-12-31 0001099132 mhtx:UndesignatedBlankCheckMember 2020-12-31 0001099132 mhtx:ClassBPreferredStockMember 2020-12-31 0001099132 mhtx:UndesignatedBlankCheckMember 2021-12-31 0001099132 mhtx:ClassBPreferredStockMember 2021-12-31 0001099132 mhtx:ClassAPreferredStockMember 2020-12-31 0001099132 mhtx:ClassAPreferredStockMember 2021-12-31 0001099132 mhtx:CoversionAgreementMember mhtx:HolderMember mhtx:ClassDPreferredStockMember 2020-12-31 0001099132 mhtx:CoversionAgreementMember mhtx:HolderMember mhtx:ClassDPreferredStockMember 2021-12-31 0001099132 mhtx:ExercisePriceRangeSevenMember 2021-01-01 2021-12-31 0001099132 mhtx:ExercisePriceRangeSixMember 2021-01-01 2021-12-31 0001099132 mhtx:ExercisePriceRangeThreeMember 2021-01-01 2021-12-31 0001099132 mhtx:ExercisePriceRangeTwoMember 2021-01-01 2021-12-31 0001099132 mhtx:ExercisePriceRangeSevenMember 2021-12-31 0001099132 mhtx:ExercisePriceRangeSixMember 2021-12-31 0001099132 mhtx:ExercisePriceRangeThreeMember 2021-12-31 0001099132 mhtx:ExercisePriceRangeTwoMember 2021-12-31 0001099132 mhtx:RelatedPartyMember 2019-10-01 2019-10-17 0001099132 mhtx:IndividualsMember 2019-10-01 2019-10-17 0001099132 mhtx:InTwoThousandNineMember mhtx:PatentLicenseAgreementMember mhtx:LosAlamosNationalSecurityLLCMember 2009-01-01 2009-12-31 0001099132 mhtx:InTwoThousandNineMember mhtx:PatentLicenseAgreementMember mhtx:LosAlamosNationalSecurityLLCMember 2019-01-01 2019-12-31 0001099132 srt:MaximumMember 2021-01-01 2021-12-31 0001099132 srt:MinimumMember 2021-01-01 2021-12-31 0001099132 mhtx:InTwoThousandEightMember mhtx:MetallicumIncMember 2008-06-01 2008-06-30 0001099132 mhtx:InTwoThousandEightMember mhtx:MetallicumIncMember 2021-01-01 2021-12-31 0001099132 mhtx:JuneTwoThousandNinteentMember 2021-01-01 2021-12-31 0001099132 2018-01-01 2018-12-31 0001099132 2019-01-01 2019-12-31 0001099132 2020-05-01 2020-05-31 0001099132 mhtx:SignificantUnobservableInputsMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0001099132 mhtx:SignificantOtherObservableInputsMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001099132 mhtx:QuotedPricesInActiveMarketsForIdenticalAssetsMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001099132 mhtx:SignificantUnobservableInputsMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001099132 mhtx:SignificantOtherObservableInputsMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001099132 mhtx:QuotedPricesInActiveMarketsForIdenticalAssetsMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001099132 mhtx:ImagionBiosystemsIncMember 2021-12-31 0001099132 mhtx:PatentLicenseAgreementMember mhtx:LosAlamosNationalSecurityLLCMember 2009-01-01 2009-01-31 0001099132 mhtx:InTwoThousandEightMember mhtx:MetallicumIncMember 2008-06-01 2008-06-12 0001099132 2019-12-31 0001099132 us-gaap:RetainedEarningsMember 2021-12-31 0001099132 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001099132 mhtx:PreferredStockSeriesCMember 2021-12-31 0001099132 us-gaap:CommonStockMember 2021-12-31 0001099132 mhtx:PreferredStockSeriesBMember 2021-12-31 0001099132 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001099132 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001099132 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001099132 us-gaap:RetainedEarningsMember 2020-12-31 0001099132 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001099132 mhtx:PreferredStockSeriesCMember 2020-12-31 0001099132 us-gaap:CommonStockMember 2020-12-31 0001099132 mhtx:PreferredStockSeriesBMember 2020-12-31 0001099132 mhtx:PreferredStockSeriesCMember 2020-01-01 2020-12-31 0001099132 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001099132 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001099132 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001099132 mhtx:PreferredStockSeriesBMember 2020-01-01 2020-12-31 0001099132 us-gaap:RetainedEarningsMember 2019-12-31 0001099132 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001099132 mhtx:PreferredStockSeriesCMember 2019-12-31 0001099132 us-gaap:CommonStockMember 2019-12-31 0001099132 mhtx:PreferredStockSeriesBMember 2019-12-31 0001099132 2020-01-01 2020-12-31 0001099132 mhtx:SeriesDconvertiblepreferredStockMember 2021-12-31 0001099132 mhtx:SeriesDconvertiblepreferredStockMember 2020-12-31 0001099132 mhtx:ClassCRedeemableConvertiblePreferredStockMember 2020-12-31 0001099132 mhtx:ClassCRedeemableConvertiblePreferredStockMember 2021-12-31 0001099132 mhtx:ClassBConvertiblePreferredStockMember 2020-12-31 0001099132 mhtx:ClassBConvertiblePreferredStockMember 2021-12-31 0001099132 mhtx:ClassAConvertiblePreferredStockMember 2020-12-31 0001099132 mhtx:ClassAConvertiblePreferredStockMember 2021-12-31 0001099132 2020-12-31 0001099132 2021-12-31 0001099132 2022-04-04 0001099132 2021-06-30 iso4217:USD shares iso4217:USD shares pure 0001099132 false --12-31 2021-12-31 FY 2021 0.001 447804 0 0 559281064 0 0 250000 49999 49999 14000 0 0 105761 105761 105761 3000 0 0.01 35000 18500000 P2Y10M2D 0.07 50000 18500000 10.00 10.00 0.001 0.001 0.001 100 105761 49999 0 0 105761 105761 49999 0 0 182525 250000 14000 0.055 0.1 15 0 0.21 10-K true false MANHATTAN SCIENTIFICS, INC. DE 000-28411 85-0460639 244 Fifth Avenue Suite 2341 New York NY 10001 212 541-2405 Common Stock, $0.001 par value No No Yes Yes Non-accelerated Filer true false false 13139946 559281064 3627 Sadler, Gibb & Associates, LLC Draper, UT 232000 353000 15000 12000 300000 300000 547000 665000 2901000 5875000 4000 6000 0 300000 2000 2000 3454000 6848000 102000 159000 1129000 853000 130000 0 1361000 1012000 0 104000 0 104000 1361000 1116000 105761 105761 105761 1058000 1058000 0.001 1000000 447804 0 0 0 0 0 0 0 0 250000 49999 49999 0 0 14000 0 0 0 0 950000000 559281064 559281064 559000 559000 68996000 68996000 -68520000 -64881000 1035000 4674000 3454000 6848000 50000 50000 727000 714000 10000 11000 737000 725000 -687000 -675000 -2974000 5014000 48000 0 26000 25000 -2952000 4989000 -3639000 4314000 559281064 558322048 -0.01 0.01 559281064 593051310 -0.01 0.01 49999 0 14000 0 557781064 558000 67632000 -69195000 -1005000 0 0 0 1341000 0 1341000 0 0 1500000 1000 23000 0 24000 0 0 0 0 4314000 4314000 49999 0 14000 0 559281064 559000 68996000 -64881000 4674000 0 0 -3639000 -3639000 49999 0 14000 0 559281064 559000 68996000 -68520000 1035000 -3639000 4314000 0 24000 2000 2000 -2974000 5014000 -48000 0 26000 26000 -1000 -105000 -10250 276000 269250 -421000 -388000 0 4000 300000 300000 0 184000 300000 480000 0 0 -121000 92000 353000 261000 232000 353000 0 0 0 0 0 1341000 NOTE 1 – BASIS OF PRESENTATION Manhattan Scientifics, Inc., a Delaware corporation (formerly Grand Enterprises, Inc) (“Grand”) was established on July 31, 1992 and has a wholly-owned subsidiary: Metallicum, Inc. (“Metallicum”). On June 12, 2008, the Company acquired Metallicum, Inc, for 15,000,000 shares of Company’s common stock, Manhattan Scientifics, Inc., operates as a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in various fields, with emphasis in the areas of nano-technologies and nano-medicine. In this capacity, the Company continues to identify emerging technologies through strategic alliances with scientific laboratories, educational institutions, and scientists and leaders in industry and government. The Company has a long standing relationship with Los Alamos Laboratories in New Mexico. During 2008, the Company refocused its efforts from the development of its fuel cell technologies to its current focus on the development of nanomaterials through the acquisition of Metallicum. Metallicum is a nanotechnology start-up company located in Colorado. Metallicum Inc. has focused on the development and manufacture of nanostructured metals for medical implants and other applications. Metallicum intends to establish manufacturing partner relationships with major Fortune 500 metals companies and strategic partnering with significant customers in the medical device & prosthetics industries as well as in auto, truck, & aircraft manufacturing industries. Metallicum’s initial products include nanostructured bulk metals and alloys in the form of rod, bar, wire and foil. The Company conducts its operations primarily in the United States. Manhattan Scientifics purchased Metallicum to acquire its licensed rights to patented technology. The technology is comprised of three US Patents (US Patent numbers 7152448, 6197129 and 6399215) for which Metallicum (subsequently, Manhattan) had been assigned an exclusive license rights by Los Alamos National Security LLC (LANL). Under the license rights, Metallicum had all rights, title and interest throughout the world in and to any and all inventions, original works of authorship, developments, concepts, know-how, and improvements on the patents or trade secrets whether or not patentable or registrable under copyright or similar laws. In January 2009, the Company entered into a patent license agreement with Los Alamos National Security, LLC for the exclusive licensing use of certain technology relating to the manufacture and application of nanostructuring metals and alloys. Pursuant to such agreement the Company provided a non-refundable fee and 2,000,000 shares of common stock. Additionally, the Company is required to pay an annual license fee which started in February 2010 and royalties on future net sales. In September 2009, the Company entered into a technology transfer agreement with Carpenter Technologies Corporation (“Carpenter”). Wherein Carpenter will fully develop, manufacture and market a new class of high strength metals under an exclusive technology transfer agreement from Manhattan Scientifics and the Los Alamos National Laboratory. The proprietary process will enable super-strength metals and alloys to make products that weigh far less than in the past and without significant cost premiums. On February 11, 2015, the Company entered into a Settlement Agreement and Mutual General Releases (the “Settlement Agreement”) with Carpenter Technology Corporation related to the agreement discussed in Note 7, pursuant to which the parties settled and released each other from any and all liabilities and claims related to the Carpenter Agreements. On November 17, 2016, Senior Scientific merged with and into Imagion Biosystems, Inc., a Nevada corporation (“Imagion”). Following the merger, Imagion held all of the liabilities, obligations and assets of Senior Scientific and the Company continued as the sole equity holder of Imagion. On June 30, 2017, Imagion completed an IPO and listing on the Australian Stock Exchange (ASX). As of December 31, 2021 , the Company owns 52,516,508 shares (1,000,000 restricted shares related to issued promissory notes interest) of Imagion, resulting in a noncontrolling interest of approximately 5% of Imagion’s issued and outstanding common stock. The Company elected to record the investment at fair value. Manhattan Scientifics success will depend in part on its ability to obtain patents and product license rights, maintain trade secrets, and operate without infringing on the proprietary rights of others, both in the United States and other countries. There can be no assurance that patents issued to or licensed by the Company will not be challenged, invalidated, or circumvented, or that the rights granted thereunder will provide proprietary protection or competitive advantages to the Company. 15000000 2000000 52516508 1000000 0.05 NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS BASIS OF CONSOLIDATION: The condensed consolidated financial statements include the accounts of Manhattan Scientific, Inc., and its wholly owned subsidiary Metallicum. All significant intercompany balances and transactions have been eliminated. GOING CONCERN: As of December 31, 2021, the Company has an accumulated deficit of 68,520,000 and negative working capital of $684,000. Because of these conditions, the Company will require additional working capital to develop business operations. The Company intends to raise additional working capital through the continued licensing of its technology as well as to generate revenues for other services. There are no assurances that the Company will be able to achieve the level of revenues adequate to generate sufficient cash flow from operations to support the Company’s working capital requirements. To the extent that funds generated are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available, the Company may not continue its operations. As of the filing date, the Coronavirus (“COVID-19”) has caused significant volatility in global markets, including the market price of our securities. The demand for our products and services has decreased and the ability of our customers to make payments for the products and services they purchased has been negatively impacted. These factors raise substantial doubt about the Company’s ability to continue within one year from the date of filing. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern. The ability to continue as a going concern is dependent on out generating cash from the sale of our common stock and/or obtaining debt financing and attaining future profitable operations. Management’s plan includes selling our equity securities and/or obtaining debt financing to fund our capital requirement and ongoing operations; however, there can be no assurance the Company will be successful in these efforts. USE OF ESTIMATES: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. A significant estimate includes the carrying value of the Company’s patents, fair value of the Company’s common stock, assumptions used in calculating the value of stock options, depreciation and amortization. CASH AND CASH EQUIVALENTS: The Company considers all highly liquid investments purchased with an original maturity of year or less at the time of purchase to be cash equivalents for the purposes of the statement of cash flows. CASH CONCENTRATION: The Company’s cash accounts are federally insured up to $250,000 for each financial institution we hold our accounts in. As of December 31, 2021 and December 31, 2020, we had cash balances of $-0- and $103,000 exceeding the federally insured limits. PROPERTY AND EQUIPMENT: Property and equipment are recorded at cost. Expenditures for major additions and improvements are capitalized, and minor replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets, the useful lives range between 3-10 years, using the straight-line method for financial statement purposes.INTANGIBLE ASSETS: License Agreements In 2008, the Company obtained licenses to the rights of certain patents regarding nanostructured materials developed by another company as a result of the acquisition of Metallicum. The purchase price paid for these licenses was $305,000, which represented its fair value. The Company obtained an exclusive license on two patents and a non-exclusive license on the third patent. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years. At December 31, 2021 and December 31, 2020, the license agreements were fully amortized. Under the terms of the agreement, the Company may be required to pay royalties, as defined, to the licensors. In 2009, the Company entered into a patent license agreement with Los Alamos National Security LLC for the exclusive use of certain technology relating to the manufacture and application of nanostructuring metals and alloys. The purchase price paid for this license agreement was $33,000 based on the fair market value of 2,000,000 shares of common stock issued. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years. At December 31, 2021 and December 31, 2020, the license agreements were fully amortized. Beginning in 2010, the Company was required to pay an annual license fee of $10,000 and may be required to pay royalties, as defined, to the licensors. DUE FROM THE SALE OF ASSETS: Non-current assets are classified as held for sale if it is highly probably that they will be recovered primarily through sale rather than through continuing use. Immediately before classification as held for sale, the assets are remeasured at the lower of their carrying amount and fair value less costs to sell. Any impairment loss on initial classification as held for sale and subsequent gains and losses on re-measurement are recognized in profit or loss. Gains are not recognized in excess of any cumulative impairment loss. During the year ended December 31, 2019, the Company sold the assets held for sale that were presented on the balance sheet as of December 31, 2018. During the year ended December 31, 2018, the Company recorded impairment and adjusted the asset valuation to $1.2 million. The Company sold the assets for a total of $1.2 million of which $300,000 was received during the year ended December 31, 2019. The remaining $900,000 will be collected during the next three years in equal increments on the anniversary date of the agreement, May 1. During May 2020 and 2021, the Company received $300,000 and $300,000 respectively and reduced the due from the sale of assets. As of December 31, 2021, the Company evaluated the collectability and determined that no allowance is needed at this time due to the payment history with this third party and the subsequent receipt of funds. MARKETABLE SECURITIES: The Company considers securities with original maturities of greater than 90 days to be available for sale securities. Securities under this classification are recorded at fair value and unrealized gains and losses within other income (loss). The estimated fair value of the available for sale securities is determined based on quoted market prices or rates for similar instruments. In addition, the cost of debt securities in this category is adjusted for amortization of premium and accretion of discount to maturity. For available for sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other income (loss). For the year ended December 31, 2021, no allowance was recorded for credit losses.REVENUE RECOGNITION: The Company recognizes revenue in accordance with generally accepted accounting principles as outlined in the Financial Accounting Standard Board’s (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue From Contracts with Customers, which consists of five steps to evaluating contracts with customers for revenue recognition: (i) identify the contract with the customer; (ii) identity the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price; and (v) recognize revenue when or as the entity satisfied a performance obligation. Revenue recognition occurs at the time we satisfy a performance obligation to our customers, when control transfers to customers, provided there are no material remaining performance obligations required of the Company or any matters of customer acceptance. We only record revenue when collectability is probable. FAIR VALUE OF FINANCIAL INSTRUMENTS: The Company recognized the fair value of financial instruments in accordance with FASB ASC 820, Fair Value Measurements and Disclosures, “Fair Value Measurements”, which provides a framework for measuring fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The standard also expands disclosures about instruments measured at fair value and establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: Level 1 — Quoted prices for identical assets and liabilities in active markets;Level 2 — Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; andLevel 3 — Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company designates cash equivalents (consisting of money market funds) and investments in securities of publicly traded companies as Level 1. The total amount of the Company’s investment classified as Level 3 is de minimis. Fair value of financial instruments: The carrying amounts of financial instruments, including cash and cash equivalents, short-term investments, accounts payable, accrued expenses and notes payables approximated fair value as of December 31, 2021 and December 31, 2020 because of the relative short term nature of these instruments. During the year ended December 31, 2017, the Company elected fair value option for its investment in Imagion Biosystems, Inc. a Nevada company (“Imagion”) based on triggering event of dilution of ownership, which lead to the deconsolidation of Imagion. Investments in Imagion are measured at fair value as opposed to equity method based on ASC 825-10. The guidance allows entities to elect to measure certain financial assets and financial liabilities (as well as certain nonfinancial instruments that are similar to financial instruments) at fair value. Investments over which an investor has the ability to exercise significant influence are eligible for the fair value option as they represent recognized financial assets. When the fair value option is elected for an instrument, all subsequent changes in fair value for that instrument are reported in earnings. As of December 31, 2021, the Company holds 52,516,508 shares of Imagion and is reported under fair value method under ASC 320. Any change in the value is reported on the income statement as an unrealized gain or loss on fair value adjustment of investments. Our financial assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2021 and 2020, consisted of the following: <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Total fair value at December 31, 2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Quoted prices in active markets for identical assets (Level1)</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Significant other observable inputs (Level 2)</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Significant unobservable inputs (Level 3)</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Investment in equity securities</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,901,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,901,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td colspan="2" style="BORDER-BOTTOM: 1px solid;">Total fair value at December 31, 2020</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td colspan="2" style="BORDER-BOTTOM: 1px solid;">Quoted prices in active markets for identical assets (Level1)</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td colspan="2" style="BORDER-BOTTOM: 1px solid;">Significant other observable inputs (Level 2)</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td colspan="2" style="BORDER-BOTTOM: 1px solid;">Significant unobservable inputs (Level 3)</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Investment in equity securities</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,875,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,875,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table>INTELLECTUAL PROPERTY / RESEARCH AND DEVELOPMENT In June 2008, we acquired Metallicum and its licensed rights to patented technology. The technology is comprised of three US Patents (US Patent numbers 7152448, 6197129 and 6399215) for which Metallicum (subsequently, Manhattan) had been assigned an exclusive license rights by Los Alamos National Security LLC (LANL). Under the license rights, Metallicum had all rights, title and interest throughout the world in and to any and all inventions, original works of authorship, developments, concepts, know-how, and improvements on the patents or trade secrets whether or not patentable or registerable under copyright or similar laws. The purchase price paid for these licenses was $305,000, which represents its fair value. The Company obtained an exclusive license on two patents and a non-exclusive license on the third patent. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years. Our ability to compete depends in part on the protection of and our ability to defend our proprietary technology and on the goodwill associated with our trade names, service marks and other proprietary rights. However, we do not know if current laws will provide us with sufficient enough protection that others will not develop technologies similar or superior to ours, or that third parties will not copy or otherwise obtain or use our technologies without our authorization. The success of our business will depend, in part, to identify technology, obtain patents, protect and enforce patents once issued and operate without infringing on the proprietary rights of others. Our success will also depend on our ability to maintain exclusive rights to trade secrets and proprietary technology we own are currently developing and will develop. We can give no assurance that any issued patents will provide us with competitive advantages or will not be challenged by others, or that the patents of others will not restrict our ability to conduct business. In addition, we rely on certain technology licensed with a perpetual term from the Los Alamos National Laboratory and may be required to license additional technologies in the future. We do not know if these third-party licenses will be available or will continue to be available to us on acceptable commercial terms or at all. The inability to enter into and maintain any of these licenses could have a material adverse effect on our business, financial condition or results of our operations. Policing unauthorized use of our proprietary technology and other intellectual property rights could entail significant expense. In addition, we do not know if third parties will bring claims of copyright or trademark infringement against us or claim that our use of certain technologies violates a patent or other intellectual property. Any claims of infringement, with or without merit, could be time consuming and expensive to defend, result in costly litigation, divert management attention, require us to enter into costly royalty or licensing arrangements or prevent us from using important technologies or methods, any of which could have a material adverse effect on our business, financial condition or results of our operations. LEASES The Company leases a facility with terms of month to month for its headquarters. The Company adopted ASC 842 on January 1, 2019 and has evaluated that has no impact on the financial statements as under the practical expedient the leases consist of terms less than one year, and therefore is not required to capitalize the lease. During June 2019, the Company entered into an assignment and assumption of lease with the landlord and another entity for the lease term through April 2021. The average aggregate annual rent for this space is $30,360.INCOME TAXES The Company accounts for income taxes under an asset and liability approach. This process involves calculating the temporary and permanent differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The temporary differences result in deferred tax assets and liabilities, which would be recorded on the Company’s consolidated balance sheets in accordance with ASC 740, which established financial accounting and reporting standards for the effect of income taxes. The Company must assess the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes that recovery is not likely, the Company must establish a valuation allowance. Changes in the Company’s valuation allowance in a period are recorded through the income tax provision on the consolidated statements of operations. ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in an entity’s financial statements and prescribes a recognition threshold and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on a tax return. Under ASC 740-10, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, ASC 740-10 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As a result of the implementation of ASC 740-10, the Company recognized no material adjustment in the liability for unrecognized income tax benefits. BASIC AND DILUTED EARNINGS (LOSS) PER SHARE In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net income (loss) per share excludes the dilutive effect of stock options or warrants and convertible notes Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2021 and 2020, 26,655,760 and 33,655,760, respectively, dilutive shares were excluded from the calculation of diluted earnings (loss) per common share, as the effect of these shares on earnings per share would have been anti-dilutive; however, dilutive shares were included from the calculation of diluted income common shares for the year ended December 31, 2021. The following table shows the computation of basic and diluted earnings (loss) per share for the year ended December 31, 2021 and 2020: <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">The Years Ended</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">December 31,2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">December 31,2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px"><td style="vertical-align:top;">Numerator:</td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Net income (loss)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3,639,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,314,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Denominator:</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Weighted-average basic shares outstanding</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">559,281,064</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">558,322,048</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Effect of dilutive securities</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">34,729,262</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Weighted-average diluted shares</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">559,281,064</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">593,051,310</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Basic earnings (loss) per share</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(0.01</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.01</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Diluted earnings (loss) per share</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(0.01</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.01</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table>STOCK BASED COMPENSATION In June 2018, FASB issued ASU No. 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Nonemployee Share Based Payment Accounting. The amendments in this Update expand the scope of stock compensation to include share-based payment transactions for acquiring goods and services from nonemployees. The guidance in this Update does not apply to transactions involving equity instruments granted to a lender or investor that provides financing to the issuer. The guidance is effective for fiscal years beginning after December 31, 2018 including interim periods within the fiscal year. The Company adopted with an effective date of January 1, 2019. Upon adoption, there was no material impact to the financial statements. RECENT ACCOUNTING PRONOUNCEMENTS In August 2018, the FASB issued ASU 2018-13, Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement, which removes, modifies, and adds certain disclosure requirements related to fair value measurements in ASC Topic 820. This guidance is effective for public companies in fiscal years beginning after December 15, 2019, with early adoption permitted. Effective January 1, 2020, we adopted ASU 2018-13. The implementation of this standard did not have any material impact on our consolidated financial statements. In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. This amendment is effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company implemented on January 1, 2022 and the implementation of this standard did not have any material impact on our consolidated financial statements. The Company has evaluated all recent accounting pronouncements and none are expected to have a material impact on the condensed consolidated financial statements. BASIS OF CONSOLIDATION: The condensed consolidated financial statements include the accounts of Manhattan Scientific, Inc., and its wholly owned subsidiary Metallicum. All significant intercompany balances and transactions have been eliminated. GOING CONCERN: As of December 31, 2021, the Company has an accumulated deficit of 68,520,000 and negative working capital of $684,000. Because of these conditions, the Company will require additional working capital to develop business operations. The Company intends to raise additional working capital through the continued licensing of its technology as well as to generate revenues for other services. There are no assurances that the Company will be able to achieve the level of revenues adequate to generate sufficient cash flow from operations to support the Company’s working capital requirements. To the extent that funds generated are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available, the Company may not continue its operations. As of the filing date, the Coronavirus (“COVID-19”) has caused significant volatility in global markets, including the market price of our securities. The demand for our products and services has decreased and the ability of our customers to make payments for the products and services they purchased has been negatively impacted. These factors raise substantial doubt about the Company’s ability to continue within one year from the date of filing. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern. The ability to continue as a going concern is dependent on out generating cash from the sale of our common stock and/or obtaining debt financing and attaining future profitable operations. Management’s plan includes selling our equity securities and/or obtaining debt financing to fund our capital requirement and ongoing operations; however, there can be no assurance the Company will be successful in these efforts. -68520000 684000 USE OF ESTIMATES: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. A significant estimate includes the carrying value of the Company’s patents, fair value of the Company’s common stock, assumptions used in calculating the value of stock options, depreciation and amortization. CASH AND CASH EQUIVALENTS: The Company considers all highly liquid investments purchased with an original maturity of year or less at the time of purchase to be cash equivalents for the purposes of the statement of cash flows. CASH CONCENTRATION: The Company’s cash accounts are federally insured up to $250,000 for each financial institution we hold our accounts in. As of December 31, 2021 and December 31, 2020, we had cash balances of $-0- and $103,000 exceeding the federally insured limits. 250000 0 103000 PROPERTY AND EQUIPMENT: Property and equipment are recorded at cost. Expenditures for major additions and improvements are capitalized, and minor replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets, the useful lives range between 3-10 years, using the straight-line method for financial statement purposes. P3Y P10Y INTANGIBLE ASSETS: License Agreements In 2008, the Company obtained licenses to the rights of certain patents regarding nanostructured materials developed by another company as a result of the acquisition of Metallicum. The purchase price paid for these licenses was $305,000, which represented its fair value. The Company obtained an exclusive license on two patents and a non-exclusive license on the third patent. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years. At December 31, 2021 and December 31, 2020, the license agreements were fully amortized. Under the terms of the agreement, the Company may be required to pay royalties, as defined, to the licensors. In 2009, the Company entered into a patent license agreement with Los Alamos National Security LLC for the exclusive use of certain technology relating to the manufacture and application of nanostructuring metals and alloys. The purchase price paid for this license agreement was $33,000 based on the fair market value of 2,000,000 shares of common stock issued. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years. At December 31, 2021 and December 31, 2020, the license agreements were fully amortized. Beginning in 2010, the Company was required to pay an annual license fee of $10,000 and may be required to pay royalties, as defined, to the licensors. 305000 P10Y P10Y 10000 DUE FROM THE SALE OF ASSETS: Non-current assets are classified as held for sale if it is highly probably that they will be recovered primarily through sale rather than through continuing use. Immediately before classification as held for sale, the assets are remeasured at the lower of their carrying amount and fair value less costs to sell. Any impairment loss on initial classification as held for sale and subsequent gains and losses on re-measurement are recognized in profit or loss. Gains are not recognized in excess of any cumulative impairment loss. During the year ended December 31, 2019, the Company sold the assets held for sale that were presented on the balance sheet as of December 31, 2018. During the year ended December 31, 2018, the Company recorded impairment and adjusted the asset valuation to $1.2 million. The Company sold the assets for a total of $1.2 million of which $300,000 was received during the year ended December 31, 2019. The remaining $900,000 will be collected during the next three years in equal increments on the anniversary date of the agreement, May 1. During May 2020 and 2021, the Company received $300,000 and $300,000 respectively and reduced the due from the sale of assets. As of December 31, 2021, the Company evaluated the collectability and determined that no allowance is needed at this time due to the payment history with this third party and the subsequent receipt of funds. 1200000 1200000 300000 900000 300000 300000 MARKETABLE SECURITIES: The Company considers securities with original maturities of greater than 90 days to be available for sale securities. Securities under this classification are recorded at fair value and unrealized gains and losses within other income (loss). The estimated fair value of the available for sale securities is determined based on quoted market prices or rates for similar instruments. In addition, the cost of debt securities in this category is adjusted for amortization of premium and accretion of discount to maturity. For available for sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other income (loss). For the year ended December 31, 2021, no allowance was recorded for credit losses. REVENUE RECOGNITION: The Company recognizes revenue in accordance with generally accepted accounting principles as outlined in the Financial Accounting Standard Board’s (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue From Contracts with Customers, which consists of five steps to evaluating contracts with customers for revenue recognition: (i) identify the contract with the customer; (ii) identity the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price; and (v) recognize revenue when or as the entity satisfied a performance obligation. Revenue recognition occurs at the time we satisfy a performance obligation to our customers, when control transfers to customers, provided there are no material remaining performance obligations required of the Company or any matters of customer acceptance. We only record revenue when collectability is probable. FAIR VALUE OF FINANCIAL INSTRUMENTS: The Company recognized the fair value of financial instruments in accordance with FASB ASC 820, Fair Value Measurements and Disclosures, “Fair Value Measurements”, which provides a framework for measuring fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The standard also expands disclosures about instruments measured at fair value and establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: Level 1 — Quoted prices for identical assets and liabilities in active markets;Level 2 — Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; andLevel 3 — Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company designates cash equivalents (consisting of money market funds) and investments in securities of publicly traded companies as Level 1. The total amount of the Company’s investment classified as Level 3 is de minimis. Fair value of financial instruments: The carrying amounts of financial instruments, including cash and cash equivalents, short-term investments, accounts payable, accrued expenses and notes payables approximated fair value as of December 31, 2021 and December 31, 2020 because of the relative short term nature of these instruments. During the year ended December 31, 2017, the Company elected fair value option for its investment in Imagion Biosystems, Inc. a Nevada company (“Imagion”) based on triggering event of dilution of ownership, which lead to the deconsolidation of Imagion. Investments in Imagion are measured at fair value as opposed to equity method based on ASC 825-10. The guidance allows entities to elect to measure certain financial assets and financial liabilities (as well as certain nonfinancial instruments that are similar to financial instruments) at fair value. Investments over which an investor has the ability to exercise significant influence are eligible for the fair value option as they represent recognized financial assets. When the fair value option is elected for an instrument, all subsequent changes in fair value for that instrument are reported in earnings. As of December 31, 2021, the Company holds 52,516,508 shares of Imagion and is reported under fair value method under ASC 320. Any change in the value is reported on the income statement as an unrealized gain or loss on fair value adjustment of investments. Our financial assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2021 and 2020, consisted of the following: <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Total fair value at December 31, 2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Quoted prices in active markets for identical assets (Level1)</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Significant other observable inputs (Level 2)</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Significant unobservable inputs (Level 3)</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Investment in equity securities</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,901,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,901,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td colspan="2" style="BORDER-BOTTOM: 1px solid;">Total fair value at December 31, 2020</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td colspan="2" style="BORDER-BOTTOM: 1px solid;">Quoted prices in active markets for identical assets (Level1)</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td colspan="2" style="BORDER-BOTTOM: 1px solid;">Significant other observable inputs (Level 2)</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td colspan="2" style="BORDER-BOTTOM: 1px solid;">Significant unobservable inputs (Level 3)</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Investment in equity securities</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,875,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,875,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table> 52516508 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Total fair value at December 31, 2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Quoted prices in active markets for identical assets (Level1)</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Significant other observable inputs (Level 2)</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Significant unobservable inputs (Level 3)</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Investment in equity securities</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,901,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,901,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td colspan="2" style="BORDER-BOTTOM: 1px solid;">Total fair value at December 31, 2020</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td colspan="2" style="BORDER-BOTTOM: 1px solid;">Quoted prices in active markets for identical assets (Level1)</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td colspan="2" style="BORDER-BOTTOM: 1px solid;">Significant other observable inputs (Level 2)</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td colspan="2" style="BORDER-BOTTOM: 1px solid;">Significant unobservable inputs (Level 3)</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Investment in equity securities</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,875,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,875,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table> 2901000 2901000 0 0 5875000 5875000 0 0 INTELLECTUAL PROPERTY / RESEARCH AND DEVELOPMENT In June 2008, we acquired Metallicum and its licensed rights to patented technology. The technology is comprised of three US Patents (US Patent numbers 7152448, 6197129 and 6399215) for which Metallicum (subsequently, Manhattan) had been assigned an exclusive license rights by Los Alamos National Security LLC (LANL). Under the license rights, Metallicum had all rights, title and interest throughout the world in and to any and all inventions, original works of authorship, developments, concepts, know-how, and improvements on the patents or trade secrets whether or not patentable or registerable under copyright or similar laws. The purchase price paid for these licenses was $305,000, which represents its fair value. The Company obtained an exclusive license on two patents and a non-exclusive license on the third patent. The value attributable to license agreements is being amortized over the period of its estimated benefit period of 10 years. Our ability to compete depends in part on the protection of and our ability to defend our proprietary technology and on the goodwill associated with our trade names, service marks and other proprietary rights. However, we do not know if current laws will provide us with sufficient enough protection that others will not develop technologies similar or superior to ours, or that third parties will not copy or otherwise obtain or use our technologies without our authorization. The success of our business will depend, in part, to identify technology, obtain patents, protect and enforce patents once issued and operate without infringing on the proprietary rights of others. Our success will also depend on our ability to maintain exclusive rights to trade secrets and proprietary technology we own are currently developing and will develop. We can give no assurance that any issued patents will provide us with competitive advantages or will not be challenged by others, or that the patents of others will not restrict our ability to conduct business. In addition, we rely on certain technology licensed with a perpetual term from the Los Alamos National Laboratory and may be required to license additional technologies in the future. We do not know if these third-party licenses will be available or will continue to be available to us on acceptable commercial terms or at all. The inability to enter into and maintain any of these licenses could have a material adverse effect on our business, financial condition or results of our operations. Policing unauthorized use of our proprietary technology and other intellectual property rights could entail significant expense. In addition, we do not know if third parties will bring claims of copyright or trademark infringement against us or claim that our use of certain technologies violates a patent or other intellectual property. Any claims of infringement, with or without merit, could be time consuming and expensive to defend, result in costly litigation, divert management attention, require us to enter into costly royalty or licensing arrangements or prevent us from using important technologies or methods, any of which could have a material adverse effect on our business, financial condition or results of our operations. LEASES The Company leases a facility with terms of month to month for its headquarters. The Company adopted ASC 842 on January 1, 2019 and has evaluated that has no impact on the financial statements as under the practical expedient the leases consist of terms less than one year, and therefore is not required to capitalize the lease. During June 2019, the Company entered into an assignment and assumption of lease with the landlord and another entity for the lease term through April 2021. The average aggregate annual rent for this space is $30,360. 30360 INCOME TAXES The Company accounts for income taxes under an asset and liability approach. This process involves calculating the temporary and permanent differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The temporary differences result in deferred tax assets and liabilities, which would be recorded on the Company’s consolidated balance sheets in accordance with ASC 740, which established financial accounting and reporting standards for the effect of income taxes. The Company must assess the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes that recovery is not likely, the Company must establish a valuation allowance. Changes in the Company’s valuation allowance in a period are recorded through the income tax provision on the consolidated statements of operations. ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in an entity’s financial statements and prescribes a recognition threshold and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on a tax return. Under ASC 740-10, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, ASC 740-10 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As a result of the implementation of ASC 740-10, the Company recognized no material adjustment in the liability for unrecognized income tax benefits. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. BASIC AND DILUTED EARNINGS (LOSS) PER SHARE In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net income (loss) per share excludes the dilutive effect of stock options or warrants and convertible notes Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2021 and 2020, 26,655,760 and 33,655,760, respectively, dilutive shares were excluded from the calculation of diluted earnings (loss) per common share, as the effect of these shares on earnings per share would have been anti-dilutive; however, dilutive shares were included from the calculation of diluted income common shares for the year ended December 31, 2021. The following table shows the computation of basic and diluted earnings (loss) per share for the year ended December 31, 2021 and 2020: <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">The Years Ended</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">December 31,2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">December 31,2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px"><td style="vertical-align:top;">Numerator:</td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Net income (loss)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3,639,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,314,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Denominator:</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Weighted-average basic shares outstanding</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">559,281,064</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">558,322,048</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Effect of dilutive securities</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">34,729,262</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Weighted-average diluted shares</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">559,281,064</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">593,051,310</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Basic earnings (loss) per share</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(0.01</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.01</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Diluted earnings (loss) per share</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(0.01</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.01</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table> 26655760 33655760 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">The Years Ended</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">December 31,2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">December 31,2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px"><td style="vertical-align:top;">Numerator:</td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Net income (loss)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3,639,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,314,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Denominator:</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Weighted-average basic shares outstanding</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">559,281,064</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">558,322,048</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Effect of dilutive securities</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">34,729,262</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Weighted-average diluted shares</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">559,281,064</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">593,051,310</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Basic earnings (loss) per share</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(0.01</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.01</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Diluted earnings (loss) per share</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(0.01</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.01</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table> -3639000 4314000 559281064 558322048 34729262 559281064 593051310 -0.01 -0.01 STOCK BASED COMPENSATION In June 2018, FASB issued ASU No. 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Nonemployee Share Based Payment Accounting. The amendments in this Update expand the scope of stock compensation to include share-based payment transactions for acquiring goods and services from nonemployees. The guidance in this Update does not apply to transactions involving equity instruments granted to a lender or investor that provides financing to the issuer. The guidance is effective for fiscal years beginning after December 31, 2018 including interim periods within the fiscal year. The Company adopted with an effective date of January 1, 2019. Upon adoption, there was no material impact to the financial statements. RECENT ACCOUNTING PRONOUNCEMENTS In August 2018, the FASB issued ASU 2018-13, Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement, which removes, modifies, and adds certain disclosure requirements related to fair value measurements in ASC Topic 820. This guidance is effective for public companies in fiscal years beginning after December 15, 2019, with early adoption permitted. Effective January 1, 2020, we adopted ASU 2018-13. The implementation of this standard did not have any material impact on our consolidated financial statements. In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. This amendment is effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company implemented on January 1, 2022 and the implementation of this standard did not have any material impact on our consolidated financial statements. The Company has evaluated all recent accounting pronouncements and none are expected to have a material impact on the condensed consolidated financial statements. NOTE 3 – INVESTMENT IN IMAGION BIOSYSTEMS As of December 31, 2021, the Company owns 52,516,508 shares of Imagion, resulting in a noncontrolling interest of Imagion’s issued and outstanding common stock. Based upon Imagion’s trading price on December 31, 2021, approximately $0.05 per share, the fair value of the Imagion shares was approximately $2,901,000. During the year ended December 31, 2021, the Company recorded an unrealized loss in its investment of $2,974,000. Below is reconciliation for the changes to the investment in Imagion for the year ended December 31, 2021: <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Balance as of December 31, 2020</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,875,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Change in the unrealized fair value of securities</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2,974,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Balance as of December 31, 2021</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,901,000</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table> 52516508 0.05 2901000 2974000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Balance as of December 31, 2020</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,875,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Change in the unrealized fair value of securities</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2,974,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Balance as of December 31, 2021</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,901,000</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table> 5875000 -2974000 2901000 NOTE 4 – NOTES PAYABLE On October 17, 2019, The Company executed a secured note with a related party for $100,000. The secured note is due on October 17, 2022. The Company agreed that the note bears interest at 10% per annum, to be paid in advance in shares of Imagion Biosystems Limited common stock (IBX), calculated at $0.015 per share with 2 million shares of IBX common stock. The amortization of debt discount for the year ended December 31, 2021 was $17,000. On October 17, 2019, The Company executed a secured note with an individual for $50,000. The secured note is due on October 17, 2022. The Company agreed that the note bears interest at 10% per annum, to be paid in advance in shares of Imagion Biosystems Limited common stock (IBX), calculated at $0.015 per share with 1 million shares of IBX common stock. The amortization of debt discount for the year ended December 31, 2021 was $9,000. <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Notes payable</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Less: Discounts on notes payable</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(20,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Notes payable, net of discounts</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">130,000</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table> 100000 2022-10-17 0.10 0.015 2000000 17000 50000 2022-10-17 0.10 0.015 1000000 9000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Notes payable</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Less: Discounts on notes payable</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(20,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Notes payable, net of discounts</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">130,000</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table> 150000 -20000 130000 NOTE 5 – CAPTIAL TRANSACTIONS Preferred Stock The Company has a total of 1,000,000 shares of authorized preferred shares which are segregated into four classes of preferred stock. The Company has 182,525 authorized shares of convertible, redeemable, 10 percent cumulative, Class A, Preferred Stock with $0.001 par value. One Class A, Preferred share is convertible into 50 restricted common shares and will be entitled to the number of votes equal to the number of shares of common stock into which such holder’s shares of Series A Preferred stock could be converted at the time of the vote. Class A, Preferred Stock is redeemable by the Company at $15 per share. Upon liquidation the holders of Series A Preferred stock will be entitled to be paid out of the assets available for distribution of the corporation an amount equal to $10 per share, before any payment will be made to the common shareholders. As of December 31, 2021 and 2020, no shares of Preferred Stock were issued and outstanding. The Company has 250,000 authorized shares of Class B, Preferred Stock with $0.001 par value. As of December 31, 2021 and 2020, 49,999 and 49,999 shares of Preferred Stock were issued and outstanding, respectively. Class B preferred shares are convertible at a rate of 1 Series B preferred share to 10 common shares. The Company has 14,000 authorized shares of redeemable, convertible, Class C, Preferred Stock with $100 stated value. Class C, Preferred Stock is not entitled to receive dividends unless dividends are paid on common stock. Upon liquidation Class C, Preferred Stock shall be treated as if it were converted to common stock prior to liquidation. Class C, Preferred Stock is convertible at $100 divided by the 10 day average closing price of common stock. The Class C, Preferred Stock is redeemable by the Company at the stated value. As of December 31, 2021 and 2020, no shares of Preferred Stock were issued and outstanding. On November 5, 2013, the Company entered into a Conversion Agreement with Marvin Maslow (the “Holder”) pursuant to which the Company agreed to convert $1,057,608 of debt (the “Debt”), including principal and interest, currently owed to Holder into 105,761 shares of Series D Preferred Shares of the Company. The Debt had been outstanding since 2007. The above transactions were approved by the Board of Directors of the Company. The Series D Preferred Stock does not pay dividends and does not have a liquidation preference. The Holder of the Series D Preferred Stock will be entitled to 20 votes for each share of common stock that the Series D Preferred Stock are convertible into. The Series D Preferred Stock has a conversion price of $0.055 (the “Conversion Price”) and a stated value of $10.00 (the “Stated Value”) per share. Each share of Series D Preferred Stock is convertible, at the option of the Holder, into such number of shares of common stock of the Company as determined by dividing Stated Value by the Conversion Price. Holder may only convert the Series D Preferred Stock upon certain Convertible Promissory Notes, whether presently outstanding or to be issued, issued to three accredited investors (the “Note Investors”) in accordance with those certain Convertible Note Purchase Agreements between the Company and the Note Investors dated April 3, 2013, have either (i) been converted in full or in part by the Note Investors into shares of common stock of the Company, (ii) the Note Investors have sold or assigned all or a part of their Convertible Promissory Notes to third parties, or (iii) the Note Investors have been paid in full or in part. The Holder will only be permitted to convert such number of Series D Preferred Stock equal to the pro rata amount of the Convertible Promissory Notes converted, assigned or paid. In the event the Note Investors agree in writing that these restrictions may be terminated, then the Holder will be entitled to convert the Series D Preferred Stock at the Holder’s election and the above restrictions will be null and void. Additionally, Holder may not convert the Series D Preferred Stock until the ten day average daily trading volume is greater than $20,000. As of the date of this filing, this has not occurred yet.In the event the Holder terminates its consulting agreement or violates a non-compete covenant, then the Series D Preferred Shares shall be returned to the Company for cancellation and the Company shall be obligated on the Debt. As the Series D Preferred Stock is conditionally redeemable, the Company has recorded the Series D Preferred Stock as mezzanine equity in the accompanying consolidated balance sheet. The Company has 447,804 and 447,804 undesignated blank check preferred stock, $0.001 par value, authorized as of December 31, 2021 and 2020. The preferred shares are to be issued in such series and to have such rights, preferences, and designation as determine by the Board of Directors of the Company. Common Stock The Company has a total of 950,000,000 shares of authorized common shares. As of December 31, 2021 and 2020, 559,281,064 and 559,281,064 shares of common stock were issued and outstanding, respectively. During the year ended December 31, 2020, the Company reclassified $1,341,000 liabilities to equity as it became certain cash would not be paid to settle and equity would be issued. Stock Activity during 2021 and 2020 During the year ended December 31, 2021, the Company had not issued common stock. During the year ended December 31, 2020, the Company issued 1,500,000 shares of common stock for services valued at $24,000. The shares were valued based on the market price of the Company’s common shares of $0.016 on the grant date. Options On March 22, 2021, the Company entered into a settlement with a third party, which the Company granted 15,000,000 shares of common stock options to purchase 15,000,000 shares of common stock at an exercise price of $0.0154. The options price was based on the closing market price of common stock on October 1, 2020. The Settlement is for the Employment Agreement with a third party, dated January 12, 2015 to which the Company agreed to issued common shares. At December 31, 2021, the 26,500,000 outstanding options had an aggregate intrinsic value of $1,595,000. A summary of the Company’s stock option activity and related information is as follows: <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Number of Options</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Weighted Average Exercise Price</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Weighted Average Remaining Life</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Number of Options Exercisable</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Aggregate Intrinsic Value </td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Outstanding as of December 31, 2019</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">22,075,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.07</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.2</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">22,075,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Granted</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">500,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Exercised</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Expired</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3,575,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.07</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3,575,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Outstanding as of December 31, 2020</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">18,500,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.07</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.84</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">18,500,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Granted</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,000,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.02</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9.68</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,000,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,500</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Exercised</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Expired</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(7,000,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.07</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(7,000,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Outstanding as of December 31, 2021</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">26,500,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.04</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">6.06</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">26,500,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">15,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td></tr></tbody></table>Exercise prices and weighted-average contractual lives of 26,500,000 stock options outstanding as of December 31, 2021 are as follows: <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td colspan="2"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2"/><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;">Options Outstanding</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;">Options Exercisable</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;">Exercise Price</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;">Number Outstanding</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;">Weighted Average Remaining Contractual Life</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;">Weighted Average Exercise Price </td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;">Number Exercisable</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;">Weighted Average Exercise Price</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td style="width:14%;">0.02</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">15,500,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">8.80</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">0.02</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">15,500,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:13%;vertical-align:bottom;text-align:right;">0.02</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;white-space: nowrap;">$</td><td>0.05</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3,000,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.50</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.05</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3,000,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.05</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;white-space: nowrap;">$</td><td>0.06</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">5,000,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">4.35</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.06</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">5,000,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.06</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;white-space: nowrap;">$</td><td>0.14</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3,000,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.75</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.14</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3,000,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.14</td><td style="white-space: nowrap;"> </td></tr></tbody></table> The fair value for options granted were determined using the Black-Scholes option-pricing model. The Company did not recognize compensation expense during the year ended December 31, 2021. 1000000 182525 0.10 0.001 One Class A, Preferred share is convertible into 50 restricted common shares and will be entitled to the number of votes equal to the number of shares of common stock into which such holder’s shares of Series A Preferred stock could be converted at the time of the vote Class A, Preferred Stock is redeemable by the Company at $15 per share Upon liquidation the holders of Series A Preferred stock will be entitled to be paid out of the assets available for distribution of the corporation an amount equal to $10 per share, before any payment will be made to the common shareholders 250000 0.001 49999 49999 Class B preferred shares are convertible at a rate of 1 Series B preferred share to 10 common shares 14000 100 Upon liquidation Class C, Preferred Stock shall be treated as if it were converted to common stock prior to liquidation Class C, Preferred Stock is convertible at $100 divided by the 10 day average closing price of common stock 1057608 105761 The Holder of the Series D Preferred Stock will be entitled to 20 votes for each share of common stock that the Series D Preferred Stock are convertible into 0.055 Additionally, Holder may not convert the Series D Preferred Stock until the ten day average daily trading volume is greater than $20,000 447804 447804 0.001 950000000 559281064 559281064 1341000 1500000 24000 0.016 15000000 15000000 0.0154 26500000 1595000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Number of Options</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Weighted Average Exercise Price</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Weighted Average Remaining Life</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Number of Options Exercisable</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Aggregate Intrinsic Value </td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Outstanding as of December 31, 2019</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">22,075,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.07</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.2</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">22,075,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Granted</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">500,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Exercised</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Expired</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3,575,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.07</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3,575,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Outstanding as of December 31, 2020</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">18,500,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.07</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.84</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">18,500,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Granted</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,000,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.02</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9.68</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,000,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,500</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Exercised</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Expired</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(7,000,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.07</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(7,000,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Outstanding as of December 31, 2021</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">26,500,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.04</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">6.06</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">26,500,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">15,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td></tr></tbody></table> 22075000 0.07 P3Y2M12D 22075000 0 0 0 -3575000 0.07 -3575000 18500000 0.07 P2Y10M2D 18500000 15000000 0.02 P9Y8M4D 15000000 15500 -7000000 0.07 -7000000 26500000 0.04 P6Y21D 26500000 15000 26500000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td colspan="2"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2"/><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;">Options Outstanding</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;">Options Exercisable</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;">Exercise Price</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;">Number Outstanding</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;">Weighted Average Remaining Contractual Life</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;">Weighted Average Exercise Price </td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;">Number Exercisable</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;">Weighted Average Exercise Price</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td style="width:14%;">0.02</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">15,500,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">8.80</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">0.02</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">15,500,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:13%;vertical-align:bottom;text-align:right;">0.02</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;white-space: nowrap;">$</td><td>0.05</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3,000,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.50</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.05</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3,000,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.05</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;white-space: nowrap;">$</td><td>0.06</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">5,000,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">4.35</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.06</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">5,000,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.06</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;white-space: nowrap;">$</td><td>0.14</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3,000,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.75</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.14</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3,000,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.14</td><td style="white-space: nowrap;"> </td></tr></tbody></table> 15500000 P8Y9M18D 0.02 15500000 0.02 3000000 P3Y6M 0.05 3000000 0.05 5000000 P4Y4M6D 0.06 5000000 0.06 3000000 P2Y9M 0.14 3000000 0.14 NOTE 6 – INCOME TAXES The provision for income taxes on the statements of operations consists of $-0- and $-0- for the years ended December 31, 2021 and 2020, respectively. Deferred tax assets are comprised of the following at December 31: <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Net operating loss carryforward</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,704,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,630,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Temporary differences</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,988,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,988,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Less valuation allowance</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(19,692,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(19,618,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Deferred tax asset, net</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table> Deferred taxes arise from temporary differences in the recognition of certain expenses for tax and financial reporting purposes. At December 31, 2021 and 2020, management determined that realization of these benefits is not assured and has provided a valuation allowance for the entire amount of such benefits. At December 31, 2021 and 2020, net operating loss carryforwards were approximately $47,275,000 and $47,043,000, respectively, for federal tax purposes that expire at various dates through 2031 and for state tax purposes expire through 2025. Utilization of net operating loss carryforwards may be subject to substantial annual limitations due to the “change in ownership” provisions of the Internal Revenue Code of 1986, as amended, and similar state regulations. The annual limitation may result in the expiration of substantial net operating loss carryforwards before utilization. For December 31, 2021 and 2020, the provision for income taxes differs from the amount computed by applying the U.S. federal statutory tax rate (21% in 2021 and 2020) to income taxes as follows: <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Tax benefit computed at 21%</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Change in valuation allowance</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Change in carryovers and tax attributes</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"> </td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Income tax provision</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table> 0 0 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Net operating loss carryforward</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,704,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,630,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Temporary differences</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,988,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,988,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Less valuation allowance</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(19,692,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(19,618,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Deferred tax asset, net</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table> 12704000 12630000 6988000 6988000 -19692000 -19618000 0 0 47275000 47043000 through 2031 through 2025 0.21 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Tax benefit computed at 21%</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Change in valuation allowance</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Change in carryovers and tax attributes</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"> </td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Income tax provision</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table> 0 0 0 0 0 0 0 NOTE 7 – LICENSE AGREEMENT On May 1, 2019, the Company, entered into an agreement with a non-affiliated third party (“Third Party”), providing for an exclusive license by the Company of its ECAP technology to the Third Party for a term of 17 years unless terminated sooner, a sublicense by the Company to the Third Party of its rights under that certain Exclusive Field-of-Use Patent License Agreement dated January 5, 2009 entered with The Los Alamos National Laboratory for a term until the expiration of the last valid claim to expire of the patents pursuant to such agreement and the sale by the Company of ECAP-C machines to the Third party. As part of the above license agreements, the Company will receive royalty payments, including minimum payments, based on a percentage of the Third Party’s sales. Royalties will be 10% on gross sales of licensed dental products and average of 5% on all other sales of licensed products. During the years ended December 31, 2021 and 2020, the Company received $50,000 and $50,000, respectively, as a minimum royalty payment. 0.10 0.05 50000 50000 NOTE 8 – COMMITMENTS AND CONTINGENCIES Legal matter contingencies The Company believes, based on current knowledge and after consultation with counsel, that it is not currently party to any material pending proceedings, individually or in the aggregate, the resolution of which would have a material effect on the Company. Provisions for losses are established in accordance with ASC 450, “Contingencies” when warranted. Once established, such provisions are adjusted when there is more information available of when an event occurs requiring a change. NOTE 9 – RELATED PARTY TRANSACTIONS As of December 31, 2021 and December 31, 2020, the Company had accrued expenses to related parties of approximately $1,129,000 and $853,000. As of December 31, 2021, the amounts are due to the Company’s sole officer for compensation $276,000 and the chairman of the board for compensation of $786,000 and the members of the board of directors of $66,250. 1129000 853000 276000 786000 66250 NOTE 10 – SUBSEQUENT EVENTS In accordance with ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2021 to the date these financial statements were issued, and there were no other material subsequent events to disclose in these financial statements, except as noted. EXCEL 50 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 51 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 52 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 89 226 1 false 42 0 false 4 false false R1.htm 000001 - Document - Cover Sheet http://mahatten.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://mahatten.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://mahatten.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) Statements 5 false false R6.htm 000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://mahatten.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 000007 - Disclosure - BASIS OF PRESENTATION Sheet http://mahatten.com/role/BasisOfPresentation BASIS OF PRESENTATION Notes 7 false false R8.htm 000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS Sheet http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMatters SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS Notes 8 false false R9.htm 000009 - Disclosure - INVESTMENT IN IMAGION BIOSYSTEMS Sheet http://mahatten.com/role/InvestmentInImagionBiosystems INVESTMENT IN IMAGION BIOSYSTEMS Notes 9 false false R10.htm 000010 - Disclosure - NOTES PAYABLE Notes http://mahatten.com/role/NotesPayable NOTES PAYABLE Notes 10 false false R11.htm 000011 - Disclosure - CAPITAL TRANSACTIONS Sheet http://mahatten.com/role/CapitalTransactions CAPITAL TRANSACTIONS Notes 11 false false R12.htm 000012 - Disclosure - INCOME TAXES Sheet http://mahatten.com/role/IncomeTaxes INCOME TAXES Notes 12 false false R13.htm 000013 - Disclosure - LICENSE AGREEMENT Sheet http://mahatten.com/role/LicenseAgreement LICENSE AGREEMENT Notes 13 false false R14.htm 000014 - Disclosure - COMMITMENTS AND CONTIGENCIES Sheet http://mahatten.com/role/CommitmentsAndContigencies COMMITMENTS AND CONTIGENCIES Notes 14 false false R15.htm 000015 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://mahatten.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 15 false false R16.htm 000016 - Disclosure - SUBSEQUENT EVENTS Sheet http://mahatten.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 16 false false R17.htm 000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Policies) Sheet http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Policies) Policies 17 false false R18.htm 000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Tables) Sheet http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Tables) Tables http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMatters 18 false false R19.htm 000019 - Disclosure - INVESTMENT IN IMAGION BIOSYSTEMS (Tables) Sheet http://mahatten.com/role/InvestmentInImagionBiosystemsTables INVESTMENT IN IMAGION BIOSYSTEMS (Tables) Tables http://mahatten.com/role/InvestmentInImagionBiosystems 19 false false R20.htm 000020 - Disclosure - NOTES PAYABLE (Tables) Notes http://mahatten.com/role/NotesPayableTables NOTES PAYABLE (Tables) Tables http://mahatten.com/role/NotesPayable 20 false false R21.htm 000021 - Disclosure - CAPITAL TRANSACTIONS (Tables) Sheet http://mahatten.com/role/CapitalTransactionsTables CAPITAL TRANSACTIONS (Tables) Tables http://mahatten.com/role/CapitalTransactions 21 false false R22.htm 000022 - Disclosure - INCOME TAXES (Tables) Sheet http://mahatten.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://mahatten.com/role/IncomeTaxes 22 false false R23.htm 000023 - Disclosure - BASIS OF PRESENTATION (Details Narrative) Sheet http://mahatten.com/role/BasisOfPresentationDetailsNarrative BASIS OF PRESENTATION (Details Narrative) Details http://mahatten.com/role/BasisOfPresentation 23 false false R24.htm 000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details) Sheet http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details) Details http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersTables 24 false false R25.htm 000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details 1) Sheet http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details 1) Details http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersTables 25 false false R26.htm 000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details Narrative) Sheet http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details Narrative) Details http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersTables 26 false false R27.htm 000027 - Disclosure - INVESTMENT IN EQUITY SECURITIES (IMAGION BIOSYSTEMS) (Details) Sheet http://mahatten.com/role/InvestmentInEquitySecuritiesImagionBiosystemsDetails INVESTMENT IN EQUITY SECURITIES (IMAGION BIOSYSTEMS) (Details) Details 27 false false R28.htm 000028 - Disclosure - INVESTMENT IN IMAGION BIOSYSTEMS (Details Narrative) Sheet http://mahatten.com/role/InvestmentInImagionBiosystemsDetailsNarrative INVESTMENT IN IMAGION BIOSYSTEMS (Details Narrative) Details http://mahatten.com/role/InvestmentInImagionBiosystemsTables 28 false false R29.htm 000029 - Disclosure - NOTES PAYABLE (Details) Notes http://mahatten.com/role/NotesPayableDetails NOTES PAYABLE (Details) Details http://mahatten.com/role/NotesPayableTables 29 false false R30.htm 000030 - Disclosure - NOTES PAYABLE (Details Narrative) Notes http://mahatten.com/role/NotesPayableDetailsNarrative NOTES PAYABLE (Details Narrative) Details http://mahatten.com/role/NotesPayableTables 30 false false R31.htm 000031 - Disclosure - CAPITAL TRANSACTIONS (Details) Sheet http://mahatten.com/role/CapitalTransactionsDetails CAPITAL TRANSACTIONS (Details) Details http://mahatten.com/role/CapitalTransactionsTables 31 false false R32.htm 000032 - Disclosure - CAPITAL TRANSACTIONS (Details 1) Sheet http://mahatten.com/role/CapitalTransactionsDetails1 CAPITAL TRANSACTIONS (Details 1) Details http://mahatten.com/role/CapitalTransactionsTables 32 false false R33.htm 000033 - Disclosure - CAPITAL TRANSACTIONS (Details Narrative) Sheet http://mahatten.com/role/CapitalTransactionsDetailsNarrative CAPITAL TRANSACTIONS (Details Narrative) Details http://mahatten.com/role/CapitalTransactionsTables 33 false false R34.htm 000034 - Disclosure - INCOME TAXES (Details) Sheet http://mahatten.com/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://mahatten.com/role/IncomeTaxesTables 34 false false R35.htm 000035 - Disclosure - INCOME TAXES (Details 1) Sheet http://mahatten.com/role/IncomeTaxesDetails1 INCOME TAXES (Details 1) Details http://mahatten.com/role/IncomeTaxesTables 35 false false R36.htm 000036 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://mahatten.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://mahatten.com/role/IncomeTaxesTables 36 false false R37.htm 000037 - Disclosure - LICENSE AGREEMENT (Details Narrative) Sheet http://mahatten.com/role/LicenseAgreementDetailsNarrative LICENSE AGREEMENT (Details Narrative) Details http://mahatten.com/role/LicenseAgreement 37 false false R38.htm 000038 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://mahatten.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://mahatten.com/role/RelatedPartyTransactions 38 false false All Reports Book All Reports mhtx_10k.htm mhtx-20211231.xsd mhtx-20211231_cal.xml mhtx-20211231_def.xml mhtx-20211231_lab.xml mhtx-20211231_pre.xml mhtx_ex311.htm mhtx_ex321.htm mhtx_ex36.htm http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 56 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "mhtx_10k.htm": { "axisCustom": 0, "axisStandard": 12, "contextCount": 89, "dts": { "calculationLink": { "local": [ "mhtx-20211231_cal.xml" ] }, "definitionLink": { "local": [ "mhtx-20211231_def.xml" ] }, "inline": { "local": [ "mhtx_10k.htm" ] }, "labelLink": { "local": [ "mhtx-20211231_lab.xml" ] }, "presentationLink": { "local": [ "mhtx-20211231_pre.xml" ] }, "schema": { "local": [ "mhtx-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 336, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 39, "http://mahatten.com/20211231": 9, "http://xbrl.sec.gov/dei/2021q4": 6, "total": 54 }, "keyCustom": 62, "keyStandard": 164, "memberCustom": 33, "memberStandard": 9, "nsprefix": "mhtx", "nsuri": "http://mahatten.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://mahatten.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000010 - Disclosure - NOTES PAYABLE", "role": "http://mahatten.com/role/NotesPayable", "shortName": "NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000011 - Disclosure - CAPITAL TRANSACTIONS", "role": "http://mahatten.com/role/CapitalTransactions", "shortName": "CAPITAL TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000012 - Disclosure - INCOME TAXES", "role": "http://mahatten.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "mhtx:LicenseAgreementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000013 - Disclosure - LICENSE AGREEMENT", "role": "http://mahatten.com/role/LicenseAgreement", "shortName": "LICENSE AGREEMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "mhtx:LicenseAgreementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000014 - Disclosure - COMMITMENTS AND CONTIGENCIES", "role": "http://mahatten.com/role/CommitmentsAndContigencies", "shortName": "COMMITMENTS AND CONTIGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000015 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://mahatten.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000016 - Disclosure - SUBSEQUENT EVENTS", "role": "http://mahatten.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Policies)", "role": "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "mhtx:ScheduleOfFairValueMeasurementOfAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Tables)", "role": "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "mhtx:ScheduleOfFairValueMeasurementOfAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000019 - Disclosure - INVESTMENT IN IMAGION BIOSYSTEMS (Tables)", "role": "http://mahatten.com/role/InvestmentInImagionBiosystemsTables", "shortName": "INVESTMENT IN IMAGION BIOSYSTEMS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000002 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://mahatten.com/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "mhtx:ScheduleOfDebtDiscount", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000020 - Disclosure - NOTES PAYABLE (Tables)", "role": "http://mahatten.com/role/NotesPayableTables", "shortName": "NOTES PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "mhtx:ScheduleOfDebtDiscount", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000021 - Disclosure - CAPITAL TRANSACTIONS (Tables)", "role": "http://mahatten.com/role/CapitalTransactionsTables", "shortName": "CAPITAL TRANSACTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000022 - Disclosure - INCOME TAXES (Tables)", "role": "http://mahatten.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2008-06-01to2008-06-12_mhtx_MetallicumIncMember_mhtx_InTwoThousandEightMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000023 - Disclosure - BASIS OF PRESENTATION (Details Narrative)", "role": "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "shortName": "BASIS OF PRESENTATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2008-06-01to2008-06-12_mhtx_MetallicumIncMember_mhtx_InTwoThousandEightMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "mhtx:ScheduleOfFairValueMeasurementOfAssetsAndLiabilitiesTableTextBlock", "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Investments", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details)", "role": "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "mhtx:ScheduleOfFairValueMeasurementOfAssetsAndLiabilitiesTableTextBlock", "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31_mhtx_QuotedPricesInActiveMarketsForIdenticalAssetsMember_us-gaap_FairValueInputsLevel1Member", "decimals": "0", "lang": null, "name": "us-gaap:Investments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details 1)", "role": "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails1", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "p", "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "mhtx:CommonStockOwnedShare", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details Narrative)", "role": "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "mhtx:CommonStockOwnedShare", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "mhtx:BeginingBalance", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000027 - Disclosure - INVESTMENT IN EQUITY SECURITIES (IMAGION BIOSYSTEMS) (Details)", "role": "http://mahatten.com/role/InvestmentInEquitySecuritiesImagionBiosystemsDetails", "shortName": "INVESTMENT IN EQUITY SECURITIES (IMAGION BIOSYSTEMS) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "mhtx:BeginingBalance", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31_mhtx_ImagionBiosystemsIncMember", "decimals": "0", "first": true, "lang": null, "name": "mhtx:CommonStockOwnedShares", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000028 - Disclosure - INVESTMENT IN IMAGION BIOSYSTEMS (Details Narrative)", "role": "http://mahatten.com/role/InvestmentInImagionBiosystemsDetailsNarrative", "shortName": "INVESTMENT IN IMAGION BIOSYSTEMS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31_mhtx_ImagionBiosystemsIncMember", "decimals": "INF", "lang": null, "name": "mhtx:TradingPricePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "mhtx:ScheduleOfDebtDiscount", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000029 - Disclosure - NOTES PAYABLE (Details)", "role": "http://mahatten.com/role/NotesPayableDetails", "shortName": "NOTES PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "mhtx:ScheduleOfDebtDiscount", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "mhtx:PreferredStockUndesignatedShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfDebtDiscountPremium", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000030 - Disclosure - NOTES PAYABLE (Details Narrative)", "role": "http://mahatten.com/role/NotesPayableDetailsNarrative", "shortName": "NOTES PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2019-10-01to2019-10-17_mhtx_IndividualsMember", "decimals": "0", "lang": null, "name": "us-gaap:ProceedsFromSecuredNotesPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "mhtx:NumberOfOptionsOutstandingBeginningBalance", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000031 - Disclosure - CAPITAL TRANSACTIONS (Details)", "role": "http://mahatten.com/role/CapitalTransactionsDetails", "shortName": "CAPITAL TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "mhtx:NumberOfOptionsOutstandingBeginningBalance", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000032 - Disclosure - CAPITAL TRANSACTIONS (Details 1)", "role": "http://mahatten.com/role/CapitalTransactionsDetails1", "shortName": "CAPITAL TRANSACTIONS (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "mhtx:ExercisePricesAndWeightedaverageContractualLivesOfStockOptionsOutstandingTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31_mhtx_ExercisePriceRangeTwoMember", "decimals": "0", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "mhtx:ReclassificationOfLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000033 - Disclosure - CAPITAL TRANSACTIONS (Details Narrative)", "role": "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "shortName": "CAPITAL TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "mhtx:ReclassificationOfLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000034 - Disclosure - INCOME TAXES (Details)", "role": "http://mahatten.com/role/IncomeTaxesDetails", "shortName": "INCOME TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "mhtx:TaxBenefitComputedAt21", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000035 - Disclosure - INCOME TAXES (Details 1)", "role": "http://mahatten.com/role/IncomeTaxesDetails1", "shortName": "INCOME TAXES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "mhtx:TaxBenefitComputedAt21", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000036 - Disclosure - INCOME TAXES (Details Narrative)", "role": "http://mahatten.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "mhtx:LicenseAgreementTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RoyaltyExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000037 - Disclosure - LICENSE AGREEMENT (Details Narrative)", "role": "http://mahatten.com/role/LicenseAgreementDetailsNarrative", "shortName": "LICENSE AGREEMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "mhtx:LicenseAgreementTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RoyaltyExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedLiabilitiesCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000038 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "role": "http://mahatten.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2021-12-31_mhtx_SoleOfficerMember", "decimals": "0", "lang": null, "name": "us-gaap:AccruedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "role": "http://mahatten.com/role/ConsolidatedStatementsOfOperations", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2019-12-31_mhtx_PreferredStockSeriesBMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)", "role": "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "AsOf2019-12-31_mhtx_PreferredStockSeriesBMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "lang": null, "name": "mhtx:CommonStockIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000007 - Disclosure - BASIS OF PRESENTATION", "role": "http://mahatten.com/role/BasisOfPresentation", "shortName": "BASIS OF PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS", "role": "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMatters", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000009 - Disclosure - INVESTMENT IN IMAGION BIOSYSTEMS", "role": "http://mahatten.com/role/InvestmentInImagionBiosystems", "shortName": "INVESTMENT IN IMAGION BIOSYSTEMS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mhtx_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 42, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r428", "r429", "r430" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm Id" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r428", "r429", "r430" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r428", "r429", "r430" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r428", "r429", "r430" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line 2" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well Known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mahatten.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "mhtx_AdjustedAssetValuation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Adjusted asset valuation" } } }, "localname": "AdjustedAssetValuation", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mhtx_AggregateAnnualRent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate annual rent" } } }, "localname": "AggregateAnnualRent", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mhtx_AggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Aggregate intrinsic value" } } }, "localname": "AggregateIntrinsicValueAbstract", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "stringItemType" }, "mhtx_AggregateIntrinsicValueBeginning": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate intrinsic value, beginning" } } }, "localname": "AggregateIntrinsicValueBeginning", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "mhtx_AggregateIntrinsicValueGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate intrinsic value, granted" } } }, "localname": "AggregateIntrinsicValueGranted", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "mhtx_AggregateIntrinsicValueOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate intrinsic value, outstanding" } } }, "localname": "AggregateIntrinsicValueOutstanding", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "mhtx_AnnualLicenseFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Annual license fee" } } }, "localname": "AnnualLicenseFee", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mhtx_BeginingBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Balance as of December 31, 2020" } } }, "localname": "BeginingBalance", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/InvestmentInEquitySecuritiesImagionBiosystemsDetails" ], "xbrltype": "monetaryItemType" }, "mhtx_BoardOfDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Board of Director [Member]" } } }, "localname": "BoardOfDirectorMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_CashConcentration": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH CONCENTRATION" } } }, "localname": "CashConcentration", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "mhtx_ChairmanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chairman [Member]" } } }, "localname": "ChairmanMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_ChangeInCarryoversAndTaxAttributes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Change in carryovers and tax attributes" } } }, "localname": "ChangeInCarryoversAndTaxAttributes", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "mhtx_ChangeInTheUnrealizedFairValueOfSecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Change in the unrealized fair value of securities" } } }, "localname": "ChangeInTheUnrealizedFairValueOfSecurities", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/InvestmentInEquitySecuritiesImagionBiosystemsDetails" ], "xbrltype": "monetaryItemType" }, "mhtx_ChangeInUnrealizedGainInInvestment": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in unrealized gain in investment" } } }, "localname": "ChangeInUnrealizedGainInInvestment", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/InvestmentInImagionBiosystemsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "mhtx_ClassAConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class A Convertible Preferred Stock [Member]", "verboseLabel": "Class A Convertible Preferred Stock [Member]" } } }, "localname": "ClassAConvertiblePreferredStockMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets", "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical", "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "mhtx_ClassAPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class A Preferred Stock [Member]" } } }, "localname": "ClassAPreferredStockMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_ClassBConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class B Convertible Preferred Stock [Member]" } } }, "localname": "ClassBConvertiblePreferredStockMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets", "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "mhtx_ClassBPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class B Preferred Stock [Member]" } } }, "localname": "ClassBPreferredStockMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_ClassCPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class C Preferred Stock [Member]" } } }, "localname": "ClassCPreferredStockMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_ClassCRedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class C Redeemable Convertible Preferred Stock [Member]" } } }, "localname": "ClassCRedeemableConvertiblePreferredStockMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets", "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "mhtx_ClassDPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class D Preferred Stock [Member]" } } }, "localname": "ClassDPreferredStockMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_CommonShareValuedAtMarketPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Market price per share" } } }, "localname": "CommonShareValuedAtMarketPrice", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "mhtx_CommonStockIssuedForServices": { "auth_ref": [], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Common stock issued for services" } } }, "localname": "CommonStockIssuedForServices", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mhtx_CommonStockOwnedShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Common stock owned shares]", "verboseLabel": "Common stock owned shares" } } }, "localname": "CommonStockOwnedShare", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "sharesItemType" }, "mhtx_CommonStockOwnedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to", "label": "Common stock owned shares", "verboseLabel": "Common stock owned shares" } } }, "localname": "CommonStockOwnedShares", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "http://mahatten.com/role/InvestmentInImagionBiosystemsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "mhtx_CoversionAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Coversion Agreement [Member]" } } }, "localname": "CoversionAgreementMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_CumulativePreferredStockInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cumulative preferred stock interest rate" } } }, "localname": "CumulativePreferredStockInterestRate", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "mhtx_DueFromTheSaleOfAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DUE FROM THE SALE OF ASSETS" } } }, "localname": "DueFromTheSaleOfAssetsPolicyTextBlock", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "mhtx_EffectOfDilutiveSecurities": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effect of dilutive securities" } } }, "localname": "EffectOfDilutiveSecurities", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails1" ], "xbrltype": "sharesItemType" }, "mhtx_EndingBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Balance as of December 31, 2021" } } }, "localname": "EndingBalance", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/InvestmentInEquitySecuritiesImagionBiosystemsDetails" ], "xbrltype": "monetaryItemType" }, "mhtx_ExercisablePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercisable price" } } }, "localname": "ExercisablePrice", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "mhtx_ExercisePriceRangeSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price 0.02 [Member]" } } }, "localname": "ExercisePriceRangeSevenMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails1" ], "xbrltype": "domainItemType" }, "mhtx_ExercisePriceRangeSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price 0.14 [Member]" } } }, "localname": "ExercisePriceRangeSixMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails1" ], "xbrltype": "domainItemType" }, "mhtx_ExercisePriceRangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price 0.06 [Member]" } } }, "localname": "ExercisePriceRangeThreeMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails1" ], "xbrltype": "domainItemType" }, "mhtx_ExercisePriceRangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price 0.05 [Member]" } } }, "localname": "ExercisePriceRangeTwoMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails1" ], "xbrltype": "domainItemType" }, "mhtx_ExercisePricesAndWeightedaverageContractualLivesOfStockOptionsOutstandingTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise prices and weighted-average contractual lives of stock options outstanding" } } }, "localname": "ExercisePricesAndWeightedaverageContractualLivesOfStockOptionsOutstandingTableTextBlock", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsTables" ], "xbrltype": "textBlockItemType" }, "mhtx_FederalTaxPurposesExpire": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal net operating loss carryforwards expiration date" } } }, "localname": "FederalTaxPurposesExpire", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "mhtx_GainLossRelatedToLitigationSettlements": { "auth_ref": [], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Gain on settlement of legal fees]", "negatedLabel": "Gain on settlement of legal fees" } } }, "localname": "GainLossRelatedToLitigationSettlements", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mhtx_GainOnSaleOfInvestment": { "auth_ref": [], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings an", "label": "Gain (Loss) on fair value adjustment of investments" } } }, "localname": "GainOnSaleOfInvestment", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "mhtx_HolderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Holder [Member]" } } }, "localname": "HolderMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_ImagionBiosystemsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Imagion Biosystems, Inc. [Member]" } } }, "localname": "ImagionBiosystemsIncMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "http://mahatten.com/role/InvestmentInImagionBiosystemsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_InTwoThousandEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "In 2008 [Member]" } } }, "localname": "InTwoThousandEightMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_InTwoThousandNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "In 2009 [Member]" } } }, "localname": "InTwoThousandNineMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_IndividualsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Individuals [Member]" } } }, "localname": "IndividualsMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_IssuedAndOutstandingSharesNoncontrollingInterest": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issued and outstanding shares noncontrolling interest" } } }, "localname": "IssuedAndOutstandingSharesNoncontrollingInterest", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative" ], "xbrltype": "percentItemType" }, "mhtx_JuneTwoThousandNinteentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "June 2019 [Member]" } } }, "localname": "JuneTwoThousandNinteentMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_LessDiscountsOnNotesPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Less: Discounts on notes payable" } } }, "localname": "LessDiscountsOnNotesPayable", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "mhtx_LessValuationAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Less valuation allowance" } } }, "localname": "LessValuationAllowance", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "mhtx_LicenseAgreementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NOTE 7 - LICENSE AGREEMENT" } } }, "localname": "LicenseAgreementTextBlock", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/LicenseAgreement" ], "xbrltype": "textBlockItemType" }, "mhtx_LosAlamosNationalSecurityLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Los Alamos National Security LLC [Member]", "verboseLabel": "Los Alamos National Security LLC [Member]" } } }, "localname": "LosAlamosNationalSecurityLLCMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_LossGainOnFairValueAdjustmentOfInvestments": { "auth_ref": [], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Loss (Gain) on fair value adjustment of investments]", "negatedLabel": "Loss (Gain) on fair value adjustment of investments" } } }, "localname": "LossGainOnFairValueAdjustmentOfInvestments", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mhtx_MarketableSecuritiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MARKETABLE SECURITIES" } } }, "localname": "MarketableSecuritiesPolicyTextBlock", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "mhtx_MetallicumIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Metallicum, Inc [Member]" } } }, "localname": "MetallicumIncMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_NumberOfOptionsExercisableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Options Exercisable" } } }, "localname": "NumberOfOptionsExercisableAbstract", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "stringItemType" }, "mhtx_NumberOfOptionsExercisableOutstandingBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Options Exercisable,Outstanding Beginning Balance" } } }, "localname": "NumberOfOptionsExercisableOutstandingBeginningBalance", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "sharesItemType" }, "mhtx_NumberOfOptionsExercisableOutstandingEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Options Exercisable,Outstanding Ending Balance" } } }, "localname": "NumberOfOptionsExercisableOutstandingEndingBalance", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "sharesItemType" }, "mhtx_NumberOfOptionsOutstandingBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Options, Outstanding Beginning Balance" } } }, "localname": "NumberOfOptionsOutstandingBeginningBalance", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "sharesItemType" }, "mhtx_NumberOfOptionsOutstandingEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Options, Outstanding Ending Balance" } } }, "localname": "NumberOfOptionsOutstandingEndingBalance", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "sharesItemType" }, "mhtx_OptionToPurchaseCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Option to purchase common stock" } } }, "localname": "OptionToPurchaseCommonStock", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "mhtx_PatentLicenseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Patent license agreement [Member]", "verboseLabel": "Patent license agreement [Member]" } } }, "localname": "PatentLicenseAgreementMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_PreferredStockLiquidationPreferenceDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred stock liquidation preference description" } } }, "localname": "PreferredStockLiquidationPreferenceDescription", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "mhtx_PreferredStockSeriesBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock Series B" } } }, "localname": "PreferredStockSeriesBMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "mhtx_PreferredStockSeriesCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock Series C" } } }, "localname": "PreferredStockSeriesCMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "mhtx_PreferredStockUndesignatedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred stock, undesignated shares" } } }, "localname": "PreferredStockUndesignatedShares", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "mhtx_PricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Price per share" } } }, "localname": "PricePerShare", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "perShareItemType" }, "mhtx_QuotedPricesInActiveMarketsForIdenticalAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quoted prices in active markets for identical assets [Member]" } } }, "localname": "QuotedPricesInActiveMarketsForIdenticalAssetsMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails" ], "xbrltype": "domainItemType" }, "mhtx_ReclassificationOfLiabilitiesToEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Reclassification of liabilities to equity" } } }, "localname": "ReclassificationOfLiabilitiesToEquity", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mhtx_ReclassificationOfLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Reclassification of liability" } } }, "localname": "ReclassificationOfLiability", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mhtx_RelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party [Member]" } } }, "localname": "RelatedPartyMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_RemainingAmountOfAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Remaining amount of assets" } } }, "localname": "RemainingAmountOfAssets", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mhtx_RestrictedSharesRelatedToIssuedPromissoryNotesInterest": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted shares related to issued promissory notes interest" } } }, "localname": "RestrictedSharesRelatedToIssuedPromissoryNotesInterest", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "mhtx_RoyaltyPercentageOnDentalProducts": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Royalty percentage on dental products" } } }, "localname": "RoyaltyPercentageOnDentalProducts", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/LicenseAgreementDetailsNarrative" ], "xbrltype": "percentItemType" }, "mhtx_RoyaltyPercentageOnOtherLicensedProducts": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Royalty percentage on other licensed products" } } }, "localname": "RoyaltyPercentageOnOtherLicensedProducts", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/LicenseAgreementDetailsNarrative" ], "xbrltype": "percentItemType" }, "mhtx_SaleOfAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Sale of asset" } } }, "localname": "SaleOfAsset", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mhtx_ScheduleOfDebtDiscount": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of debt discount" } } }, "localname": "ScheduleOfDebtDiscount", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "mhtx_ScheduleOfFairValueMeasurementOfAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of fair value measurement of assets and liabilities" } } }, "localname": "ScheduleOfFairValueMeasurementOfAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersTables" ], "xbrltype": "textBlockItemType" }, "mhtx_SeriesDconvertiblepreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series D convertible preferred Stock [Member]" } } }, "localname": "SeriesDconvertiblepreferredStockMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "mhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Number of Options, Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationInPeriod", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "sharesItemType" }, "mhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Options Exercisable, Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredExercisableNumber", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "sharesItemType" }, "mhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Options Exercisable, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedExercisableNumber", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "sharesItemType" }, "mhtx_SharesIssuedInAdvanceForDebt": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares issued in advance for debt" } } }, "localname": "SharesIssuedInAdvanceForDebt", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "mhtx_SignificantOtherObservableInputsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant other observable inputs [Member]" } } }, "localname": "SignificantOtherObservableInputsMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails" ], "xbrltype": "domainItemType" }, "mhtx_SignificantUnobservableInputsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant unobservable inputs [Member]" } } }, "localname": "SignificantUnobservableInputsMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails" ], "xbrltype": "domainItemType" }, "mhtx_SoleOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sole Officer [Member]" } } }, "localname": "SoleOfficerMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_StateTaxPurposesExpire": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "State net operating loss carryforwards expiration date" } } }, "localname": "StateTaxPurposesExpire", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "mhtx_StockActivityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Activity [Member]" } } }, "localname": "StockActivityMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_TaxBenefitComputedAt21": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Tax benefit computed at 21%" } } }, "localname": "TaxBenefitComputedAt21", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "mhtx_TradingPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trading price per share" } } }, "localname": "TradingPricePerShare", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/InvestmentInImagionBiosystemsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "mhtx_UndesignatedBlankCheckMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Undesignated blank check [Member]" } } }, "localname": "UndesignatedBlankCheckMember", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mhtx_WeightedAverageExercisePriceBeginning": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, beginning" } } }, "localname": "WeightedAverageExercisePriceBeginning", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "perShareItemType" }, "mhtx_WeightedAverageExercisePriceExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, exercisable" } } }, "localname": "WeightedAverageExercisePriceExercisable", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails1" ], "xbrltype": "perShareItemType" }, "mhtx_WeightedAverageExercisePriceExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Expired" } } }, "localname": "WeightedAverageExercisePriceExpired", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "perShareItemType" }, "mhtx_WeightedAverageExercisePriceOutstandingEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, outstanding ending balance" } } }, "localname": "WeightedAverageExercisePriceOutstandingEndingBalance", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "perShareItemType" }, "mhtx_WeightedAverageLifeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Life" } } }, "localname": "WeightedAverageLifeAbstract", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "stringItemType" }, "mhtx_WeightedAverageLifeGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Life, Granted" } } }, "localname": "WeightedAverageLifeGranted", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "durationItemType" }, "mhtx_WeightedAverageLifeOutstandingBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Life, Outstanding Beginning Balance" } } }, "localname": "WeightedAverageLifeOutstandingBeginningBalance", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "durationItemType" }, "mhtx_WeightedAverageLifeOutstandingEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Life, Outstanding Ending Balance" } } }, "localname": "WeightedAverageLifeOutstandingEndingBalance", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "durationItemType" }, "mhtx_WorkingCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Working capital deficit" } } }, "localname": "WorkingCapital", "nsuri": "http://mahatten.com/20211231", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "srt_MaximumMember": { "auth_ref": [ "r187", "r214", "r245", "r246", "r347", "r348", "r349", "r350", "r351", "r352", "r371", "r410", "r411", "r423", "r424" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r187", "r214", "r245", "r246", "r347", "r348", "r349", "r350", "r351", "r352", "r371", "r410", "r411", "r423", "r424" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r187", "r214", "r235", "r245", "r246", "r347", "r348", "r349", "r350", "r351", "r352", "r371", "r410", "r411", "r423", "r424" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r187", "r214", "r235", "r245", "r246", "r347", "r348", "r349", "r350", "r351", "r352", "r371", "r410", "r411", "r423", "r424" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BASIS OF PRESENTATION (Details Narrative)" } } }, "localname": "AccountingChangesAndErrorCorrectionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccretionExpenseIncludingAssetRetirementObligationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVESTMENT IN IMAGION BIOSYSTEMS (Details Narrative)" } } }, "localname": "AccretionExpenseIncludingAssetRetirementObligationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r34" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses - related parties", "verboseLabel": "Accrued expenses - related parties" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets", "http://mahatten.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AcruedIncomeTaxesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details)" } } }, "localname": "AcruedIncomeTaxesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AdditionalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CAPITAL TRANSACTIONS (Details Narrative)" } } }, "localname": "AdditionalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r24", "r263", "r339" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in-capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r88", "r89", "r90", "r260", "r261", "r262", "r309" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income (loss) to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r57", "r67", "r198", "r326" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of debt discount", "verboseLabel": "Amortization of Debt Discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows", "http://mahatten.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r83", "r130", "r133", "r139", "r151", "r173", "r174", "r175", "r177", "r178", "r179", "r180", "r181", "r182", "r184", "r185", "r298", "r303", "r317", "r337", "r339", "r391", "r401" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets]", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r7", "r9", "r40", "r83", "r151", "r173", "r174", "r175", "r177", "r178", "r179", "r180", "r181", "r182", "r184", "r185", "r298", "r303", "r317", "r337", "r339" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets, Current]", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r248", "r259" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date Axis" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r248", "r259" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Common stock ,shares acquired" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CAPITAL TRANSACTIONS" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r3", "r87", "r125" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "NOTE 1 - BASIS OF PRESENTATION" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/BasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r4", "r29", "r69" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "periodEndLabel": "CASH, END OF PERIOD", "periodStartLabel": "CASH, BEGINNING OF PERIOD" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets", "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r13", "r70" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "CASH AND CASH EQUIVALENTS" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r63", "r318" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "[Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]", "totalLabel": "NET DECREASE IN CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash FDIC insured amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURES OF NONCASH INVESTING AND FINANCING ACTIVITIES:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r81", "r83", "r103", "r104", "r105", "r107", "r109", "r115", "r116", "r117", "r151", "r173", "r178", "r179", "r180", "r184", "r185", "r212", "r213", "r216", "r220", "r317", "r432" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/ConsolidatedBalanceSheets", "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical", "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTIGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r168", "r169", "r170", "r172", "r420" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "NOTE 8 - COMMITMENTS AND CONTIGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CommitmentsAndContigencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r88", "r89", "r309" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized", "verboseLabel": "Common Stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued", "verboseLabel": "Common Stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r22", "r227" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding", "verboseLabel": "Common Stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r22", "r339" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common, authorized 950,000,000 shares, 559,281,064 and 559,281,064 shares issued, and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r76", "r300" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "BASIS OF CONSOLIDATION" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConversionOfStockAmountConverted1": { "auth_ref": [ "r72", "r73", "r74" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Common stock converted amount" } } }, "localname": "ConversionOfStockAmountConverted1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertiblePreferredStockTermsOfConversion": { "auth_ref": [ "r20", "r21", "r228", "r230", "r231", "r232" ], "lang": { "en-us": { "role": { "documentation": "Description of conversion terms for preferred stock.", "label": "Convertible preferred stock terms of conversion" } } }, "localname": "ConvertiblePreferredStockTermsOfConversion", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r80", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r196", "r199", "r200", "r202", "r206" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "NOTE 4 - NOTES PAYABLE" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/NotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r186", "r203" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "[Debt Instrument, Convertible, Conversion Price]", "verboseLabel": "Conversion price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r36", "r197", "r327" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r37", "r187", "r314" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt due date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DeferredTaxAssetsNetCurrent": { "auth_ref": [ "r268", "r269", "r270", "r271", "r278" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards classified as current.", "label": "Deferred tax asset, net" } } }, "localname": "DeferredTaxAssetsNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r283", "r284" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carryforward" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r283", "r284" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Temporary differences" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r67", "r166" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromRelatedPartiesCurrent": { "auth_ref": [ "r5", "r14", "r23", "r86", "r176", "r178", "r179", "r183", "r184", "r185", "r333" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).", "label": "Due from the sale of assets - current portion" } } }, "localname": "DueFromRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromRelatedPartiesNoncurrent": { "auth_ref": [ "r30", "r86", "r176", "r178", "r179", "r183", "r184", "r185", "r333" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due after one year (or one business cycle).", "label": "Due from the sale of assets" } } }, "localname": "DueFromRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r53", "r93", "r94", "r95", "r96", "r97", "r101", "r103", "r107", "r108", "r109", "r112", "r113", "r310", "r311", "r395", "r408" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic income (loss) per common share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Basic earnings (loss) per share" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INCOME (LOSS) PER COMMON SHARE:", "verboseLabel": "Numerator:" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r53", "r93", "r94", "r95", "r96", "r97", "r103", "r107", "r108", "r109", "r112", "r113", "r310", "r311", "r395", "r408" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted income (loss) per common share", "verboseLabel": "Diluted earnings (loss) per share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r110", "r111" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "BASIC AND DILUTED EARNINGS (LOSS) PER SHARE" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r84", "r273", "r290" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Provision for income taxes, rates" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r47", "r48", "r49", "r88", "r89", "r90", "r92", "r98", "r100", "r114", "r153", "r227", "r233", "r260", "r261", "r262", "r286", "r287", "r309", "r319", "r320", "r321", "r322", "r323", "r324", "r412", "r413", "r414", "r441" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "NOTE 3 - INVESTMENT IN IMAGION BIOSYSTEMS" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/InvestmentInImagionBiosystems" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "Class of asset." } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r312", "r316" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Fair Value By Asset Class Axis" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r195", "r204", "r205", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r244", "r313", "r344", "r345", "r346" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r195", "r236", "r237", "r242", "r244", "r313", "r344" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r195", "r204", "r205", "r236", "r237", "r242", "r244", "r313", "r345" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r195", "r204", "r205", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r244", "r313", "r346" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "FAIR VALUE OF FINANCIAL INSTRUMENTS" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r195", "r204", "r205", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r244", "r344", "r345", "r346" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FederalDepositInsuranceCorporationPremiumExpense": { "auth_ref": [ "r396" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for Federal Deposit Insurance Corporation (FDIC) insurance.", "label": "Cash exceeding insured amount" } } }, "localname": "FederalDepositInsuranceCorporationPremiumExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r145", "r146", "r148", "r149", "r150", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r201", "r225", "r308", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r432", "r433", "r434", "r435", "r436", "r437", "r438" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument Axis" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Amortization period" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r171" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain on settlement of legal fees" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r55" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingCostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF OPERATIONS" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r84", "r274", "r276", "r281", "r288", "r291", "r293", "r294", "r295" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "NOTE 6 - INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": { "auth_ref": [ "r265", "r275" ], "lang": { "en-us": { "role": { "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.", "label": "Income Tax Examination, Likelihood of Unfavorable Settlement" } } }, "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r85", "r99", "r100", "r129", "r272", "r289", "r292", "r409" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income tax provision", "verboseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/IncomeTaxesDetails1", "http://mahatten.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r46", "r266", "r267", "r276", "r277", "r280", "r285" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r273" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Change in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r64", "r71" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income taxes paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r66" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "[Increase (Decrease) in Accounts Payable and Accrued Liabilities]", "verboseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": { "auth_ref": [ "r66" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Accounts payable and accrued expenses - related party" } } }, "localname": "IncreaseDecreaseInAccountsPayableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r66" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "[Increase (Decrease) in Prepaid Expense]", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r77", "r165", "r373", "r374", "r375", "r377" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "INTANGIBLE ASSETS" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r50", "r128", "r325", "r328", "r397" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "[Interest Expense]", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r71" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest paid" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtFairValue": { "auth_ref": [ "r417", "r418", "r419" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.", "label": "Fair value of investment" } } }, "localname": "InvestmentOwnedAtFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/InvestmentInImagionBiosystemsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Investments": { "auth_ref": [ "r406" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.", "label": "Investment in equity securities", "verboseLabel": "Investment in equity securities" } } }, "localname": "Investments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVESTMENT IN IMAGION BIOSYSTEMS" } } }, "localname": "InvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LICENSE AGREEMENT" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r33", "r83", "r134", "r151", "r173", "r174", "r175", "r178", "r179", "r180", "r181", "r182", "r184", "r185", "r299", "r303", "r304", "r317", "r337", "r338" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 21.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "[Liabilities]", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r28", "r83", "r151", "r317", "r339", "r393", "r404" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "[Liabilities and Equity]", "totalLabel": "TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r35", "r83", "r151", "r173", "r174", "r175", "r178", "r179", "r180", "r181", "r182", "r184", "r185", "r299", "r303", "r304", "r317", "r337", "r338", "r339" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "[Liabilities, Current]", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r10", "r11", "r12", "r18", "r19", "r83", "r151", "r173", "r174", "r175", "r178", "r179", "r180", "r181", "r182", "r184", "r185", "r299", "r303", "r304", "r317", "r337", "r338" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "[Liabilities, Noncurrent]", "totalLabel": "Total long-term liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term liabilities:" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r63" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r63" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "[Net Cash Provided by (Used in) Investing Activities]", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r63", "r65", "r68" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "[Net Cash Provided by (Used in) Operating Activities]", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r44", "r45", "r49", "r52", "r68", "r83", "r91", "r93", "r94", "r95", "r96", "r99", "r100", "r106", "r130", "r132", "r135", "r138", "r140", "r151", "r173", "r174", "r175", "r178", "r179", "r180", "r181", "r182", "r184", "r185", "r311", "r317", "r394", "r407" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://mahatten.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "[Net Income (Loss) Attributable to Parent]", "terseLabel": "Net income (loss)", "totalLabel": "NET INCOME (LOSS)", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows", "http://mahatten.com/role/ConsolidatedStatementsOfOperations", "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "RECENT ACCOUNTING PRONOUNCEMENTS" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r56" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "[Nonoperating Income (Expense)]", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r18", "r392", "r402" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Notes payable - related parties, net of discounts", "verboseLabel": "Notes payable, net of discounts" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets", "http://mahatten.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NOTES PAYABLE" } } }, "localname": "NotesPayableAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r32" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesNoncurrent": { "auth_ref": [ "r38", "r86", "r333" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).", "label": "[Notes Payable, Related Parties, Noncurrent]", "verboseLabel": "Notes payable - related parties, net of discounts" } } }, "localname": "NotesPayableRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingCostsAndExpenses": { "auth_ref": [], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.", "label": "[Operating Costs and Expenses]", "totalLabel": "Total operating costs and expenses" } } }, "localname": "OperatingCostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingCostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating costs:" } } }, "localname": "OperatingCostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r130", "r132", "r135", "r138", "r140" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "[Operating Income (Loss)]", "totalLabel": "Loss from operations before other income and expenses" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r282" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating loss carryforwards net" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BASIS OF PRESENTATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r17", "r390", "r400" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax": { "auth_ref": [ "r41", "r42", "r43", "r307" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).", "label": "Reclassification of liability to equity" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income and (expenses):" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r60" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "[Payments to Acquire Property, Plant, and Equipment]", "negatedLabel": "Purchase of fixed assets" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r248", "r259" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name Axis" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockConversionBasis": { "auth_ref": [ "r21", "r228" ], "lang": { "en-us": { "role": { "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.", "label": "Convertible preferred stock, terms of conversion feature" } } }, "localname": "PreferredStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r21", "r212" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Capital stock, shares par value", "verboseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockRedemptionPricePerShare": { "auth_ref": [ "r211", "r228", "r229" ], "lang": { "en-us": { "role": { "documentation": "The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer.", "label": "[Preferred Stock, Redemption Price Per Share]", "verboseLabel": "Conversion price" } } }, "localname": "PreferredStockRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockRedemptionTerms": { "auth_ref": [ "r211", "r228" ], "lang": { "en-us": { "role": { "documentation": "The redemption terms of preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity. The redemption features of this capital stock are solely within the control of the issuer.", "label": "Preferred stock redemption terms" } } }, "localname": "PreferredStockRedemptionTerms", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized", "verboseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r21", "r212" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued", "verboseLabel": "Preferred stock shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding", "verboseLabel": "Preferred stock shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r21", "r339" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred, authorized 1,000,000 and 447,804 shares undesignated, 0 and 0 shares issued, and outstanding, respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockVotingRights": { "auth_ref": [ "r21", "r228" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Voting rights, description" } } }, "localname": "PreferredStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r6", "r8", "r163", "r164" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.", "label": "Weighted average number diluted shares" } } }, "localname": "ProFormaWeightedAverageSharesOutstandingDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ProceedsFromSaleOfInvestmentProjects": { "auth_ref": [ "r59" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of investment projects held by an entity in hopes of getting a future return or interest from it.", "label": "Proceeds from sale of investments" } } }, "localname": "ProceedsFromSaleOfInvestmentProjects", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyHeldForSale": { "auth_ref": [ "r58" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth.", "label": "Proceeds from sale of assets held for sale", "verboseLabel": "Proceeds from sale of assets held for sale" } } }, "localname": "ProceedsFromSaleOfPropertyHeldForSale", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSecuredNotesPayable": { "auth_ref": [ "r61" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from borrowings supported by a written promise to pay an obligation that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).", "label": "Secured note" } } }, "localname": "ProceedsFromSecuredNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r44", "r45", "r49", "r62", "r83", "r91", "r99", "r100", "r130", "r132", "r135", "r138", "r140", "r151", "r173", "r174", "r175", "r178", "r179", "r180", "r181", "r182", "r184", "r185", "r297", "r301", "r302", "r305", "r306", "r311", "r317", "r398" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]", "verboseLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r15", "r16", "r167", "r339", "r399", "r405" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r31", "r167", "r421", "r422" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property and equipment useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INCOME TAXES (Tables)" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount": { "auth_ref": [ "r207", "r208", "r209", "r210" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of preferred shares (regardless of class), preferred partnership units (regardless of class), preferential membership interests, or any other form of preferred equity regardless of investee entity legal form.", "label": "Series D convertible preferred mandatory redeemable, authorized 105,761 shares, 105,761 and 105,761 shares issued and outstanding, respectively" } } }, "localname": "RedeemableNoncontrollingInterestEquityPreferredCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r243", "r332", "r333" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "http://mahatten.com/role/InvestmentInImagionBiosystemsDetailsNarrative", "http://mahatten.com/role/NotesPayableDetailsNarrative", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r243", "r332", "r333", "r334" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction Axis" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r243", "r332", "r334", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party Transactions By Related Party Axis" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "http://mahatten.com/role/InvestmentInImagionBiosystemsDetailsNarrative", "http://mahatten.com/role/NotesPayableDetailsNarrative", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r330", "r331", "r333", "r335", "r336" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "NOTE 9 - RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r264", "r372", "r425" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingCostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "RESEARCH AND DEVELOPMENT" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r25", "r233", "r263", "r339", "r403", "r415", "r416" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r88", "r89", "r90", "r92", "r98", "r100", "r153", "r260", "r261", "r262", "r286", "r287", "r309", "r412", "r414" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r78", "r79" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "REVENUE RECOGNITION" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r51", "r83", "r126", "r127", "r131", "r136", "r137", "r141", "r142", "r143", "r151", "r173", "r174", "r175", "r178", "r179", "r180", "r181", "r182", "r184", "r185", "r317", "r398" ], "calculation": { "http://mahatten.com/role/ConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RoyaltyExpense": { "auth_ref": [ "r54" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.", "label": "Minimum Royalty Payment" } } }, "localname": "RoyaltyExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/LicenseAgreementDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r279" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Summary of deferred tax assets" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of basic and diluted earnings (loss) per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Provision for income taxes differs from amount computed by applying U.S. federal statutory tax rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r251", "r254", "r255" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Summary of Company's stock option activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSubsequentEventsTextBlock": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, losses resulting from fire or flood, losses on receivables, significant realized and unrealized gains and losses that result from changes in quoted market prices of securities, declines in market prices of inventory, changes in authorized or issued debt (SEC), significant foreign exchange rate changes, substantial loans to insiders or affiliates, significant long-term investments, and substantial dividends not in the ordinary course of business.", "label": "NOTE 10 - SUBSEQUENT EVENTS" } } }, "localname": "ScheduleOfSubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).", "label": "Schedule of changes to the investment in Imagion" } } }, "localname": "ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/InvestmentInImagionBiosystemsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVESTMENT IN IMAGION BIOSYSTEMS (Tables)" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Stock options available for grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Number of Options Exercisable, Outstanding Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of Options, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r259" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value]", "verboseLabel": "Aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r252", "r259" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number]", "verboseLabel": "Number of Options, Outstanding Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails1", "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r247", "r249" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "[Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price]", "verboseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted Average Exercise Price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r248", "r250" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "STOCK-BASED COMPENSATION" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetails1" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "[Shares, Issued]", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermLeasesPolicyTextBlock": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy election for short-term lease to recognize lease payments on straight-line basis over lease term and variable lease payments as incurred.", "label": "LEASE" } } }, "localname": "ShortTermLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r75", "r87" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMatters" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r20", "r21", "r22", "r81", "r83", "r103", "r104", "r105", "r107", "r109", "r115", "r116", "r117", "r151", "r173", "r178", "r179", "r180", "r184", "r185", "r212", "r213", "r216", "r220", "r227", "r317", "r432" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/ConsolidatedBalanceSheets", "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical", "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r39", "r47", "r48", "r49", "r88", "r89", "r90", "r92", "r98", "r100", "r114", "r153", "r227", "r233", "r260", "r261", "r262", "r286", "r287", "r309", "r319", "r320", "r321", "r322", "r323", "r324", "r412", "r413", "r414", "r441" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "http://mahatten.com/role/CapitalTransactionsDetails1", "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/ConsolidatedBalanceSheets", "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical", "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit", "http://mahatten.com/role/InvestmentInImagionBiosystemsDetailsNarrative", "http://mahatten.com/role/NotesPayableDetailsNarrative", "http://mahatten.com/role/RelatedPartyTransactionsDetailsNarrative", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED BALANCE SHEETS" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r88", "r89", "r90", "r114", "r376" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative", "http://mahatten.com/role/CapitalTransactionsDetails1", "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/ConsolidatedBalanceSheets", "http://mahatten.com/role/ConsolidatedBalanceSheetsParenthetical", "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit", "http://mahatten.com/role/InvestmentInImagionBiosystemsDetailsNarrative", "http://mahatten.com/role/NotesPayableDetailsNarrative", "http://mahatten.com/role/RelatedPartyTransactionsDetailsNarrative", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Comman stock payable for services, shares", "verboseLabel": "Common stock issued for services, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Common stock shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/BasisOfPresentationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Comman stock payable for services, amount", "verboseLabel": "Common stock issued for service, value" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative", "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r21", "r22", "r227", "r233" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Fair value of common stock issued" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Stock Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r22", "r26", "r27", "r83", "r144", "r151", "r317", "r339" ], "calculation": { "http://mahatten.com/role/ConsolidatedBalanceSheets": { "order": 22.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "[Stockholders' Equity Attributable to Parent]", "periodEndLabel": "Balance, amount", "periodStartLabel": "Balance, amount", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets", "http://mahatten.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r82", "r213", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r226", "r233", "r234" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "NOTE 5 - CAPITAL TRANSACTIONS" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "GOING CONCERN" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalDeferredPurchasePrice": { "auth_ref": [ "r72", "r73", "r74" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral.", "label": "Licenses purchased price" } } }, "localname": "SupplementalDeferredPurchasePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r145", "r146", "r148", "r149", "r150", "r201", "r225", "r308", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r432", "r433", "r434", "r435", "r436", "r437", "r438" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/CapitalTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r118", "r119", "r120", "r121", "r122", "r123", "r124" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "USE OF ESTIMATES" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted-average diluted shares" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r102", "r109" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average number of common shares outstanding (Diluted)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Denominator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r101", "r109" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average number of common shares outstanding (Basic)", "verboseLabel": "Weighted-average basic shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://mahatten.com/role/ConsolidatedStatementsOfOperations", "http://mahatten.com/role/SummaryOfSignificantAccountingPoliciesAndRelatedMattersDetails1" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r125": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r152": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "http://asc.fasb.org/topic&trid=2196965" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r172": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=51888271" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r206": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(12)(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(16)(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "14", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "15", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21564-112644" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r234": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121825205&loc=d3e27249-109313" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31928-109318" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31958-109318" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r295": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.11)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123399704&loc=SL77918418-209957" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r336": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.23)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.14)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(h))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r426": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r427": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r428": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r429": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580" }, "r430": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r431": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r432": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r433": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r434": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r435": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r436": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r437": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r438": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r439": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r440": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r87": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" } }, "version": "2.1" } ZIP 57 0001477932-22-002079-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-22-002079-xbrl.zip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end

Cover - USD ($)	12 Months Ended
Cover - USD ($)	Dec. 31, 2021	Apr. 04, 2022	Jun. 30, 2021
Cover [Abstract]
Entity Registrant Name	MANHATTAN SCIENTIFICS, INC.
Entity Central Index Key	0001099132
Document Type	10-K
Amendment Flag	false
Entity Voluntary Filers	No
Current Fiscal Year End Date	--12-31
Entity Well Known Seasoned Issuer	No
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Dec. 31, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2021
Entity Common Stock Shares Outstanding		559,281,064
Entity Public Float			$ 13,139,946
Document Annual Report	true
Document Transition Report	false
Entity Incorporation State Country Code	DE
Entity Tax Identification Number	85-0460639
Entity Interactive Data Current	Yes
Entity File Number	000-28411
Entity Address Address Line 1	244 Fifth Avenue
Entity Address Address Line 2	Suite 2341
Entity Address City Or Town	New York
Entity Address State Or Province	NY
Entity Address Postal Zip Code	10001
City Area Code	212
Security 12b Title	Common Stock, $0.001 par value
Local Phone Number	541-2405
Auditor Name	Sadler, Gibb & Associates, LLC
Auditor Location	Draper, UT
Auditor Firm Id	3627

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 232,000	$ 353,000
Prepaid expenses	15,000	12,000
Due from the sale of assets - current portion	300,000	300,000
Total current assets	547,000	665,000
Investment in equity securities	2,901,000	5,875,000
Property and equipment, net	4,000	6,000
Due from the sale of assets	0	300,000
Other assets	2,000	2,000
Total assets	3,454,000	6,848,000
Current liabilities:
Accounts payable and accrued expenses	102,000	159,000
Accrued expenses - related parties	1,129,000	853,000
Notes payable - related parties, net of discounts	130,000	0
Total current liabilities	1,361,000	1,012,000
Long-term liabilities:
Notes payable - related parties, net of discounts	0	104,000
Total long-term liabilities	0	104,000
Total liabilities	1,361,000	1,116,000
Series D convertible preferred mandatory redeemable, authorized 105,761 shares, 105,761 and 105,761 shares issued and outstanding, respectively	1,058,000	1,058,000
STOCKHOLDERS' EQUITY
Preferred, authorized 1,000,000 and 447,804 shares undesignated, 0 and 0 shares issued, and outstanding, respectively	0	0
Common, authorized 950,000,000 shares, 559,281,064 and 559,281,064 shares issued, and outstanding, respectively	559,000	559,000
Additional paid-in-capital	68,996,000	68,996,000
Accumulated deficit	(68,520,000)	(64,881,000)
Total stockholders' equity	1,035,000	4,674,000
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY	3,454,000	6,848,000
Class A Convertible Preferred Stock [Member]
STOCKHOLDERS' EQUITY
Preferred, authorized 1,000,000 and 447,804 shares undesignated, 0 and 0 shares issued, and outstanding, respectively	0	0
Class B Convertible Preferred Stock [Member]
STOCKHOLDERS' EQUITY
Preferred, authorized 1,000,000 and 447,804 shares undesignated, 0 and 0 shares issued, and outstanding, respectively	0	0
Class C Redeemable Convertible Preferred Stock [Member]
STOCKHOLDERS' EQUITY
Preferred, authorized 1,000,000 and 447,804 shares undesignated, 0 and 0 shares issued, and outstanding, respectively	$ 0	$ 0

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
Capital stock, shares par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, undesignated shares	447,804	447,804
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	950,000,000	950,000,000
Common stock, shares issued	559,281,064	559,281,064
Common stock, shares outstanding	559,281,064	559,281,064
Class A Convertible Preferred Stock [Member]
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class B Convertible Preferred Stock [Member]
Preferred stock, shares authorized	250,000	250,000
Preferred stock, shares issued	49,999	49,999
Preferred stock, shares outstanding	49,999	49,999
Class C Redeemable Convertible Preferred Stock [Member]
Preferred stock, shares authorized	14,000	14,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series D convertible preferred Stock [Member]
Preferred stock, shares authorized	105,761	105,761
Preferred stock, shares issued	105,761	105,761
Preferred stock, shares outstanding	105,761	105,761

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	Dec. 31, 2021	Dec. 31, 2020
CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue	$ 50,000	$ 50,000
Operating costs:
General and administrative expenses	727,000	714,000
Research and development	10,000	11,000
Total operating costs and expenses	737,000	725,000
Loss from operations before other income and expenses	(687,000)	(675,000)
Other income and (expenses):
Gain (Loss) on fair value adjustment of investments	(2,974,000)	5,014,000
Gain on settlement of legal fees	48,000	0
Interest expense	(26,000)	(25,000)
Total other income (expense)	(2,952,000)	4,989,000
NET INCOME (LOSS)	$ (3,639,000)	$ 4,314,000
INCOME (LOSS) PER COMMON SHARE:
Weighted average number of common shares outstanding (Basic)	559,281,064	558,322,048
Basic income (loss) per common share	$ (0.01)	$ 0.01
Weighted average number of common shares outstanding (Diluted)	559,281,064	593,051,310
Diluted income (loss) per common share	$ (0.01)	$ 0.01

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Total	Preferred Stock Series B	Common Stock	Preferred Stock Series C	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)
Balance, shares at Dec. 31, 2019		49,999	557,781,064	14,000
Balance, amount at Dec. 31, 2019	$ (1,005,000)	$ 0	$ 558,000	$ 0	$ 67,632,000	$ (69,195,000)
Reclassification of liability to equity	1,341,000	0	$ 0	0	1,341,000	0
Comman stock payable for services, shares			1,500,000
Comman stock payable for services, amount	24,000	0	$ 1,000	0	23,000	0
Net income	4,314,000	$ 0	$ 0	$ 0	0	4,314,000
Balance, shares at Dec. 31, 2020		49,999	559,281,064	14,000
Balance, amount at Dec. 31, 2020	4,674,000	$ 0	$ 559,000	$ 0	68,996,000	(64,881,000)
Net income	(3,639,000)		$ 0		0	(3,639,000)
Balance, shares at Dec. 31, 2021		49,999	559,281,064	14,000
Balance, amount at Dec. 31, 2021	$ 1,035,000	$ 0	$ 559,000	$ 0	$ 68,996,000	$ (68,520,000)

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	Dec. 31, 2021	Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ (3,639,000)	$ 4,314,000
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Common stock issued for services	0	24,000
Depreciation and amortization	2,000	2,000
Loss (Gain) on fair value adjustment of investments	2,974,000	(5,014,000)
Gain on settlement of legal fees	48,000	0
Amortization of debt discount	26,000	26,000
Changes in:
Prepaid expenses	(3,000)	1,000
Accounts payable and accrued expenses	(105,000)	(10,250)
Accounts payable and accrued expenses - related party	276,000	269,250
Net cash used in operating activities	(421,000)	(388,000)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of fixed assets	0	(4,000)
Proceeds from sale of assets held for sale	300,000	300,000
Proceeds from sale of investments	0	184,000
Net cash provided by (used in) investing activities	300,000	480,000
CASH FLOWS FROM FINANCING ACTIVITIES:
Net cash provided by financing activities	0	0
NET DECREASE IN CASH	(121,000)	92,000
CASH, BEGINNING OF PERIOD	353,000	261,000
CASH, END OF PERIOD	232,000	353,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid	0	0
Income taxes paid	0	0
SUPPLEMENTAL DISCLOSURES OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Reclassification of liabilities to equity	$ 0	$ 1,341,000

BASIS OF PRESENTATION (Details Narrative) - shares		1 Months Ended
BASIS OF PRESENTATION (Details Narrative) - shares	Jun. 12, 2008	Jan. 31, 2009	Dec. 31, 2021
Metallicum, Inc [Member] \| In 2008 [Member]
Common stock ,shares acquired	15,000,000
Los Alamos National Security LLC [Member] \| Patent license agreement [Member]
Common stock shares issued		2,000,000
Imagion Biosystems, Inc. [Member]
Common stock owned shares			52,516,508
Issued and outstanding shares noncontrolling interest			5.00%
Restricted shares related to issued promissory notes interest			1,000,000

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Investment in equity securities	$ 2,901,000	$ 5,875,000
Quoted prices in active markets for identical assets [Member] \| Level 1 [Member]
Investment in equity securities	2,901,000	5,875,000
Significant other observable inputs [Member] \| Level 2 [Member]
Investment in equity securities	0	0
Significant unobservable inputs [Member] \| Level 3 [Member]
Investment in equity securities	$ 0	$ 0

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Numerator:
Net income (loss)	$ (3,639,000)	$ 4,314,000
Denominator:
Weighted-average basic shares outstanding	559,281,064	558,322,048
Effect of dilutive securities	0	34,729,262
Weighted-average diluted shares	559,281,064	593,051,310
Basic earnings (loss) per share	$ (0.01)	$ 0.01
Diluted earnings (loss) per share	$ (0.01)	$ 0.01

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details Narrative) - USD ($)	1 Months Ended		12 Months Ended
	May 31, 2020	Jun. 30, 2008	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2009
Common stock owned shares			52,516,508
Proceeds from sale of assets held for sale	$ 300,000		$ 300,000	$ 300,000	$ 300,000
Remaining amount of assets					900,000
Accumulated deficit			(68,520,000)	(64,881,000)
Working capital deficit			684,000
Cash FDIC insured amount			250,000
Cash exceeding insured amount			$ 0	$ 103,000
Adjusted asset valuation						$ 1,200,000
Sale of asset					1,200,000
Income Tax Examination, Likelihood of Unfavorable Settlement			An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.
Weighted average number diluted shares			26,655,760	33,655,760
Minimum [Member]
Property and equipment useful lives			3 years
Maximum [Member]
Property and equipment useful lives			10 years
In 2008 [Member] \| Metallicum, Inc [Member]
Licenses purchased price		$ 305,000	$ 35,000
Amortization period		10 years	10 years
June 2019 [Member]
Aggregate annual rent			$ 30,360
In 2009 [Member] \| Los Alamos National Security LLC [Member] \| Patent license agreement [Member]
Fair value of common stock issued					$ 300,000
Annual license fee							$ 10,000

INVESTMENT IN EQUITY SECURITIES (IMAGION BIOSYSTEMS) (Details)	12 Months Ended
	Dec. 31, 2021 USD ($)
INVESTMENT IN IMAGION BIOSYSTEMS
Balance as of December 31, 2020	$ 5,875,000
Change in the unrealized fair value of securities	(2,974,000)
Balance as of December 31, 2021	$ 2,901,000

INVESTMENT IN IMAGION BIOSYSTEMS (Details Narrative) - Imagion Biosystems, Inc. [Member]	Dec. 31, 2021 USD ($) $ / shares shares
Common stock owned shares	52,516,508
Trading price per share \| $ / shares	$ 0.05
Fair value of investment \| $	$ 2,901,000
Change in unrealized gain in investment	2,974,000

NOTES PAYABLE (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
NOTES PAYABLE
Notes payable	$ 150,000
Less: Discounts on notes payable	(20,000)
Notes payable, net of discounts	$ 130,000	$ 0

NOTES PAYABLE (Details Narrative) - USD ($) $ / shares in Units, shares in Millions	1 Months Ended	12 Months Ended
	Oct. 17, 2019	Dec. 31, 2021	Dec. 31, 2020
Amortization of Debt Discount		$ 26,000	$ 26,000
Individuals [Member]
Secured note	$ 50,000
Price per share	$ 0.015
Shares issued in advance for debt	1
Interest rate	10.00%
Amortization of Debt Discount	$ 9,000
Debt due date	Oct. 17, 2022
Related Party [Member]
Secured note	$ 100,000
Price per share	$ 0.015
Shares issued in advance for debt	2
Interest rate	10.00%
Amortization of Debt Discount	$ 17,000
Debt due date	Oct. 17, 2022

CAPITAL TRANSACTIONS (Details) - USD ($)	12 Months Ended
CAPITAL TRANSACTIONS (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
CAPITAL TRANSACTIONS
Number of Options, Outstanding Beginning Balance	18,500,000	22,075,000
Number of Options, Granted	15,000,000
Number of Options, Expired	(7,000,000)	(3,575,000)
Number of Options, Outstanding Ending Balance	26,500,000	18,500,000
Weighted Average Life
Weighted Average Life, Outstanding Beginning Balance	2 years 10 months 2 days	3 years 2 months 12 days
Weighted Average Life, Granted	9 years 8 months 4 days
Weighted Average Life, Outstanding Ending Balance	6 years 21 days	2 years 10 months 2 days
Weighted Average Exercise Price
Weighted Average Exercise Price, beginning	$ 0.07	$ 0.07
Weighted Average Exercise Price, Granted	0.02
Weighted Average Exercise Price, Expired	0.07	0.07
Weighted Average Exercise Price, outstanding ending balance	$ 0.04	$ 0.07
Number of Options Exercisable
Number of Options Exercisable,Outstanding Beginning Balance	18,500,000	22,075,000
Number of Options Exercisable, Granted	15,000,000	50,000
Number of Options Exercisable, Expired	(7,000,000)	(3,575,000)
Number of Options Exercisable,Outstanding Ending Balance	26,500,000	18,500,000
Aggregate intrinsic value
Aggregate intrinsic value, beginning	$ 15,500	$ 0
Aggregate intrinsic value, granted		0
Aggregate intrinsic value, outstanding	$ 15,000	$ 0

CAPITAL TRANSACTIONS (Details 1)	12 Months Ended
CAPITAL TRANSACTIONS (Details 1)	Dec. 31, 2021 $ / shares shares
Number of Options, Outstanding Beginning Balance	26,500,000
Exercise Price 0.05 [Member]
Number of Options, Outstanding Beginning Balance	3,000,000
Weighted Average Remaining Contractual Life	3 years 6 months
Weighted Average Exercise Price \| $ / shares	$ 0.05
Number of Options Exercisable, Outstanding Beginning Balance	3,000,000
Weighted Average Exercise Price, exercisable \| $ / shares	$ 0.05
Exercise Price 0.06 [Member]
Number of Options, Outstanding Beginning Balance	5,000,000
Weighted Average Remaining Contractual Life	4 years 4 months 6 days
Weighted Average Exercise Price \| $ / shares	$ 0.06
Number of Options Exercisable, Outstanding Beginning Balance	5,000,000
Weighted Average Exercise Price, exercisable \| $ / shares	$ 0.06
Exercise Price 0.14 [Member]
Number of Options, Outstanding Beginning Balance	3,000,000
Weighted Average Remaining Contractual Life	2 years 9 months
Weighted Average Exercise Price \| $ / shares	$ 0.14
Number of Options Exercisable, Outstanding Beginning Balance	3,000,000
Weighted Average Exercise Price, exercisable \| $ / shares	$ 0.14
Exercise Price 0.02 [Member]
Number of Options, Outstanding Beginning Balance	15,500,000
Weighted Average Remaining Contractual Life	8 years 9 months 18 days
Weighted Average Exercise Price \| $ / shares	$ 0.02
Number of Options Exercisable, Outstanding Beginning Balance	15,500,000
Weighted Average Exercise Price, exercisable \| $ / shares	$ 0.02

CAPITAL TRANSACTIONS (Details Narrative) - USD ($)		1 Months Ended	12 Months Ended
CAPITAL TRANSACTIONS (Details Narrative) - USD ($)	Nov. 05, 2013	Mar. 22, 2021	Dec. 31, 2021	Dec. 31, 2020
Reclassification of liability			$ 1,341,000
Common Stock, shares authorized			950,000,000	950,000,000
Common Stock, shares issued			559,281,064	559,281,064
Common Stock, shares outstanding			559,281,064	559,281,064
Preferred stock shares outstanding			0	0
Preferred stock shares issued			0	0
Preferred stock, shares authorized			1,000,000	1,000,000
Number of Options, Outstanding Beginning Balance			26,500,000
Aggregate intrinsic value			$ 1,595,000
Preferred stock, par value			$ 0.001	$ 0.001
Common stock issued for service, value				$ 24,000
Stock Option [Member]
Number of Options, Outstanding Beginning Balance			26,500,000
Exercisable price		$ 0.0154
Option to purchase common stock		15,000,000
Stock options available for grant		15,000,000
Stock Activity [Member]
Common stock issued for services, shares				1,500,000
Common stock issued for service, value				$ 24,000
Market price per share				$ 0.016
Class A Preferred Stock [Member]
Preferred stock, shares authorized			182,525	182,525
Preferred stock, par value			$ 0.001	$ 0.001
Cumulative preferred stock interest rate			10.00%	10.00%
Convertible preferred stock, terms of conversion feature			One Class A, Preferred share is convertible into 50 restricted common shares and will be entitled to the number of votes equal to the number of shares of common stock into which such holder’s shares of Series A Preferred stock could be converted at the time of the vote
Conversion price			$ 15
Preferred stock redemption terms			Class A, Preferred Stock is redeemable by the Company at $15 per share
Preferred stock liquidation preference description			Upon liquidation the holders of Series A Preferred stock will be entitled to be paid out of the assets available for distribution of the corporation an amount equal to $10 per share, before any payment will be made to the common shareholders
Class B Preferred Stock [Member]
Preferred stock shares outstanding			49,999	49,999
Preferred stock shares issued			49,999	49,999
Preferred stock, shares authorized			250,000	250,000
Preferred stock, par value			$ 0.001	$ 0.001
Convertible preferred stock, terms of conversion feature			Class B preferred shares are convertible at a rate of 1 Series B preferred share to 10 common shares
Class C Preferred Stock [Member]
Preferred stock shares outstanding			0	0
Preferred stock shares issued			0	0
Preferred stock, shares authorized			14,000	14,000
Preferred stock, par value			$ 100	$ 100
Convertible preferred stock, terms of conversion feature			Class C, Preferred Stock is convertible at $100 divided by the 10 day average closing price of common stock
Preferred stock liquidation preference description			Upon liquidation Class C, Preferred Stock shall be treated as if it were converted to common stock prior to liquidation
Undesignated blank check [Member]
Preferred stock, shares authorized			447,804	447,804
Preferred stock, par value			$ 0.001	$ 0.001
Coversion Agreement [Member] \| Holder [Member] \| Class D Preferred Stock [Member]
Preferred stock shares outstanding			105,761	105,761
Preferred stock shares issued			105,761	105,761
Preferred stock, par value			$ 10.00	$ 10.00
Common stock converted amount	$ 1,057,608
Conversion price			$ 0.055	$ 0.055
Voting rights, description			The Holder of the Series D Preferred Stock will be entitled to 20 votes for each share of common stock that the Series D Preferred Stock are convertible into
Convertible preferred stock terms of conversion			Additionally, Holder may not convert the Series D Preferred Stock until the ten day average daily trading volume is greater than $20,000

INCOME TAXES (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
INCOME TAXES
Net operating loss carryforward	$ 12,704,000	$ 12,630,000
Temporary differences	6,988,000	6,988,000
Less valuation allowance	(19,692,000)	(19,618,000)
Deferred tax asset, net	$ 0	$ 0

INCOME TAXES (Details 1) - USD ($)	12 Months Ended
INCOME TAXES (Details 1) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
INCOME TAXES
Tax benefit computed at 21%	$ 0	$ 0
Change in valuation allowance	0	0
Change in carryovers and tax attributes	0	0
Income tax provision	$ 0	$ 0

INCOME TAXES (Details Narrative) - USD ($)	12 Months Ended
INCOME TAXES (Details Narrative) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
INCOME TAXES
Provision for income taxes	$ 0	$ 0
Operating loss carryforwards net	$ 47,275,000	$ 47,043,000
Provision for income taxes, rates	21.00%	21.00%
Federal net operating loss carryforwards expiration date	through 2031
State net operating loss carryforwards expiration date	through 2025

LICENSE AGREEMENT (Details Narrative) - USD ($)	12 Months Ended
LICENSE AGREEMENT (Details Narrative) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
LICENSE AGREEMENT
Minimum Royalty Payment	$ 50,000	$ 50,000
Royalty percentage on dental products	10.00%
Royalty percentage on other licensed products	5.00%

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Accrued expenses - related parties	$ 1,129,000	$ 853,000
Sole Officer [Member]
Accrued expenses - related parties	276,000
Chairman [Member]
Accrued expenses - related parties	786,000
Board of Director [Member]
Accrued expenses - related parties	$ 66,250